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Abstract 
Background 
Acute diarrhea and acute respiratory tract infections (ARTIs) continue to lead the infectious 
cause of morbidity and mortality among children <5 years of age in developing countries, 
including Indonesia. Efforts to prevent diarrheal disease by probiotics and milk calcium 
supplementation as alternative strategy are promising. We investigated the efficacy of 
calcium with or without two probiotic strains, tested independently, on incidence and 
duration of acute diarrhea and ARTIs among Indonesian children. In addition, cumulative 
duration and severity of diarrhea due to rotavirus or other causes, growth, and iron and zinc 
status were tested. The associations of food-hygiene practices with diarrhea prevalence in 
children were also determined. 
Methods 
We conducted a 6-month, double-blind, placebo-controlled trial. A total of 494 Indonesian 
healthy children aged 1 to 6 years randomly received low-lactose milk with low calcium 
content (LC; ∼50 mg/day; n = 124), regular calcium content (RC; ∼440 mg/day; n = 126), 
RC with 5.108 colony-forming units per day of Lactobacillus casei CRL 431 (casei; n = 120), 
or RC with 5.108 colony-forming units per day of Lactobacillus reuteri DSM 17938 (reuteri; 
n = 124). Incidence and duration of diarrhea were the primary outcomes. Secondary 
outcomes were incidence and duration of ARTIs, severity of diarrhea (modified Vesikari 
score and fecal osmolarity, calprotection and mucin), growth, and iron and zinc status. The 
cross-sectional association between food-hygiene practices and 7-day record period of 
diarrhea prevalence was assessed among 274 randomly selected children aged 12-59 months 
in a low socioeconomic urban area of Jatinegara sub-district of East Jakarta, Indonesia. 
Results 
Incidence of World Health Organization-defined diarrhea (≥3 loose/liquid stools in 24 
hours) was not significantly different between RC and LC (relative risk 0.99; 95% confidence 
interval (CI): 0.62-1.58), between casei and RC (relative risk 1.21; 95% CI: 0.76-1.92), or 
between reuteri and RC (relative risk 0.76; 95% CI: 0.46-1.25) groups. Incidence of all 
reported diarrhea (≥2 loose/liquid stools in 24 hours) was significantly lower in the reuteri 
versus RC group (relative risk 0.68; 95% CI: 0.46-0.99). Irrespective of the definition used, 
reuteri significantly reduced diarrhea incidence in children with lower nutritional status 
(below-median height-and-weight-for-age z score). None of the interventions affected 
ARTIs. The mean total duration (131 children, 190 diarrheal episodes) was 1.35 days shorter 
in the reuteri group (relative risk 0.60; 95% CI: 0.36-0.99) in a 6-month period, likely by 
mainly affecting rotavirus-positive diarrhea. Rotavirus prevalence in diarrheal cases (30%) 
was not significantly different across the groups. None of the supplements affected diarrhea 
severity based on Vesikari score and fecal markers, except for a higher fecal mucin 
concentration in the casei group (P = .006). The increase in weight gain, weight-for-age z 
score (WAZ) changes and monthly weight and height velocities were significantly higher in 
the reuteri compared with RC group over 6 months period, whereas. L. casei, although giving 
less benefit, modestly improved weight velocity. Changes in underweight and stunting 
prevalence, anemia prevalence and iron and zinc status were similar among groups. No 
  
  
 
serious adverse events related to the interventions were reported. Children living in a house 
with clean sewage had a significantly lower diarrhea prevalence compared to those who did 
not have one or had dirty sewage (adjusted odds ratio 0.16; 95% CI: 0.03-0.73). The overall 
food-hygiene practice score was not significantly associated with diarrhea in the total group, 
but it was in children aged <2 years (adjusted odds ratio 4.55; 95% CI: 1.08-19.1). 
Conclusion 
L. reuteri may prevent diarrhea especially in children with lower nutritional status, reduce 
total duration of diarrheal episodes, and modestly improve growth over 6 months, but does 
not affect diarrhea severity. L. casei modestly improves monthly weight velocity, but does 
not reduce diarrhea incidence, duration or severity. However, it seems too early to 
recommend probiotics (e.g. L. reuteri) for routine use or for follow-up in public health 
programs to prevent diarrhea in children in developing countries. Milk calcium alone does 
not affect any of the outcomes. Moreover, none of the dietary treatments affect incidence and 
duration of ARTIs, and iron and zinc status in Indonesian children. In addition to other 
major determinants, poor mother’s food-hygiene practices contributes to the occurrence of 
diarrhea in Indonesian children <2 years.  
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Background 
Acute diarrhea and acute respiratory tract infections (ARTIs) continue to lead the infectious 
cause of morbidity and mortality among children <5 years of age in developing countries.1-3 
Despite the substantially declining mortality rate from diarrhea,4 the overall incidence of this 
disease in developing countries has remained high and relatively stable over the past two 
decades with an estimated 2.5 billion cases of diarrhea occurring among children in this age 
group each year.1 Whereas ARTIs represent 30-50% of the pediatric medical consultations 
and 20-40% of the hospitalizations in children.5 Similar to other developing countries,  
diarrhea contributes to 25% of mortality and 14% of morbidity,6 whereas ARTIs 
(pneumonia) contribute to 16% of mortality rate7 among younger children in Indonesia. 
Correspondingly, the prevalence of these diseases and malnutrition among children aged <5 
years in low socioeconomic urban communities in Indonesia remains high.8, 9   
Infection and malnutrition are interrelated.10 Diarrhea and other infections contribute to 
malnutrition, and malnutrition increases the susceptibility of children to infection, which 
constitutes to a vicious cycle.10, 11 Infection adversely impacts to malnutrition through a 
decreased nutritional intake, a diminished intestinal absorptive function of vital nutrients, 
and an increased catabolism and sequestration of nutrients required for tissue synthesis and 
growth12, 13 during the acute episode and recovery period. Malnutrition, in turn, decreases the 
ability of the immune system to fight against infections12 primarily because of disruption of 
epithelial integrity and inflammation,11 causing frequent or repeated infections. Multiple and 
recurrent infections further cause impaired intestinal absorptive function that lead to 
malnutrition.13 Furthermore, impaired innate and adaptive host immune responses and 
disrupted intestinal barrier function due to both infection and malnutrition together increase 
children’s susceptibility to repeated infections leading to intestinal injury and nutrient 
malabsorption during the critical stage of child development.11,13 Malnutrition contributes 
53% of childhood deaths14 and leads to poor health outcomes in childhood that persist into 
adulthood13  Therefore, strategies to increase resistance to infections and to break the cycle 
between diarrhea and malnutrition in this population are needed.   
Today, simple, safe, effective and yet relatively inexpensive preventive strategies including 
provision of safe water and sanitation, exclusive breastfeeding, hand washing with soap, 
vitamin A and zinc supplementation, and vaccinations are available in developing countries. 
These prevention strategies are important public health goals that will impact in reducing 
mortality and better growth and development of children in developing countries.15 
However,  these interventions are not always effective to reduce the burden of these 
diseases.3 Despite all these efforts, the morbidity from these diseases remains persistently 
high. The World Health Organization (WHO) identified the following reasons with respect to 
this problem: suboptimal access to and utilization of available services, lack of focus and 
coordination on preventive interventions,  lack of population-targeted interventions in age 
groups other than under-five, surveillance, research, monitoring and evaluation, and 
community mobilization and empowerment, and ineffective intersectoral coordination.3 In 
addition, these approaches do not adequately address broader growth and developmental 
processes that could yield long-term benefits.16 Moreover, no single intervention seems to be 
sufficient to eliminate the global burden of these diseases.16  
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Efforts to prevent diarrheal disease by dietary modulation of intestinal host defenses as 
alternative strategy are promising.17 These efforts include supplementation of probiotics and 
milk calcium. This chapter provides the state of the art and background information on the 
intervention strategy using probiotics and calcium supplementation as means to reduce 
incidence, duration and severity of diarrhea and respiratory infections among Indonesian 
children aged 1-6 years. In addition, the potential effects of milk supplemented with 
probiotics and calcium on growth, iron and zinc status are elaborated. Moreover, important 
food hygiene determinants associated with diarrhea are addressed. At the end of this 
chapter, a detailed rationale and aims of the thesis are presented. 
 
Effects of probiotics and calcium on incidence of diarrhea and 
respiratory tract infections 
Calcium 
A strictly-controlled human study reported that supplementation of healthy adults with 
calcium from milk increased resistance to foodborne enterotoxigenic Escherichia coli 
(ETEC) as it reduced infection-induced diarrhea.17 Several pre-clinical animal infection 
studies showed protective effects of calcium against Salmonella as well,18, 19 but verification 
in humans is missing. Unfortunately, and besides other micronutrient deficiencies, many 
Indonesian children <5 years have a low dietary calcium intake not meeting their age-
specific recommended daily allowances.20, 21  
 
Whether calcium, previously shown to reduce infection-induced diarrhea in 
adults, is equally effective in children with a low habitual calcium intake and 
frequent episodes of intestinal infections, is currently unknown. 
 
Probiotics 
There is a significant expansion of the probiotic market as well as concomitant research in 
the developed world,22 particularly in Japan and Europe.23, 24 However, it remains a scientific 
curiosity for clinicians, confusing to the general public, and a dilemma for policy makers 
whether probiotics should be used as a public health strategy to prevent diarrhea in 
developing countries.22 Accumulating evidence on probiotics efficacies in the treatment of 
diarrhea in developed countries has increased expectations of the food industry to expand 
their probiotics market to developing countries where infectious diarrhea risk is greater. 
However, this market expansion is not always supported by sound evidence obtained from 
well-designed RCTs in appropriate human target populations. Clearly, most previous studies 
on probiotics were mainly in hospital-based settings aiming at treatment of diarrhea in 
developed countries.25 So far, very limited published data is available to support that 
probiotics can be routinely recommended for prevention or reduction of infection in healthy 
children 1-6 years in developing countries.   
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a) Probiotics: Strain-specificity 
Probiotics are defined by the Food Agriculture Organization (FAO)/WHO in 2001 as “live 
microorganisms which when administered in adequate amounts confer a health benefit on 
the host”.26 Probiotics include a large number of species of microorganisms, especially 
Lactobacillus and Bifidobacterium.26 The clinical effects of probiotics are generally known as 
strain-specific. Strain-specific effects means that the probiotic effects in treatment or 
prevention, depend on the specific bacteria, which should be defined not only at the genus 
and species level, but also at  strain level.27  
b) Probiotics: Minimum dosage 
It is important to determine the minimum effective dose or the level of viable cells of the 
probiotic strain in Colony Forming Units (CFU)/day in the carrier food and optimal period 
of probiotic administration in demonstrating the general or specific health effects or 
wellbeing in the target population.26 However, information on minimum dose and optimal 
period of administration of probiotics remains unclear.28, 29 Likely, the minimum dose 
required for a probiotic effect may depend on the probiotic strain used28 and/or on the food 
matrix in which the probiotic is ingested.30 The minimum effective dose of ≥108 CFU/day has 
been recommended for therapeutic effects during the FAO/WHO consultation meeting in 
2001.31 The rationale of this recommendation is derived from some studies reporting a 
minimum effective dose for therapeutic cultures to be a daily intake of 106-109 viable CFU,32 
however, other studies showed that the minimum dose of strains such as L. rhamnosus GG 
to yield fecal recovery was 1010 CFU/day,33, 34 and L. johnsonii LJ1 to elicit immune effects 
was 109 CFU/day, whereas a dose of <108 CFU did not.35 The minimum dose of 109 CFU/day 
and consumption of 100 g or ml (a food containing at least 107 cells per gram or milliliter) 
was recommended for dairy products by the Japanese Fermented Milk and Lactic Acid 
Bacteria Beverages Association.28, 31, 36  
c) Probiotics: Clinical effects in pediatrics 
Numerous studies in pediatric populations have suggested a potential effect of probiotics in 
alleviating or preventing acute infectious diarrhea, antibiotic-associated diarrhea (AAD),  
necrotizing enterocolitis (NEC), allergic and atopic disease, inflammatory bowel disease 
(IBD), viral infections of the respiratory tract and dental caries.37 However, clear evidence of 
benefit was mainly seen in acute viral gastrointestinal tract infections and AAD.38  
d) Probiotics: Randomized trials on acute diarrhea and ARTIs 
Probiotics tested for use in the treatment and prevention of diarrhea in children are from the 
species of Lactobacillus rhamnosus, L. casei, L. reuteri, L. acidophilus, L. bulgaricus, 
Bifidobacterium lactis, B. breve, Streptococcus thermophiles, Enterococcus, E.  coli Nissle 
1917, and the yeast Saccharomyces boulardii.39  Among these probiotics, L. rhamnosus GG 
is the most extensively studied strain for the treatment of infectious diarrhea in children. 
Other probiotic strains, L. casei CRL 431 and L. reuteri  DSM 17938 are related to strains 
previously suggested to have anti-diarrheal benefits in young children.40-43 
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Several meta-analyses and reviews have concluded that probiotics may prevent or 
reduce duration of diarrhea in children. However, the beneficial effects are 
probiotic strain and dose dependent and evidence was obtained mainly in 
developed countries.44-47 Moreover, several randomized trials have explored 
benefits of probiotics in the prevention of ARTIs in children,15, 48-50 but have yielded 
contradictory conclusions.51-53 
 
 
 
So far, recommendations to supplement with calcium or probiotics in community 
settings in developing countries are not justified.46  
 
 
Effects of probiotics and calcium on duration and severity of 
diarrhea in Indonesian children   
Rotavirus is the leading cause of severe diarrhea-related hospitalization among children in 
both developed and developing countries.54, 55 It is estimated to cause >500,000 deaths 
annually in children under five, with 80% of these deaths occurring in developing 
countries.56 In Indonesia, it was estimated that 60% of hospital and 41% of outpatient clinic 
admissions of children for diarrhea were rotavirus-positive.57 Yet, bacterial infections are 
also an important cause of acute diarrhea in developing countries58 and may lead to severe 
disease.59  
Severity of diarrhea 
The pathophysiology, etiology, and clinical sequelae of acute diarrhea are well described.60, 61 
So far, there is limited information on severity of diarrhea and the impact of dietary 
interventions in clinical trials.60 Some studies assessed severity of gastroenteritis using a 
single indicator such as diarrheal stool output, diarrhea duration of >7 d, treatment failure, 
occurrence of dehydration, or death.62 Other studies scored symptoms of diarrhea using 
qualitative or semi-quantitative severity scales.63 
a) Clinical measurement of diarrhea severity: Vesikari score 
The most commonly used severity scale is the Vesikari 20-point scale in which an episode of 
gastroenteritis with a score of ≥11 is considered severe.63, 64 This scale has been adopted as 
validated on the basis of its frequent use in clinical trials, and can be used as a measure of 
diarrhea severity in young children.60 Despite being commonly used in cohort studies on 
diarrhea and rotavirus vaccines, the Vesikari scale has not been applied by any trial on 
probiotics in a community setting in a developing country. A very limited number of 
probiotic studies in developing countries used single measures to assess severity of diarrhea 
such as diarrhea duration, treatment failure, dehydration and stool output.65, 66 A modified 
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Vesikari score (18-points scale) was recently recommended to be used as a measure of 
diarrhea severity in outpatient clinical studies of young children.60  
b) Objective measurement of diarrhea severity: fecal markers 
During diarrhea, normal intestinal physiology is disturbed due to the presence and 
colonization of pathogens resulting in altered intestinal water absorption and secretion,67  
mucosal barrier permeability, mucosal host defense mechanisms and intestinal 
inflammation68-71 Currently, there is great interest in non-invasive, objective to measure 
markers to quantify intestinal infection severity and/or mucosal inflammation in large 
clinical studies. Candidates of such potential markers are fecal osmolarity, calprotectin and 
mucin.  
Diarrhea severity can be quantified by determination of fecal osmolarity. The most 
obvious characteristic of infectious diarrhea is an increased fecal water excretion due to 
reduced intestinal absorption or increased secretion of electrolytes,69 and thus an increased 
luminal presence of osmolytes attracting water.67   
Calprotectin is a calcium-binding protein with antimicrobial action,72 richly found in 
neutrophils in stool and body fluids.59 It is the most promising marker due to its resistance 
to proteolytic degradation and stability in stool.73 Levels in stool increase upon intestinal 
infection and other inflammatory diseases of the gastrointestinal tract.74-76  
Mucins are a family of heavily glycosylated proteins that are the major organic components 
of the mucus layer covering and protecting epithelial cells in many human organs, including 
the entire gastrointestinal tract.77, 78 Mucins are secreted as large aggregates by mucosal 
goblet cells79 and are crucial for intestinal mucus formation.80, 81 The mucus network is an 
indispensable part of gut barrier function as this viscous layer protects the delicate epithelial 
cells underneath from aggressive components in the fecal stream, including bacterial 
pathogens and their toxins.80 Fecal mucin excretion is enhanced upon intestinal infection 
and defects in mucus production leading to colonic inflammation.17, 82  
 
Probiotic studies on infectious, immune and inflammatory outcomes in humans 
are inconsistent, appear to be highly probiotic strain-dependent, and are mainly 
focused on rotavirus diarrhea in children.39, 44, 46, 83, 84 Dietary calcium improves 
intestinal resistance to infectious diarrhea due to Salmonella enteritidis18, 85 and 
enterotoxigenic E. coli (ETEC)17 in animal models. Dietary calcium also increases 
intestinal resistance to ETEC in a  human proof-of-principle infection study in 
adults.17 However, its effect on duration and severity of acute diarrheal disease due 
to rotavirus or other causes in children is unknown.  
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Effects of probiotics and calcium on growth and iron and zinc 
status in children 
Undernutrition and multiple micronutrients (MMNs) deficiencies persist as the most serious 
nutritional problems among children <5 years in developing countries.86-88 The Indonesian 
national prevalence of stunting (37%) and wasting (14%) is higher, and underweight (18%) is 
similar compared to the estimated overall prevalence of undernutrition among under-five 
children in the developing world.7, 89 Deficiencies in vitamin A, iron, zinc and iodine are most 
prevalent in Indonesian children.90, 91 Because intake of dairy products in these children is 
minimal during their growth period and dairy is an excellent source of calcium,92 calcium 
deficiency may also be prevalent.  
Studies reporting benefits of nutrition interventions on growth and micronutrient status of 
under-five children used different approaches of supplementation and fortified foods.88, 93-98 
Overall, the results of these studies are conflicting.99, 100  In addition, some studies indicated 
that nutrient-dense foods may help to prevent stunting and wasting in young children, but 
more data are needed to identify the impact of this approach.101-103 Probiotics are often 
supplemented to dairy foods and both probiotics45-47 and calcium in milk17 may strengthen 
intestinal infection resistance. However, the impact of probiotics on growth and 
micronutrient status is uncertain. In addition to a mice study with L. casei CRL 431,104, 105  
several human studies showed a positive effect of probiotics on weight gain in children aged 
5 months to 5 years.106-109 Two reviews reported that calcium supplementation in healthy 
children has no effect on weight, height, body fat, or lean mass in randomized clinical trials 
(RCTs).110, 111 However, such evidence in children in developing countries is scarce. 
Milk naturally rich in calcium and fortified with probiotics may provide extra energy, high 
quality protein and micronutrients, but less is known whether the combination of milk and 
probiotics may influence the absorption of iron and zinc. Probiotics are often used to improve 
digestibility and uptake of nutrients by intestinal cells112 and may be beneficial in 
malnutrition when gut function is impaired and epithelial cell functioning can be 
improved.113 Acute inhibitory effects of calcium on iron absorption in adults were shown in 
some studies,114-116 but not in others.117-119 Previous studies reported variable findings on the 
effects of milk or calcium supplementation on zinc absorption in adults.120 The possibility 
that calcium interferes with iron and zinc absorption and affects iron and zinc status in 
children is an important concern,121, 122 but very few studies were performed in a pediatric 
population. Previous studies were conducted mainly in developed countries involving 
children with adequate calcium and iron intake and showed contradictive results. An RCT in 
1-year old children showed that extra calcium resulted in a dose-related decrease in both 
heme and non-heme iron absorption.123 However, RCTs conducted in older children and 
adolescent girls found no effects of calcium supplementation on iron status and the inhibition 
of iron status may not persist after adaptation to an increased calcium diet.121, 124, 125  
Until now, evidence is inconclusive whether prolonged dietary supplementation 
with calcium and probiotics in children with low habitual calcium intake in 
developing countries like Indonesia, affects growth, and iron and zinc status.  
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Food-hygiene practices and diarrhea prevalence  
Morbidity and overall incidence of diarrhea among children in developing countries has 
remained high due to multiple determinants126 such as malnutrition,127 low socioeconomic 
status and education of mothers,128, 129 lack of safe drinking-water, inadequate sanitation and 
poor hygiene,130, 131 crowding,132 and low maternal age.133 These determinants of diarrheal 
disease are strongly linked to poverty and social inequities.3 Furthermore, diarrhea incidence  
differs greatly with the seasons and is highest in the first two years of life and declines as a 
child grows older.1  Diarrhea and malnutrition, alone or acting in concert, constitute major 
causes of morbidity and mortality among under-five children throughout the tropical world.1, 
127, 134 Many studies showed that prevalence of diarrhea was inversely associated with growth 
in both height-for-age Z-score (HAZ) and weight-for-age Z-score (WAZ).135-137  
Various studies conducted in urban settings of developing countries focused on the risk 
factors of diarrhea related to environmental conditions and utilization of sanitation 
facilities.138-140 A previous study on food-hygiene missed some important practices such as 
food storage, thorough cooking and adequate holding temperature141 as endorsed by 
WHO.142 Mothers and children in low socioeconomic urban areas in East Jakarta with 
limited hygiene and sanitation facilities tend to have poor hygiene practices such as using 
dirty cooking or eating utensils for their children.143 While poor hygiene practices, especially 
in food preparation and feeding, may increase the risk of having diarrhea, up to 70% of 
diarrhea episodes are actually caused by water and food contaminated with pathogens.144 
The prevalence and determinants of diarrhea, not only unsafe water, and poor sanitation and 
hygiene, but also poor food-hygiene practice among children in low socioeconomic urban 
areas of East Jakarta are important information to design any intervention study, health 
plans and policies related to mother and child hygienic behavior.  
 
Although the determinants of diarrhea in children are well described, information on 
the role of food-hygiene practice in the development of diarrhea and malnutrition 
among children in low socioeconomic urban community is generally lacking.141 
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Rationale, objectives and outline of the thesis 
Rationale  
As the overview above makes clear, important food-hygiene practices associated with 
diarrhea are not fully described. The effect of probiotics and calcium supplementation as 
alternative intervention to reduce incidence, duration and severity of diarrhea and 
respiratory infections among Indonesian children aged 1-6 years are very relevant to be 
investigated. Also, the potential effects of calcium in milk and probiotics supplementation on 
growth, iron and zinc status need to be further elucidated. The rationale of the studies in this 
thesis are presented below: 
Whether calcium, previously shown to reduce infection-induced diarrhea in adults, is 
equally effective in children with a low habitual calcium intake and frequent episodes of 
intestinal infections, is currently unknown.  
Several meta-analyses and reviews have concluded that probiotics may prevent or reduce 
duration of diarrhea in children. However, the beneficial effects are probiotic strain and 
dose dependent and evidence was obtained mainly in developed countries. Moreover, 
several studies have explored benefits of probiotics in the prevention of ARTIs in children. 
So far, recommendations to supplement with calcium or probiotics in community settings 
in developing countries are not justified. 
Probiotic studies on infectious, immune and inflammatory outcomes in humans are 
inconsistent, appear to be highly probiotic strain-dependent, and are mainly focused on 
rotavirus diarrhea in children. A Cochrane systematic review concluded that probiotics 
reduced diarrhea duration in infants and children by 29.2 hours in clinical settings, but 
probiotic effects on diarrhea duration and severity have not been evaluated in community 
settings.  
Calcium increases intestinal resistance to enterotoxigenic E. coli in adults, but an effect on 
diarrhea duration and severity due to rotavirus or other causes in children is unknown.  
Until now, evidence is inconclusive whether prolonged dietary supplementation with 
calcium and probiotics in children with low habitual calcium intakes in developing 
countries like Indonesia, affects growth, and iron and zinc status.  
Although the determinants of diarrhea in children are well described, information on the 
role of food-hygiene practice in the development of diarrhea and malnutrition among 
children in low socioeconomic urban community is generally lacking.  
Objectives and outline of thesis 
The above mentioned rationale provides us valuable objectives to be studied in this thesis:  
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(1) Do probiotics and calcium supplementation affect incidence and duration of diarrhea and 
ARTIs, severity of diarrhea as well as growth, iron and zinc status in Indonesian children? 
Answers to this question will provide recommendations for nutritional intervention 
strategies to prevent diarrhea and ARTIs. Moreover, it may show medical professionals, 
public health and food policy makers how to improve growth, iron and zinc status.   
(2) What is the role of poor food-hygiene practices as determinants of diarrhea among 
children in low socioeconomic urban areas of East Jakarta? The answer to this question will 
provide important information to design intervention studies, health plans and policies 
related to mother and child hygienic behavior.  
The specific research questions and objectives addressed in this thesis are: 
What are the effects of an intervention using probiotics and calcium on reducing the 
incidence and duration of diarrhea and respiratory infections?  
In chapter 2, we investigated the efficacy of dietary calcium with or without two probiotic 
strains, L. casei CRL 431 and L. reuteri DSM 17938 tested independently, on incidence and 
duration of acute diarrhea and ARTIs during 6 months of intervention among children aged 
1-6 years living in low socioeconomic urban area of East Jakarta, Indonesia.  
What are the effects of probiotics and calcium on diarrhea duration and severity in 
Indonesian children? 
In chapter 3, we investigated the efficacy of dietary calcium with or without two probiotic 
strains on duration and severity of acute diarrheal disease due to rotavirus or other causes. 
Severity of diarrhea was assessed by the Vesikari score based on the mothers’ subjective 
information and by objective measurement of the markers osmolarity, mucin and 
calprotection in diarrheal and normal fecal samples collected during the intervention. 
 
What are the potential effects of probiotics and calcium on growth and iron and zinc status 
in children? 
In chapter 4, we investigated the hypothesis that milk supplemented with probiotics would 
improve growth, and iron and zinc status, whereas milk calcium alone would improve 
growth, but reduce iron and zinc status of Indonesian children.  
 
What is the association between food-hygiene practices and diarrhea prevalence in 
Indonesian young children from low socioeconomic urban areas? 
In chapter 5, we determined the prevalence of diarrhea and malnutrition in Indonesian 
children and assessed the association of food-hygiene practice with the occurrence of 
diarrheal disease among under-five children living in selected low socioeconomic urban area 
in Jatinegara sub-districts of East Jakarta.  
 
Finally, chapter 6 presents the summary of the main findings and discusses the clinical 
effects of the interventions, public health implications and recommendations, and directions 
for future research.  
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Study location in Indonesia 
The field work described in this thesis was conducted in urban communities representing 
flooding (Kampung Melayu village) and non-flooding area (Rawabunga village) of Jatinegara 
sub district, East Jakarta, Indonesia (Figure 1.1). These areas were selected because of their 
high population density, low socioeconomic status, and high prevalence of diarrhea and 
underweight in under-five children.145, 146  
Jakarta is the capital city of Indonesia and is located in the western part of Java Island, 
which consists of five municipalities (eg. East Jakarta). Jatinegara is one of the sub districts 
in East Jakarta and is located at low land 0-10 m above sea level, as most of other Jakarta 
area. It has a tropical climate with two distinctive seasons: a rainy season (December-April) 
and a dry season (May-November).147 This sub district is prone to flooding because of three 
rivers crossing this area together.147  Ciliwung river is one of the major rivers which used to 
be the source for water supply in this area of Jakarta. Although floods in Jakarta peak in 
January and February,148 floods in Kampung Melayu village can be lasting between  
November and March almost every year. The population registered in this sub-district in 
2002 was 262,699 with approximately 72,166 households living in an area of 10.6 km2.147  
Figure 1.1 Map of study location in East Jakarta 
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Abstract 
Objective 
To investigate the effects of calcium and probiotics on the incidence and duration of 
acute diarrhea and acute respiratory tract infections (ARTIs) in low-socioeconomic 
communities of Jakarta, Indonesia. 
Methods 
We conducted a 6-month, double-blind, placebo-controlled study in 494 healthy 
children aged 1 to 6 years who received low-lactose milk with low calcium content (LC; 
∼50 mg/day; n = 124), regular calcium content (RC; ∼440 mg/day; n = 126), RC with 
5.108 colony-forming units per day of Lactobacillus casei CRL 431 (casei; n = 120), or 
RC with 5.108 colony-forming units per day of Lactobacillus reuteri DSM 17938 
(reuteri; n = 124). Number and duration of diarrhea and ARTIs episodes were primary 
and secondary outcomes, respectively. 
Results 
Incidence of World Health Organization–defined diarrhea (≥3 loose/liquid stools in 24 
hours) was not significantly different between RC and LC (relative risk [RR]: 0.99 [95% 
confidence interval (CI): 0.62–1.58]), between casei and RC (RR: 1.21 [95% CI: 0.76–
1.92]), or between reuteri and RC (RR: 0.76 [95% CI: 0.46–1.25]) groups. Incidence of 
all reported diarrhea (≥2 loose/liquid stools in 24 hours) was significantly lower in the 
reuteri versus RC group (RR: 0.68 [95% CI: 0.46–0.99]). Irrespective of the definition 
used, reuteri significantly reduced diarrhea incidence in children with lower nutritional 
status (below-median height-and-weight-for-age z score). None of the interventions 
affected ARTIs. 
Conclusions 
RC milk, alone or with L. casei, did not reduce diarrhea or ARTIs in Indonesian 
children. L. reuteri may prevent diarrhea, especially in children with lower nutritional 
status.  
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Introduction 
Acute diarrhea and respiratory tract infections (ARTIs) continue to lead the infectious cause 
of morbidity and mortality among children <5 years in developing countries.1-3 In Indonesia, 
diarrhea and ARTIs (pneumonia) contribute to 25% and 16% of mortality rate among young 
children, respectively.4  Moreover, the prevalence of these diseases and malnutrition among 
children aged <5 years in low socioeconomic urban communities in Indonesia remained 
high.5, 6 Infection and malnutrition are interrelated,7 and strategies to increase resistance to 
infections in this population are needed.  
Preventive strategies (including provision of safe water and sanitation, exclusive 
breastfeeding, hand washing, vitamin A and zinc supplementation, and vaccinations) are 
available in developing countries. However,  these interventions are not always effective in 
reducing burden of these diseases.3  
Efforts to prevent diarrheal disease by dietary modulation of intestinal host defenses as 
alternative strategy are promising.8 A strictly-controlled human study reported that 
supplementation of healthy adults with regular milk, naturally high in calcium, reduced 
foodborne enterotoxigenic Escherichia coli (ETEC)-induced diarrhea.8  In addition to other 
micronutrient deficiencies, many Indonesian children aged <5 years unfortunately have a 
low dietary calcium intake not meeting their age-specific recommended daily allowance.9, 10 
Whether calcium is equally beneficial in children with low calcium intake and frequent 
episodes of intestinal and respiratory infections is currently unknown.  
Several meta-analyses and reviews have concluded that probiotics may prevent or reduce 
duration of diarrhea in children. However, the beneficial effects depend on the probiotic 
strain and dose, and evidence was obtained mainly in developed countries.11-14 Moreover, 
several studies have explored benefits of probiotics in the prevention of ARTIs in children.15-
18 So far, recommendations to supplement with calcium or probiotics in community settings 
in developing countries are not justified.13 Therefore, we investigated the efficacy of dietary 
calcium with or without two probiotic strains on incidence and duration of acute diarrhea 
and ARTIs in children.  The probiotic strains used are related to strains previously suggested 
to have antidiarrheal benefits in young children.19-22 
 
Methods 
Study design  
A randomized, double-blind, placebo-controlled trial was conducted between August 2007 
and September 2008 in low socioeconomic urban communities representing non-flooding 
and flooding areas of East Jakarta, Indonesia. The protocol was approved by both the 
Medical Ethics Committee of the Faculty of Medicine, University of Indonesia and of 
Wageningen University. All parents provided written informed consent before inclusion. 
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Subjects 
Children aged 1 to 6 years were selected from community registry for the first screening 
phase to assess eligibility based on the basis of the following inclusion criteria: apparently 
healthy, not being breastfed, and if consuming milk, calcium intake was <75% of the age-
specific recommended daily allowances. In the second phase, registered physicians 
interviewed mothers and examined the children to check the exclusion criteria: symptoms of 
chronic/congenital diseases and disabilities, pulmonary tuberculosis, history of allergy, 
diarrhea on admission, antibiotics use within 2 weeks before study start, severe wasting (less 
than−3 SD of weight-for-height z score), calcium intake >375 mg/day according to a 
validated semi-quantitative food-frequency questionnaire, not capable or willing to drink 
milk with a straw in a 2-day acceptance test, showing allergy or intolerance to the products, 
and/or sibling of included child (twins excepted).  
Interventions 
Children were randomly assigned to receive low-lactose milk: with a low calcium content 
(LC; ~50 mg/day); regular-calcium content (RC; ~440 mg/day); RC plus Lactobacillus casei 
CRL 431 (5x108 colony-forming units [CFU]/day [casei]), or RC plus Lactobacillus reuteri 
DSM 17938 (5x108 CFU/day [reuteri]). Milk was sweetened, chocolate-flavored, ambient 
stable (sterilized by using ultra-high temperatures), and packed in tetra packs (Frisian Flag, 
Indonesia, Jakarta, Indonesia). Milk was consumed with straws coated inside with the oil 
drop as placebo (BioGaia AB, Stochkholm, Sweden) or with either L. casei CRL 431 (Chr 
Hanssen, Hørsholm, Denmark) or L. reuteri DSM 17938 (BioGaia AB) in vegetable oil. 
Probiotic dosage was based on supplier's information of efficacy, application in children, 
safety concerns when dosed for longer periods of time, and technical reasons (ie, straw 
coating). The different milk drinks and straws were indistinguishable for the investigators 
and participants. The composition of the milks and straws is described in Table 2.1.  
Milks and straws were stored cooled (<100C) at all times until delivery. Viability of the 
probiotics was checked each month by selective plating. Field workers distributed milk and 
straws twice a week to the parents, who were instructed to store products refrigerated and 
prevent sun exposure. Parents without refrigerators obtained the products from the field 
workers’ house on daily basis and/or children consumed the products directly at the field 
workers’ house.  
Mothers were instructed to provide the children 180 mL of milk twice daily (not with a meal) 
by using the straws provided. Mothers were requested to maintain the child's habitual diet 
but to exclude probiotic, prebiotic or high calcium foods/drinks other than the supplied 
ones. The amount of milk consumed was measured by using a calibrated stick put into the 
tetra-paks to score the remaining volume by using a pretested 5-point scale. The field 
workers observed the children drinking milk at least once a week and empty packages had to 
be shown during visits. During diarrheal episodes, children continued or restarted drinking 
milk as soon as possible but after being rehydrated with oral rehydration solution according 
to World Health Organization (WHO) guidelines.23 We followed the local standard for 
outpatient and hospital care for diarrhea and ARTI, which per WHO guidelines.23-25 Liability 
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insurance was provided for the children during the study. Activities with creative and 
educational contents were implemented to maintain compliance of both mothers and 
children.  
Table 2.1 Composition of LC and RC milk and probiotic straws 
Composition LC RC Casei Reuteri 
UHT Milk (per 100 ml) 
        Energy, kcal 93.8 98.0 98.0 98.0 
    Fat, ga 3.5 3.9 3.9 3.9 
    Protein, ga 3.9 3.8 3.8 3.8 
    Total carbohydrate, ga 11.7 12.0 12.0 12.0 
    Lactose, g 0.07 0.09 0.09 0.09 
    Vitamin A, µg 32 30 30 30 
    Calcium, mga 15 129 129 129 
    Phosphor, mg 32 77 77 77 
    Magnesium, mg 6 6 6 6 
    Iron, mg 0.30 0.30 0.30 0.30 
    Zinc, mg 0.14 0.14 0.14 0.14 
Straw probiotic (CFU/day) 
        Lactobacillus  casei CRL 431  - - 5x108 
     Lactobacillus  reuteri DSM 17938 - - 
 
5x108 
UHT, ultra-high temperature; CFU, colony-forming unit. 
 a Based on chemical analyses.   
Randomization and blinding 
Eligible children were admitted to the study on enrolment basis and stratified according to 
area of living (flooding and non-flooding), age (<57 and ≥57 months) and gender. A 
randomization table with treatment codes and block size of eight was generated using SAS 
version 9.1 (SAS Institute, Inc, Cary, NC) by an independent individual at Wageningen 
University. Twin siblings of subjects (n=3) were allocated to the same treatment group. 
Researchers, mothers, children, and laboratory personnel were unaware of the treatment 
until all biochemical and data analyses were finished and until after the blind review 
meeting. The data safety monitoring board (DSMB) and an independent person at SEAMEO 
RECFON kept three sets of sealed envelopes allowing deblinding per subject without 
disclosing other children’s treatments.  
Outcomes 
The primary outcomes were the number and duration of diarrheal episodes.  The main 
secondary outcomes were the number and duration of ARTI episodes. Diarrhea was defined 
according to the WHO definition (≥3 loose/liquid stools in 24 hours).23 In addition, all 
reported diarrhea (broader definition: ≥2 loose/liquid stools in 24 hours) was evaluated. 
Stool frequency was counted when there was at least 1-hour interval since the previous 
defecation.26 An episode was considered to have ended on the last day of diarrhea followed 
by 2 diarrhea-free days.27 Duration of diarrhea was defined as number of days from first until 
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last excretion of the loose or liquid stool that is not followed by another abnormal stool in 
each episode.26, 28 
The presence of ARTI was defined when a child had ≥ 1respiratory symptom(s) (runny nose, 
cough, sore throat) and/or ≥ 1 additional respiratory symptom(s) or 1 constitutional 
symptom (fever, headache, restless, aphony, shortness of breath, acute ear pain and 
discharge.29, 30 These symptoms were confirmed with a physician’s diagnosis of acute-upper 
(rhinitis, pharyngitis, sinusitis, otitis, and common cold) and lower (pneumonia, bronchitis, 
and bronchiolitis) respiratory tract infection.31 ARTI duration was the number of consecutive 
days with ≥ 2defined signs and symptoms, with a 7-day symptom-free interval before a new 
episode could occur.32  
Data collection  
Field workers collected fecal samples before and at the end of intervention, as well as during 
diarrheal episodes. Diarrheal samples were collected from onset of diarrhea until maximally 
3 days later. Stools contaminated with urine or that had fallen into the toilet or the child’s 
underwear were discarded. Collected stools were kept cool (-200C) at the field workers’ 
house until storage in a freezer (-700C) at the laboratory. Stools were freeze-dried and 
analyzed for calcium8 and rotavirus (diarrheal samples).33  
Before and at intervention end, non-fasting venous blood was drawn in the morning by 
trained phlebotomists. A study physician examined health status of children and field 
workers performed anthropometric measurements. Lightly clothed children were weighed 
without shoes using an electronic scale (SECA model 890, SECA, Hamburg, Germany) with a 
precision of 0.1 kg. Body stature was measured using a microtoise with a precision of 0.1 cm. 
Routine hematology was performed using an automatic analyzer (ADVIA® 120; Bayer 
Diagnostics, Tarrytown, NY).34 A high-sensitivity chemiluminescent assay (Immulite® 
Dade-Behring, Los Angeles, CA) was used to measure serum high-sensitivity C-reactive 
protein concentration.35 Serum α1-acid glycoprotein was measured by using an enzyme-
linked immunosorbent assay.36  
Follow up observation for diarrhea, ARTIs and adverse events 
During the trial, mothers recorded daily defecation patterns (time, frequency and stool’s 
visual appearance)37 and feces was graded as 1 (normal), 2 (loose), 3 (semi liquid), and 4 
(liquid) on a structured form.38  Field workers verified records twice a week and mothers or 
caregivers were instructed to report newly observed symptoms of intestinal infection 
immediately. In addition, the occurrences of ARTIs were determined and recorded by field 
workers on a structured, pretested form.  Final diarrhea and ARTI diagnosis and recording 
in the trial database were verified by the physicians.   
Adverse events were recorded by using International Classification of Diseases, 10th Revision 
codes.39 Severity and likelihood of relation to the intervention were scored by the physician 
and continuously monitored by the DSMB. An independent expert monitored trial conduct 
and accordance to protocol. 
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Statistical analysis  
Sample size was calculated on the basis of mean episodes and duration of diarrhea, with a 
preset level of significance of 5% and a power of 80% allowing two-sided testing, and taking 
20% dropouts and non-compliant cases into account. A minimum sample size of 480 
patients for four treatment groups was required to detect a 21% reduction of mean number 
of diarrheal episodes and 0.7 day reduction of mean diarrhea duration over a 6-month 
intervention period. These effect sizes were based on meta-analyses of probiotics.13, 40 
Intention-to-treat analysis was performed for all outcomes and for all eligible children who 
were randomly allocated to treatment and had consumed the intervention products at least 
once. Analyses were conducted according to a predefined data analysis protocol. 
The χ2 test was used for comparison of categorical variables between groups, and Fisher 
exact test was used when the expected count was <5. Student’s t-test was used to identify 
differences in normally distributed variables between predefined groups (between LC and 
RC; RC and casei; RC and reuteri). The Mann-Whitney U test was applied when data were 
not normally distributed. PASW Statistic 17.0.3 for windows (SPSS, Chicago, IL 2009) was 
used for analyses. 
Disease incidence was the number of episodes divided by child-years of observation.41 For 
count outcomes, Poisson regression was used, or the negative binomial model in case of 
excess zeros and overdispersion, to estimate the relative risk (RR) and 95% confidence 
intervals (CIs) between groups.42 For this purpose, STATA for windows release 11 (STATA 
Corp, College Station, TX) was used. The dependent variable was number of episodes, and 
treatment group the independent variable. The variables area, age, gender, diarrhea and 
ARTI prevalence within the 2 weeks before study start, household monthly expenditure and 
weight-for-height z score at baseline were included in the model as covariates. Potential 
effect modification by age, habitual calcium intake, and baseline nutritional status were 
assessed by adding interaction terms to the regression model. The adjusted Cox proportional 
hazards regression model for recurrent events was performed to compare the proportion of 
children without diarrhea and ARTIs in all groups.  
 
Results 
A total of 3,150 children were screened in phase 1 and 1,343 in phase 2. Of 497 eligible 
children, 3 refused to have baseline measurements taken. In total, 494 children were 
randomly allocated to 4 treatments groups (Figure 2.1) and included in the intention-to-
treat analysis.  
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Figure 2.1 Flow diagram of study subjects.  
ITT, intention-to-treat; TB, tuberculosis. 
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Table 2.2 Baseline characteristics of the Indonesian children in according to assigned 
treatment 
Characteristic 
LC  RC  Casei  Reuteri  
(n=124) (n=126) (n=120) (n=124) 
Living in flooding area, n (%) 81 (65) 82 (66) 78 (65) 82 (66) 
Male, n (%) 67 (54) 68 (54) 66 (55) 68 (55) 
Age, mean ± SD, mo 59.3 ± 14.3 58.9 ± 14.2 60.3 ±13.7 58.9 ±15.1 
Family size, mean ± SD 5.1 ± 1.7 5.4 ±1.7 5.2 ± 1.8 5.0 ±1.8 
Household expenditure, mean ± SD, 
US$/moa 189 ± 97 194 ± 139 159 ± 69 203 ± 181 
Mother's education <6 y, n (%) 43 (36) 43 (35) 52 (42) 50 (40) 
Diarrhea 2 wk before study, n (%) 20 (16) 13 (10) 24 (20) 15 (12) 
ARTI 2 wk before study, n (%)b 48 (39) 51 (41) 52 (43) 56 (45) 
Serum HS-CRP, median (IQR), mg/L 0.79 (0.23-1.82) 0.75 (0.28-2.90) 0.75 (0.30-2.50) 0.66 (0.25-3.03) 
Serum AGP, median (IQR), g/L 0.79 (0.69-0.93) 0.82 (0.70-0.95) 0.83 (0.70-0.97) 0.81 (0.71-0.94) 
Anemia, n (%) 24 (19) 33 (26) 24 (20) 24 (19) 
Nutritional status  
       Weight-for-age z score, mean ± SD -1.27 ± 1.1 -1.40 ± 0.9 -1.15 ± 1.1 -1.26 ±1.2 
   Height-for-age z score, mean ± SD -1.53 ± 1.0 -1.65 ± 0.9 -1.39 ± 1.0 -1.47 ± 1.1 
   Weight-for-height z score, mean ± SD -0.51 ± 1.0 -0.59 ± 1.2 -0.58 ± 1.0 -0.65 ± 0.9 
   Fecal calcium, median (IQR), mg/g 7.6 (4.7-11.1) 7.5 (4.8-10.4) 6.6 (4.8-9.3) 7.8 (5.1-11.4) 
Habitual dietary intake,c mean ± SD 
       Energy, kcal/d 1,033 ± 368 1,066 ± 329 1,024 ± 369 976 ± 310 
   Protein, g/d 34.3 ± 13.5 36.3 ± 12.9 33.5 ± 13.6 32.9 ± 11.0 
   Carbohydrate, g/d  155 ± 58 157 ± 48 156 ± 58 146 ± 49 
   Fat, g/d  32.2 ± 13.2 34.5 ± 13.9 31.8 ± 13.7 30.9 ± 11.4 
   Fiber, g/d  4.5 ± 3.1 5.1 ± 3.5 4.9 ± 3.7 4.6± 2.8 
   Calcium, mg/d  235 ± 95 241 ± 97 228 ± 105 228 ± 94 
   Iron, mg/d  6.1 ± 2.7 6.6 ± 2.6 6.2 ± 2.7 6.1 ± 2.4 
   Zinc, mg/d 4.4 ± 2.0 4.8 ± 1.9 4.4 ± 2.0 4.4 ± 1.6 
AGP, α1-acid glycoprotein; HS-CRP, high-sensitivity C-reactive protein.  
a Student’s t test, significantly different, RC versus casei and reuteri versus casei (P < .05). 
b χ2 test, significantly different, RC versus reuteri (P < .05). 
c Assessed by using a semiquantitative food-frequency questionnaire. 
At admission, all study groups were comparable with respect to socio-demographic, health 
and nutritional status, and habitual dietary intake (Table 2.2). About 21% of children were 
anemic, 23% underweight, 31% stunted and 3% wasted. The compliance to study products 
was high (94%) and similar among groups. Both probiotic strains remained >90% viable 
during the intervention period. 
The incidence of WHO-defined diarrhea was not significantly different among groups 
(Figure 2.2, Table 2.3). Duration of episodes also did not differ across groups. 
For the outcome all reported diarrhea, children receiving RC and L reuteri (reuteri group) 
experienced a significant 32% reduction of diarrheal episodes compared with the RC group 
(RR: 0.68 [95% CI: 0.46–0.99]) (Table 2.3). In addition, the adjusted Cox probability 
curves showing the proportion of diarrhea-free children was better (P = .036) (Figure 2.3). 
For the other treatment groups, results from WHO-defined and all reported diarrhea were 
comparable. 
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Importantly, significant interactions with nutritional status were observed (P < .05) for both 
diarrhea outcomes. Stratified analysis showed a strong and significant effect of L reuteri in 
children with below-median weight-for-age z score (RR WHO-defined diarrhea compared to 
RC group: 0.44 [95% CI: 0.21–0.92]; RR all reported diarrhea: 0.54 [95% CI: 0.31–0.94]) 
and in children with below-median height-for-age z score (RR WHO-defined diarrhea: 0.44 
[95% CI: 0.21–0.90]; RR all reported diarrhea: 0.53 [95% CI 0.30–0.92]). In children above 
the median z scores the results for the reuteri group were not significantly different from the 
RC group. The prevalence of underweight and stunting was not significantly changed by the 
interventions (data not shown). 
Table 2.3 Effect of probiotics and calcium on incidence of diarrhea and ARTIs among 
Indonesian children 
Outcome measures 
LC  RC  Casei  Reuteri  
(n=124) (n=126) (n=120) (n=124) 
WHO-defined diarrhea episodes (≥3 loose/liquid stools in 24 h)   
   Mean incidence/child/y  0.91 0.86 1.05 0.67 
   No. of episodes,  mean ± SD 0.40 ± 0.81 0.38 ± 0.78 0.47 ± 0.87 0.30 ± 0.56 
   Adjusted RR (95% CI)a 1.00 (ref) 0.99 (0.62 - 1.58) - - 
    - 1.00 (ref) 1.21 (0.76 - 1.92) 0.76 (0.46 - 1.25) 
   Duration of episodes, mean ± SD, d  3.06 ± 4.43 2.94 ± 3.25 2.37 ± 2.68 2.68 ± 3.05 
All diarrhea episodes (2 and ≥3 loose/liquid stools in 24 h) 
   Mean incidence/child/y 1.73 1.86 2.04 1.28 
   No. of episodes, mean ± SD 0.73 ± 1.14 0.77 ± 1.38 0.87 ± 1.32 0.56 ± 0.77 
   Adjusted RR (95% CI)a 1.00 (ref) 1.10 (0.77 - 1.59) - - 
       - 1.00 (ref) 1.06 (0.74 - 1.53) 0.68 (0.46 - 0.99) 
   Duration of episodes, mean ± SD, d  2.57 ± 4.09 2.03 ± 2.84 2.08 ± 2.40 1.91 ± 2.52 
ARTIs episodes 
    
   Mean incidence/child/y 7.22 7.52 7.07 7.45 
   No. of episodes, mean ± SD 2.41 ± 1.59 2.43 ± 1.61 2.36 ± 1.62 2.48 ± 1.56 
   Adjusted RR (95% CI)b 1.00 (ref) 1.00 (0.86 - 1.18) - - 
    - 1.00 (ref) 0.97 (0.82 - 1.14) 0.99 (0.84 - 1.16) 
   Duration of episodes, mean ± SD, d 4.87 ± 4.05 4.90 ± 3.70 4.96 ± 3.71 4.58 ± 3.43 
     
ref, reference group of comparison. 
a Negative binomial model, adjusted for area of living, gender, age, diarrhea and ARTIs 2 weeks before the study, household expenditure and  
  weight-for-height z score. 
b Poisson model, adjusted for area of living, gender, age, diarrhea and ARTIs 2 weeks before the study, household expenditure and weight-for- 
  height z score.  
- presents an irrelevant comparison, which was not included in the analysis. 
The percentages of diarrheal samples positive for rotavirus according to study group were as 
follows: LC, 28%; RC, 25%; casei, 28%; and reuteri, 19%. Differences were not significant.  
The incidence, number of episodes and duration of ARTIs were not significantly different 
among treatments (Figure 2.4, Table 2.3).  
Reported adverse events (International Classification of Disease, 10th Revision codes) were 
comparable among groups, except for change in bowel habits (less regular defecation) and 
asthma.  Nine children in the reuteri group experienced change in bowel habits, compared to 
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two in the RC group. Although based on a few cases, this difference was statistically 
significant. Three children had asthma in the reuteri group and none in the RC group (P 
< .05).  The proportions of antibiotic use during the intervention were 9% in LC, 15% in RC,  
 
Figure 2.2 Adjusted Cox survival curve of the WHO-defined diarrhea (≥3 loose/liquid stools in 24 hours) 
episodes. Adjusted for area of living, gender, age, diarrhea and ARTIs 2 weeks before the study, household 
expenditure. and weight-for-height z score. No significant differences between interventions were observed. 
Probability of survival without diarrhea in relation to duration of diarrheal episodes (days) for 4 groups. No 
significant differences between interventions were observed. 
 
Figure 2.3 Adjusted Cox survival curve of all reported diarrhea (≥2 loose/liquid stools in 24 hours) episodes. 
Adjusted for area of living, gender, age, diarrhea and ARTIs 2 weeks before the study, household expenditure, 
and weight-for-height z score. Probability of survival without diarrhea in relation to duration of diarrheal 
episodes (days) for 4 groups. Significant differences occurred between the RC and reuteri groups (P = .036). 
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Figure 2.4 Adjusted Cox survival curve of ARTI episodes. Adjusted for area of living, gender, age, diarrhea and 
ARTIs 2 weeks before the study, household expenditure, and weight-for-height z score. Probability of survival 
without acute respiratory infections in relation to duration of episodes (days) for 4 groups. No significant 
differences between interventions were observed.  
15% in casei and 9% in reuteri group.  The median duration of antibiotic use was higher in 
the RC group (median 10 days, interquartile range (IQR) 4–14) compared to reuteri group (3 
days, IQR 2.5–4.5,  P= .025) but not different from the other groups (LC 4 days, IQR 3–7.5 
and casei  5 days, IQR 3–11). One child died from bone tuberculosis 3.5 months after study 
end, which was unrelated to study participation according to the DSMB. 
 
Discussion 
Neither calcium nor L. casei CRL 431 affected any of the diarrheal outcomes. In contrast, L. 
reuteri DSM 17938 supplementation significantly reduced the incidence of all reported 
diarrhea (-32% in ≥2 loose/liquid stools in 24-h) and nonsignificantly reduced the incidence 
of WHO-defined diarrhea (24% in ≥3 loose/liquid stools in 24 hours). Notably, for both 
diarrhea outcomes the protective effect of L reuteri DSM 17938 was significant in children 
with lower nutritional status (below-median height- and weight-for-age z score). None of the 
interventions affected incidence or duration of ARTIs. No serious adverse events related to 
the interventions were reported.  
We applied the WHO definition of diarrhea to collect data on the primary outcome. Because 
the WHO considers fecal consistency more important than the number of stools23, 43 and 
their definition leaves room for registration of any increase in normal stool frequency, we 
also evaluated the outcome of all reported diarrhea (a broader definition of diarrhea).  The 
WHO definition is the best validated, it may not be generalizable to different settings such as 
our intervention, which included children of older age and an urban community setting.44 
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Moreover, mothers in the study area usually reported diarrhea when their child defecated ≥2 
loose/liquid stools and broader diarrhea definitions were applied by other clinical trials.45-47 
We did not only rely on mother’s perception but implemented an active surveillance to verify 
mother’s daily records with twice-a-week visits of trained field workers and twice-a-month 
visits of field supervisors. The physician and monitoring expert accompanied the field 
workers on several of their home visits. All endpoints were assessed using structured and 
pretested forms as applied by others.26, 29, 37, 38 The forms were adapted to the local situation 
and were used by field workers who were rigorously trained and supervised on their 
application.  
Previous evidence on the preventive effect of probiotics on diarrhea and ARTIs has been 
limited to small studies, mainly hospital or day-care center based, with a short follow-up 
period and performed in developed countries.11-13, 40, 48 Therefore, our study in a low-
socioeconomic community of a developing country, with a much higher number of subjects 
and longer follow-up, provides critical data to help establish the relevance of these 
interventions for the prevention of diarrhea in developing countries. To our knowledge, our 
study is the first large randomized controlled trial, focusing on the effect of calcium with or 
without one of two specific probiotics to reduce diarrhea and respiratory tract infections in 
these settings. Our results indicate that the effect of a probiotic, such as L. reuteri DSM 
17938, on diarrhea is modified by nutritional status and is confined to children with lower 
nutritional status. 
The rationale for using calcium in children is based on a proof-of-principle study with adults 
orally challenged with live but attenuated enterotoxigenic Escherichia coli. Dietary calcium 
strongly reduced infection-induced diarrhea in that study.8  Animal studies show protective 
effects against Salmonella as well,49, 50 but human verification for that is still lacking. 
Rotavirus is responsible for 60% of hospitalized and 41% of outpatient clinics diarrheal cases 
in Indonesian children.51 Important bacterial pathogens among children in developing 
countries are E coli (10%–20%), Salmonella (<5%), Shigella (5%-10%), Campylobacter and 
Vibrio cholera (exact %’s unknown).52 The absence of a beneficial effect of calcium in our 
trial may indicate a difference in efficacy between children and adults and/or that protective 
effects are pathogen-dependent.  
The application of probiotics to prevent or treat acute diarrhea is based on the assumption 
that they antagonize intestinal pathogens. Possible mechanisms include the synthesis of 
antimicrobial substances, competitive inhibition of pathogen adhesion, competition with 
pathogens for growth substrates, modification of toxin and non-toxin receptors involved in 
bacterial recognition, and stimulation of the immune responses to pathogens.53 Thus far, 
only 3 randomized trials have focused on the role of probiotics in prevention of acute 
diarrhea in a community setting in developing countries.17,54,55 These studies found 
inconsistent effects and differed in probiotic strain and dose, intervention duration, and 
study subject’s age. In our study, the effect size of diarrhea reduction by L. reuteri was higher 
compared with a 14% reduction by supplementing L. casei shirota in a comparable study in 
India,55 a 6% reduction by Bifidobacterium lactis HN019 combined with prebiotic 
oligosaccharides in India17 and 6% reduction using L. rhamnosus GG in Peru.54  
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Strains of L reuteri have been used safely as a probiotic in adults,56 children,19 infants,21,57 
and newborns58 in developed countries. The original strain L. reuteri (American Type 
Culture Collection Strain  55730),  from which L. reuteri DSM 17938 has been derived by 
removal of antibiotic resistance gene-carrying plasmids,59 has been shown to significantly 
reduce duration of watery diarrhea associated with rotavirus in children aged 6 to 36 
months19,20 and diarrheal episodes in infants in day care centers.21 In our study, children 
supplemented with L. reuteri experienced a few adverse events, mainly referring to a less 
regular defecation pattern. L. reuteri did not lead to any serious event related to the 
intervention, and positive results included a lower proportion and shorter duration of 
antibiotic use. 
Milk fermented with L.  casei CRL 431 and Lactobacillus acidophilus reduced the incidence 
of diarrhea in children,60 eliminated diarrhea due to post-gastroenteritis syndrome of 
malnourished hospitalized children,61 and significantly reduced the number of daily stools, 
diarrheal duration and vomiting of children with persistent diarrhea.22  Our results underline 
that probiotic effects are strain-specific as we found protective effects of L. reuteri DSM 
17938 against acute diarrhea in children, whereas supplementation of L. casei CRL 431 
(without other strains) was without effect. The dosage of our probiotics strains (5x108 
CFU/day) is within the effective dosage recommended by Food and Agriculture Organization 
of the United Nations/WHO.62  
The major strength of this study was its focus on prevention in contrast to most previous 
studies, which aimed at treatment of institutionalized children. Additional strengths were its 
double-blind design, the strict adherence to a rigorous protocol, the use of validated 
instruments in the assessment of diarrheal episodes, long duration of the intervention, and 
the excellent compliance rate. Per-protocol analysis, excluding the few noncompliant 
subjects (6%) and subjects having chronic antibiotic usage, did not change the outcome. A 
weakness of this study is the lack of microbiological data identifying the diarrhea-inducing 
pathogens. This subject was not pursued because such stool analysis generally has poor 
diagnostic yield and incurs high costs.63 As a consequence, specific effects of calcium or 
probiotics, if any, against specific diarrheal pathogens may have been missed. 
 
Conclusions 
Supplementation of L reuteri, at least on a diet including regular calcium milk, is one of the 
potential interventions to reduce the burden of acute infectious diarrhea in children. These 
results need to be confirmed by at least one other independent study in a comparable 
community. 
This trial has been registered at www.clinicaltrials.gov (identifier NCT00512824). 
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What’s Known on This Subject: 
Some but not all randomized trials have shown effects of probiotics on incidence and 
duration of diarrhea and respiratory tract infections among children in developing 
countries. Calcium improves resistance to intestinal infections in adults, but efficacy in 
children is unknown. 
 
What This Study Adds: 
Lactobacillus reuteri DSM 17938 may prevent diarrhea, especially in children with lower 
nutritional status. Regular calcium milk, alone or with Lactobacillus casei CRL 431, did 
not reduce diarrhea. None of the interventions affected respiratory tract infections in 
these Indonesian children. 
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Abstract 
Objectives   
Diarrheal morbidity and mortality are still prevalent among children in developing 
countries. We investigated whether supplementation with probiotics and calcium 
reduces duration and severity of acute diarrhea in Indonesian children. 
Methods 
We performed a 6-month randomized, double-blind, placebo-controlled trial of 494 
healthy children aged 1-6 years living in low-socioeconomic communities of  East 
Jakarta. Children received low-lactose milk with: low calcium content ≈50 mg Ca/day 
(LC; n=124), regular calcium content ≈440 mg Ca/day (RC; n=126), RC with 5x108 
colony-forming units per day Lactobacillus reuteri DSM 17938 (n=124), or RC with 
5x108 colony-forming units per day Lactobacillus casei CRL 431 (n=120). Diarrhea 
duration and severity were observed during each episode. Severity was assessed using a 
modified Vesikari score, and diarheal samples were analyzed for osmolarity, mucin, 
calprotectin and rotavirus presence.  
Results 
131 children experienced 190 diarrheal episodes. Probiotic strains and calcium did not 
significantly affect the number of diarrheal episodes, but mean total duration was 1.35 
days shorter in the reuteri group (relative risk [RR], 0.60; 95% confidence interval [CI]: 
0.36–0.99) and tended to be 0.93 days shorter in the casei group (RR 0.64; 95% CI: 
0.39–1.03). Rotavirus prevalence in diarrheal cases was 30% and not significantly 
different between treatment groups.  Rotavirus-positive episodes (36 of 120 analysed 
samples) were shortened by L. reuteri (P = .04) and calcium (P = .009), whereas, L. 
casei shortened duration of rotavirus-negative episodes (P = .04). None of the 
supplements affected diarrhea severity based on Vesikari score and the fecal markers, 
except  for a higher fecal mucin concentration in the casei group (P = .006). 
Conclusions  
L. reuteri DSM 17938 reduced total duration of diarrheal episodes. None of the dietary 
treatments affected diarrhea severity in Indonesian children.  
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Introduction 
Rotavirus is the leading cause of diarrhea-related hospitalization among children in both 
developed and developing countries.1,2 It is estimated to cause >500,000 deaths annually in 
children under five, with 80% of these deaths occurring in developing countries.3 In 
Indonesia, it was estimated that 60% of hospital and 41% of outpatient clinic admissions of 
children for diarrhea were rotavirus-positive.4 Yet, bacterial infections are also an important 
cause of acute diarrhea in developing countries5 and may lead to severe disease.6 
The pathophysiology, etiology, and clinical sequelae of acute diarrhea are well described.7,8 
However, information on diarrhea duration and severity and the impact of dietary 
interventions in clinical trials is limited.7,9 A Cochrane systematic review indicated that 
probiotics reduced diarrhea duration in infants and children by 29.2 hours in clinical 
settings,10 but probiotics’ effect  on diarrhea duration and severity have not been evaluated at 
large scale trial in community settings. Some studies, including probiotics studies, assessed 
severity of gastroenteritis using a single indicator such as diarrheal stool output, diarrhea 
duration of >7 days, treatment failure, occurrence of dehydration, or death.11-13 Other studies 
scored diarrhea symptoms using severity scales.14 The most commonly used severity scale is 
the Vesikari 20-point scale in which an episode of gastroenteritis with a score of ≥11 is 
considered severe.14,15 This scale has been adopted as validated on the basis of its frequent 
use in clinical trials, and can be used as a measure of diarrhea severity in young children.7 
Despite being commonly used by cohort studies on diarrhea and rotavirus vaccines, the 
Vesikari scale has not been applied by any trial on probiotics in a community setting in a 
developing country.     
During diarrhea, normal intestinal physiology is disturbed due to the presence and 
colonization of pathogens resulting in altered intestinal water absorption and secretion,16 
mucosal barrier permeability and host defence mechanisms, and intestinal inflammation.17-20 
There is increasing interest in non-invasive, objective biomarkers to quantify intestinal 
infection severity and/or mucosal inflammation in clinical studies. Candidates of such 
potential biomarkers are fecal osmolarity, calprotectin and mucin. Calprotectin is a calcium-
binding protein with antimicrobial action,21 richly found in neutrophils in stool and body 
fluids.6 It is a  promising marker due to its resistance to proteolytic degradation and stability 
in stool.22 Levels in stool increase upon intestinal infection and other inflammatory diseases 
of the gastrointestinal tract.23, 24  Mucins are a family of heavily glycosylated proteins that are 
secreted as large aggregates by mucosal goblet cells25 and is crucial for intestinal mucus 
formation.26, 27 The mucus network is an indispensible part of gut barrier function as this 
viscous layer protects the delicate epithelial cells underneath from aggressive components in 
the fecal stream, including bacterial pathogens and their toxins.26 Fecal mucin excretion is 
enhanced upon intestinal infection and defects in mucus production lead to colonic 
inflammation.28,29 Diarrhea severity can also be quantified by determination of fecal 
osmolarity. The most obvious characteristic of infectious diarrhea is increased fecal water 
excretion due to reduced absorption or increased secretion of electrolytes,18 or increased 
luminal presence of osmolytes attracting water.16 
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Efforts to prevent or reduce diarrheal disease by dietary modulation of intestinal host 
defenses are promising.28 However, probiotic studies on infection, immune and 
inflammatory outcomes in humans are inconsistent, appear to be highly probiotic strain-
dependent, and mainly focused on rotavirus diarrhea in children.30-32 Dietary calcium 
reduces  infectious diarrhea due to Salmonella enteritidis33, 34 and enterotoxigenic E. coli 
(ETEC)28 in animal models and to ETEC in a  human proof-of-principle study in adults.28 
However, its effect in children is unknown. Therefore, we conducted a randomized 
controlled community trial in which calcium with or without probiotics was supplemented 
for 6 months to Indonesian children to investigate its effect on duration and severity of acute 
diarrheal disease due to rotavirus or other causes.  
 
Methods 
Subjects 
Detailed inclusion and exclusion criteria of subjects has been described elsewhere.35 Briefly, 
we included children aged 1–6 years who were apparently healthy, not being breastfed, no 
symptoms of chronic/congenital diseases and disabilities, not having pulmonary 
tuberculosis, no history of allergy, not having diarrhea on admission, did not use antibiotics 
within 2 weeks before study start, not severely wasting,  calcium intake ≤ 375 mg/day  
according to a validated semiquantitative food-frequency questionnaire, capable or willing to 
drink liquid milk with a straw in a 2-day acceptance test,  did show allergy or intolerance to 
the products, and/or not a sibling of included child (twins excepted). All parents signed the 
informed consent before inclusion. The protocol was approved by the Medical Ethics 
Committee of the Faculty of Medicine of the University of Indonesia and of Wageningen 
University, The Netherlands. This study was registered with ClinicalTrials.gov (ID 
NCT00512824). 
 Study design 
A randomized, double-blind, placebo-controlled trial was conducted in fifteen urban 
communities representing non-flooding and flooding areas of East Jakarta, Indonesia. These 
areas were selected on the basis of a number of criteria: high population density, low 
socioeconomic status, and high prevalence of diarrhea and underweight in under-five 
children, based on routine data from the primary health care system and local government.  
Children were randomly assigned to receive low lactose (0.01 g/L) milk: with a low calcium 
content (≈50 mg Ca/day, LC); regular calcium content (≈440 mg Ca/day, RC); RC plus 
Lactobacillus casei CRL 431 (5x108 CFU/day, casei); or RC plus Lactobacillus reuteri DSM 
17938 (5x108 CFU/day, reuteri). Milk was sweetened, chocolate-flavored, ambient stable 
(UHT-sterilized), and packed in tetra packs (Frisian Flag Indonesia, Jakarta). Milk was 
consumed with straws coated inside with the oil drop as placebo (BioGaia AB, Sweden) or 
with either L. casei CRL 431 (Christian Hanssen, Denmark) or L. reuteri DSM 17938 (an 
antibiotic resistance gene-depleted derivative daughter strain of L. reuteri ATCC 55730, 
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BioGaia)36 in vegetable oil. Probiotic dosage was based on supplier's information of efficacy, 
application in children, and safety concerns when dosed for longer time. The different milk 
drinks and straws were indistinguishable for the investigators and participants. The 
composition of the milks and straws is described in Table 2.1. Viability of the probiotics was 
checked each month by using selective plating.  
Eligible children were admitted to the study on enrolment basis and stratified according to 
area of living (flooding and non-flooding), age (< 57 months and ≥ 57 months) and sex. A 
randomization table with treatment codes and block size eight was generated using SAS 
version 9.1 (SAS Institute, Inc, Cary, NC) by an independent person at Wageningen 
University. Twin siblings of subjects (n=3) were allocated to the same treatment group. 
Researchers, mothers, children, and laboratory personnel were unaware of the treatment 
until all biochemical and data analyses were finished and until after the blind review 
meeting. Faecal calcium at endline was kept blinded from the study team until all other data 
were fully deblinded. Data Safety Monitoring Board (DSMB) and an independent person at 
SEAMEO RECFON kept three sets of deblinding envelopes allowing deblinding per subject 
without disclosing other children’s treatments.  
Field workers distributed milk and straws twice a week to the parents, who were instructed 
to store products refrigerated and prevent sun exposure. Parents without refrigerators 
obtained the products from the field workers’ house on daily basis and/or children 
consumed the products directly at the field workers’ house. Mothers were instructed to 
provide the children 180 mL of milk twice daily (not with a meal) using the straws provided. 
Field workers observed the children drinking milk at least once a week and empty packages 
had to be shown during visits. During diarrheal episodes, children continued or restarted 
drinking milk as soon as possible but after being rehydrated with Oral Rehydration Solution  
according to WHO guidelines.37  
Adverse events were recorded by using International Classification of Diseases, 10th Revision 
codes as described elsewhere.35 We followed the local standard for outpatient and hospital 
care for diarrhea and acute respiratory tract infections which were per WHO guidelines as 
described elsewhere.35 An independent expert monitored trial conduct and accordance to 
protocol. 
Laboratory measurements 
Field workers collected fecal samples before and at the end of intervention, and during 
diarrheal episodes. Mothers recorded daily defecation pattern (time, frequency and stool’s 
visual appearance).35 Field workers verified records twice a week and mothers or caregivers 
were instructed to report newly observed symptoms of intestinal infection immediately. 
Records of field worker were randomly checked by the fieldsupervisor. Final diarrhea and 
adverse events diagnoses, and Vesikari scores in the trial database were entered by 
fieldsupervisors and verified by the study physicians.  Stools were freeze-dried and analyzed 
for calcium (base- and endline samples),28 rotavirus (diarrheal samples),38 and fecal mucin, 
osmolarity and calprotectin (diarrheal and endline fecal samples). Fecal mucin was assessed 
using a specific fluorimetric assay of O-linked glycoproteins.28 Fecal osmolites were 
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measured to assess the relative amount of water present in the original feces.28 Calprotectin 
in feces was measured using a commercial ELISA (Calpro, NovaTec Immundiagnostica 
GmbH, Dietzenbach, Germany).39 
Outcome assessments 
The outcomes presented in this paper were duration of diarrheal episodes, diarrhea severity 
and the presence of rotavirus in diarrheal samples.  Diarrhea was defined according to WHO 
definition (≥3 loose/liquid stools in 24 hours).37 Stool frequency was counted when there 
was at least one hour interval between subsequent defecation moments.12 An episode was 
considered to have ended on the last day of diarrhea followed by 2 diarrhea-free days.11 The 
number of episodes is the sum of all diarrheal episodes that occurred during the intervention 
period. Duration of a diarrheal episode was defined as number of days from first until last 
excretion of the loose or liquid stool that is not followed by another abnormal stool in each of 
the episodes.12 The cumulative (total) duration of diarrhea was the sum of all diarrheal days 
of all episodes per child per 6-month of intervention period.40, 41 
Severity of diarrhea was assessed by the modified Vesikari score (MVS) based on the 
mothers’ subjective information and by objective measurement of the above-mentioned fecal 
biomarkers. Vesikari score was slightly adjusted to better fit with the community situation 
and study population. The original 20-point numerical score includes the assessment of 
diarrhea duration (3-points), maximal diarrhea frequency in 24-hour (3-points), vomiting 
duration in days (3-points), maximal vomiting frequency in 24 hour (4-points), fever in 
degrees Celcius (3-points), dehydration percentage (3-points) and rehydration given or 
hospitalization (2-points).15 We graded the severity by using a slightly modified 18-point 
Vesikari scale and asked a qualitative report of mothers for fever (yes or no) instead of rectal 
temperature. Also, the percent dehydration was replaced by estimated degree of 
dehydration,7,14,38,42 since this variable is not easily assessed in a community setting. We 
defined mild to moderate disease as scores of <11 and severe disease as scores of ≥11.7 
Statistical analysis 
Sample size was calculated based on the mean episodes and duration of diarrhea, with a pre-
set level of significance of 5% and a power of 80% allowing two-sided testing, and taking 
20% dropouts and non-compliant cases into account. A minimum sample size of 480 for 
four treatment groups was required to detect a 21% reduction of the mean number of 
diarrheal episodes and 0.7 day reduction of mean diarrhea duration over a 6-month 
intervention period. These effect sizes were estimated based on meta-analyses of 
probiotics.32, 43  
Intention-to-treat (ITT) analysis was performed for all outcomes and for all eligible children 
who were randomly allocated to treatment and had consumed the intervention products at 
least once. Analyses were carried out according to a predefined data analysis protocol. 
For all outcomes, double data entry was applied. Chi-square test was used for comparison of 
categorical variables between groups and Fisher exact test was used when expected count <5. 
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Student’s t-test was used to identify differences in normally distributed variables between 
predefined groups (between LC and RC; RC and casei; RC and reuteri). Mann-Whitney U 
test was applied when data were not normally distributed. We used PASW Statistic 17.0.3 for 
windows (SPSS, Chicago, IL 2009) for the analyses.  
Disease incidence was the number of episodes divided by child-years of observation.44 For 
count outcomes (episodes, duration and vesikari score) we used the Negative binomial 
model in case of excess zeros and over-dispersion, to estimate the relative risk (RR) and 95% 
Confidence Intervals (CI) between groups.45 For this purpose, we used STATA for windows 
release 11 (College Station, Texas 2009). Mann-Whitney U test was performed to evaluate 
the treatment-effect (median differences) on fecal calprotectin, mucin and osmolarity in 
children who suffered from diarrhea. Number of episodes, total duration of episodes, 
Vesikari score and fecal osmolarity, mucin and calprotectin were the dependent variables 
and treatment group the independent variable. The variables area, age, sex, diarrhea and 
acute respiratory infections prevalence within 2-week before study start, household monthly 
expenditure and weight-for-height z-score at baseline were included in the model as 
covariates. Potential effect modification by baseline age, habitual calcium intake and 
nutritional status were assessed by adding interaction terms to the regression model.  
 
Results  
A total of 3,150 children were screened in phase 1 and 1,343 in phase 2. From the 497 eligible 
children, 3 refused to have baseline measurements taken. In total, 494 children were 
randomly allocated to four treatments groups (Figure 3.1) and were included in ITT 
analysis.  
At admission, all study groups were comparable regarding socio-demographic characteristics 
(including environment, and maternal hygiene and caring), health and hematology status, 
and habitual dietary intake (Table 3.2). Changes of habitual dietary intake between baseline 
and endline were not significantly different between groups. The compliance to study 
products use was high (94%) and similar among groups. Both probiotic strain remained 
>90% viable during the intervention.  
The incidence and mean number of WHO-defined diarrhea episodes were not significantly 
different among groups (Table 3.3). As reported elsewhere, incidence of all reported 
diarrhea  was significantly lower in the reuteri group particularly among children with lower 
nutritional status.35 
Analyses of the diarrheal children (n=131, together having 190 episodes) showed that mean 
cumulative duration of diarrhea in the reuteri group was significantly shorter (40%) as 
compared to the RC group (95% CI 0.36–0.99); P<.049). Supplementation with L. reuteri 
shortened the cumulative diarrhea episode duration by 1.35 days. The cumulative duration of 
diarrheal episodes tended to be shorter (36%) in the casei group as well but the effect did not 
reach statistical significance (95% CI 0.39–1.03; P=0.07).  
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  Figure 3.1 Flow diagram of study subjects. 
 ITT, intention-to-treat; TB, tuberculosis. 
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Table 3.2 Baseline characteristics of the Indonesian children in four intervention groups  
Characteristic 
LC 
(n=124) 
RC 
(n=126) 
Casei 
(n=120) 
Reuteri 
(n=124) 
     
Areas      
Flooding 81 (65%) 82 (65%) 78 (65%) 82 (66%) 
Non flooding 43 (35%) 44 (35%) 42 (35%) 41 (34%) 
Age (months) 59.3 (14.3) 58.9 (14.2) 60.3 (13.7) 58.9 (15.1) 
Sex (male) 67 (54%) 68 (54%) 66 (55%) 68 (55%) 
Household expenditure  
(US$ per months) a 
189 (97) 194 (139) 159 (69) 203 (181) 
Mother's education <6 years 43 (36%) 43 (35%) 52 (42%) 50 (40%) 
     
Health status     
Diarrhea 2 wk prior to study 20 (16%) 13 (10%) 24 (20%) 15 (12%) 
ARI 2 wk prior to studyb  48 (39%) 51 (41%) 52 (43%) 56 (45%) 
     
Hematology profile      
hs-CRP (mg/L) 0.8 (0.2, 1.8) 0.8 (0.3, 2.9) 0.8 (0.3, 2.5) 0.7 (0.3, 3.0) 
AGP (g/L) 0.8 (0.7, 0.9) 0.8 (0.7, 1.0) 0.8 (0.7, 1.0) 0.8 (0.7, 0.9) 
Anemia 24 (19%) 33 (26%) 24 (20%) 24 (19%) 
     
Nutritional status, mean (SD)    
Weight-for-age  -1.26 (1.2) -1.15 (1.1) -1.27 (1.1) -1.40 (0.9) 
Height-for-age  -1.47 (1.1) -1.39 (1.0) -1.53 (1.0) -1.65 (0.9) 
Weight-for-height  -0.65 (0.9) -0.58 (1.0) -0.51 (1.0) -0.59 (1.2) 
Fecal calcium (mg/g) 7.6 (4.7, 11.1) 7.5 (4.8, 10.4) 6.6 (4.8, 9.3) 7.8 (5.1, 11.4) 
     
Dietary intake,c mean (SD)    
Energy (kcal/d) 1033 (368) 1066 (329) 1024 (369) 976 (310) 
Protein (g/d) 32.9 (11.0) 33.5 (13.6) 34.3 (13.5) 36.3 (12.9) 
Carbohydrate (g/d)  146 (49) 156 (58) 155 (58) 157 (48) 
Fat (g/d)  30.9 (11.4) 31.8 (13.7) 32.2 (13.2) 34.5 (13.9) 
Fiber (g/d)  4.6 (2.8) 4.9 (3.7) 4.5 (3.1) 5.1 (3.5) 
Calcium (mg/d)  228 (94) 228 (105) 235 (95) 241 (97) 
Iron (mg/d)  6.1 (2.4) 6.2 (2.7) 6.1 (2.7) 6.6 (2.6) 
Zinc (mg/d) 4.4 (1.6) 4.4 (2.0) 4.4 (2.0) 4.8 (1.9) 
Note: Data are number, number (%), mean (SD, median (interquartile range).  
LC indicates low calcium; RC, regular calcium; ARI, acute respiratory infections; hs-CRP, serum high-sensitivity 
C-reactive protein; AGP, alpha 1-acid glycoprotein. 
a Student’s t test,  significantly different between RC vs casei (P<.05). 
b Chi-square test, significantly different between RC vs reuteri (P <.05). 
c Defined as the percentage of children with hemoglobin values  < 11.0 g/dL (children < 5 years) or < 11.5 gd/L 
(children 5–11 years).  
c Assessed using a semi-quantitative food frequency questionnaire. 
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Table 3.3  Effect of probiotics and calcium on the number of episodes and severity of acute 
diarrhea assessed by the modified Vesikari score 
Variable LC RC Casei Reuteri 
All children, n=494 124 126 120 124 
   Mean incidence/child/year 0.91 0.86 1.05 0.67 
   Mean number of episode (SD) 0.40 (0.81) 0.38 (0.78) 0.47 (0.87) 0.30 (0.56) 
Adjusted RR (95% CI) 1.00 (ref) 0.99 (0.62–1.58) 
  
  
1.00 (ref) 1.21 (0.76–1.92) 0.76 (0.46–1.25) 
Diarrheal children, n=131a 33 31 36 31 
   Mean number of episodes (SD) 1.52 (0.87) 1.55 (0.81) 1.53 (0.91) 1.19 (0.40) 
Adjusted RR (95% CI) 1.00 (ref) 1.08 (0.72–1.62) 
  
  
1.00 (ref) 0.94 (0.63–1.42) 0.74 (0.47–1.14) 
   Mean cumulative duration in days (SD) 4.64 (5.58) 4.55 (5.06) 3.62 (4.69) 3.20 (3.51) 
Adjusted RR (95% CI) 1.00 (ref) 1.18 (0.72–1.92) 
  
  
1.00 (ref) 0.64 (0.39–1.03) 0.60 (0.36–0.99)b 
   Mean Vesikari score (SD) 3.86 (1.37) 3.85 (1.09) 3.96 (1.58) 3.63 (1.19) 
Adjusted RR (95% CI) 1.00 (ref) 1.02 (0.79–1.32) 
  
    1.00 (ref) 1.01 (0.78–1.31) 0.92 (0.71–1.21) 
Note: LC indicates low calcium; RC, regular calcium 
Data are mean (SD) and Relative Risk (95% Cl); Cl, confidence interval; ref, reference group of comparison.     
Adjusted for area of living, sex, age, diarrhea and ARI 2 weeks prior to the study, household expenditure and weight-for-height z-score.  
a These are all diarrheal children regardless whether fecal samples could be collected. Also, some children had multiple episodes. 
b Negative binomial model, significantly different between reuteri vs RC (P < .049). 
Calcium did not affect duration of diarrheal episodes. Six episodes of persistent diarrhea 
(diarrhea duration >14 days) were recorded: 1 in RC, 3 in LC and 1 in the casei group) (data 
not shown). It should be noted that, except for one episode, almost all diarrhea in our study 
was categorized as mild based on the symptom severity scores of the MVS. Vesikari scores 
were not different between the dietary treatment groups RC and LC (RR 1.02, 95% CI 0.79–
1.32), casei and RC (RR 1.01, 95% CI 0.78–1.31) or reuteri and RC (RR 0.92, 95% CI 0.71–
1.21) (Table 3.3). 
From the 190 diarrheal episodes, 120 stool samples could be collected for rotavirus analysis. 
Failure to collect stool in the remaining episodes was mainly due to unwillingness of children 
who experienced recurrent diarrhea to retake their stool or difficulty to obtain samples of 
watery diarrhea. Rotavirus was detected in 36 of 120 (30%) collected stools. The prevalence 
of rotavirus in collected diarrheal samples was 28% in RC, 31% in LC, 33% in casei and 26% 
in the reuteri group (Table 3.4).  
Diarrhea duration of rotavirus-positive episodes was significantly shorter in RC group (RC vs 
LC RR 0.40 95% CI 0.20-0.80; P = .009); and shorter in reuteri group (reuteri vs RC RR 
0.38 95% CI 0.15–0.98; P = .04). In rotavirus-negative episodes, diarrhea duration was 
shorter in the casei group (casei vs RC RR 0.52 95% CI 0.28-0.96; P = .04). Despite 
statistical significance, it should be noticed that especially the rotavirus-positive results are 
based on relatively few cases. Severity of diarrhea, as assessed by the Vesikari score, did not 
differ between rotavirus-negative and rotavirus–positive episodes on total group level 
(Table 3.4) and within dietary treatment groups (data not shown). 
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Figure 3.2 Diarrhea-induced changes in fecal (A) osmolarity, (B) mucin and (C) calprotectin in  
samples collected during diarrheal episodes (red part of the bars) and levels of these markers at 
endline (normal situation; blue part of the bars) in the intervention groups and all groups combined. 
Mean values per child were used for children that experienced multiple episodes. RC, regular calcium; 
LC, low calcium.  
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Fecal osmolarity, mucin and calprotectin were assessed in 87 children, together having 113 
episodes from the total 190 episodes of diarrhea observed during the study. Missing samples 
were due to practical difficulties in collecting watery diarrhea samples and not fullfilling the 
minimum volume needed for laboratory analyses. Also, one child missed the endline 
measurement. Diarrheal episodes were characterized by clear increases in fecal osmolarity, 
mucin and calprotectin in all groups in comparison with (normal) fecal samples collected at 
study endline (n=87; Figure 3.2). A significantly greater diarrhea-induced change in fecal 
mucin was observed in the casei group in comparison with the RC group (P = .006). Also, 
fecal mucin tended to increase during diarrhea in the LC group, but the effect was not 
statistically significant (P = 0.09) (Figure3.2). There was no significant correlation between 
Vesikari scores and the fecal biomarkers of diarrhea severity. This may be due to the fact that 
most diarrheal episodes were classified as mild (mean Vesikari scores were only 3-4 on a 
total scale of 0-18) and variability in scores was thus rather low (Table 3.3). In addition, 
diarrheal episode duration was not significantly correlated with any diarrhea severity marker 
or the MVS (data not shown). Reported adverse events (ICD-10)  and the proportion and 
duration of antibiotic use were described elsewhere.35  
Table 3.4 Prevalence of rotavirus-related diarrhea and severity of diarrheal disease as 
assessed by the modified Vesikari score among the groups  
Variable LC RC Casei Reuteri All 
Diarrheal children (episode), n  33 (50) 31 (48) 36 (54) 31 (37) 131 (190) 
Children (episode) analyzed for rotavirus,  n 24 (29) 22 (32) 26 (36) 22 (24) 94 (120) 
Rotavirus prevalence, n (%) 
 
 
         Rotavirus-positive 9 (31%) 9 (28%) 12 (33%) 6 (26%) 36 (30%) 
       Rotavirus-negative 20 (69%) 23 (72%) 24 (67%) 17 (74%) 84 (70%) 
Duration of diarrheal episodes (days), mean (SD)     
       Rotavirus-positive  5.4 (6.0)a 2.4 (1.7) 2.3 (1.9) 1.9 (2.2)a 3.0 (3.5) 
       Rotavirus-negative  4.1 (5.2) 4.0 (4.2) 2.1 (2.1)a 2.6 (3.2) 3.2 (3.9) 
Severity of diarrheal episodes (score),b mean (SD)    
       Rotavirus-positive  4.7 (1.9) 4.1 (1.5) 3.8 (0.7) 4.3 (2.1) 4.2 (1.5) 
       Rotavirus-negative 3.9 (1.6) 4.5 (1.7) 4.4 (1.9) 3.8 (1.3) 4.2 (1.7) 
Note: 120 collected samples for rotavirus analysis from the 190 diarrheal cases.  
aNegative binomial model, significantly different between: RC vs LC (relative risk [RR] 0.40; 95% CI: 0.20–0.80; P = .009); reuteri vs 
RC (RR 0.38; 95% CI: 0.15–0.98; P = .04); casei vs RC (RR 0.52; 95% CI: 0.28–0.96; P = .04); Adjusted for area of living, sex, and age.  
bTotal Vesikari score of diarrhea (score range 0-18-point; score<11 is mild; score ≥ 11 is severe). Mean values per child were used for 
children who experienced multiple episodes. 
 
Discussion 
This community-based, randomized controlled trial has shown that the probiotic strains and 
calcium did not significantly affect the number of WHO-defined diarrheal episodes. Analyses 
of the diarrheal children (n=131, together having 190 episodes) showed that the mean 
cumulative duration of diarrhea in the reuteri group was significantly shorter (-40%) as 
compared to the RC group (P = .049). Diarrhea duration tended to be shorter in the casei 
group (-36%) as well but the effect was not statistically significant (P = .07). Stratified 
analysis discriminating between rotavirus-positive and rotavirus-negative diarrheal episodes 
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showed that the beneficial effect of L. reuteri on diarrhea duration was mainly in rotavirus-
positive episodes (P = .04), whereas L. casei mainly shortened rotavirus-negative diarrhea (P 
= .04). Although, calcium did not affect overall diarrhea duration, it significantly reduced 
rotavirus-positive episode duration (P = .01). Despite statistical significance, we like to stress 
that these rotavirus-specific effects are based on a relatively small numbers of cases (Table 
3.4), as rotavirus is just one of the many intestinal pathogens responsible for childhood 
diarrhea. Confirmation that L. reuteri, and also L. casei and calcium, can shorten acute 
diarrheal episodes dependent on the intestinal pathogen involved, needs to come from larger 
(>500 subjects) controlled intervention studies. 
L. reuteri supplementation shorted the cumulative diarrhea duration by 1.35 days in a 6-
month period, which is in line with other reported probiotic interventions in children. A 
recent Cochrane review concluded that diarrhea duration in infants and children  was 
reduced by 29.2 hours in those taking probiotics for <14 days (95% CI 25.14–33.25 hours, 
fixed effect model; 30.48 hours, 95% CI 18.51–42.46, random effects model, 12 trials, n 
=970).10, 46 This effect was larger than the previously reported effect sizes based on meta-
analyses studies undertaken by Szajweska in 2001 and McFarland in 2006 for all probiotic 
strains in children showing a reduction of 18.2 hours30 and  13.4 hours,47 respectively. Our 
study is also consistent with reviews or meta-analyses on efficacy of specific probiotics to 
reduce diarrhea duration in children: Van Niel et al showed a reduction of  0.7 days by 
Lactobacilli administration,43 Szajewska et al indicated a reduction of 1.1 days in infants 
treated with L. casei GG48 and Chmielewska et al showed a reduction of 0.92 days by L. 
reuteri ATCC 55730.49,50 These effects were more evident in hospital-based settings of 
developed countries,51 whereas two studies performed in a community setting in developing 
countries52,53 did not explicitly present the effect on diarrhea duration and another study 
failed to show an effect of probiotics on diarrhea duration.54 Our observed reduction in 
rotavirus-induced diarrhea duration of  0.5 days was much lower than the 2.1 days reduction 
found in a meta-analyses in 2007.48  
It should be taken into account that effect sizes of nutritional interventions, aimed to prevent 
disease, are generally of a much smaller magnitude than those obtained by pharmaceutical 
interventions to cure existing disease. Although, the potential benefit from probiotics 
supplementation on diarrhea duration is likely small,55 it might still be clinically relevant in 
children that need to grow up in a poor environment with low nutritional food intake and 
high infection pressure. Each additional diarrhea-free day can help to prevent further 
deterioration of their delicate nutritional status and well-being. It should be remarked that, 
from public health perspective, the number of diarrheal episodes children experience is more 
important than durationof the episodes. Occurrence of multiple episodes is more harmful to 
children’s growth, whereas long episode duration is not associated with growth 
impairment.56 In that respect, it is important to notice that in the present study L. reuteri 
DSM 17938 supplementation tended to reduce the number of WHO-defined diarrheal 
episodes by 24% (P = .28) and all reported diarrhea episodes by 32% (P = .046).35 It also 
implies that future probiotic research in developing countries should give more attention to 
prevention of acute diarrheal disease in children instead of treatment as done in the past.67 
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There was no significant beneficial effect of dietary calcium or one of probiotic strains on 
diarrhea severity measured by Vesikari score. We applied a MVS similar to Freedman et al.7 
The MVS was considered to be reliable, valid, and easy to administrate by mothers and field 
workers. This method was pre-tested to ensure its applicability in our study population. In 
our study population, all diarrheal episodes with the exception of one, had a MVS<11. This  
score  is categorized as mild and is in contrast with the high percentage of severe diarrhea 
(Vesikari >11) observed in rotavirus vaccine studies in medical care settings in sub-Sahara 
Africa (>45%)57 and Asia (>63%).58 The low MVS in our study (groups mean scores were 3-4) 
demonstrate that diarrhea in outpatients and/or children in community settings is typically 
of a milder type.  
Considering that expected effect sizes of dietary interventions are generally small, we wanted 
to include objectively measurable and quantitative fecal biomarkers of diarrhea severity in 
our study besides the more subjective and semi-quantitative MVS. Although our study 
population suffered from milder diarrhea than the diarrhea in the above-mentioned studies, 
there were clear responses in the applied diarrhea severity biomarkers when comparing 
normal fecal endline samples with samples collected in diarrheal episodes. Fecal calprotectin 
concentrations increased >2-fold during acute diarrheal episodes in the present study.  
Application of this biomarker in clinical trials and medical practice is growing as fecal 
calprotectin is useful in the diagnosis and quantification of gut mucosal inflammation and 
monitoring of therapeutic efficacy, both in adults and children.59 However, it is unspecific 
because multiple causes increase the presence of intestinal neutrophils, leading to increased 
fecal concentration of this protein.60 The increased levels in the diarrheal samples of our 
study likely reflect infection-induced intestinal mucosal inflammation.6 Analysis of stool 
osmolarity is helpful in evaluating patients with diarrhea. When gastrointestinal digestion or 
microbiota-related metabolism is altered, diarrhea can result from osmotic forces in the 
lumen (e.g. lactose in lactose malabsorbers) or an increased secretory state (e.g. bacterial 
enterotoxin-induced diarrhea).61 Though not statistically significant, the reuteri group had 
the lowest infection-induced change in fecal osmolarity and Vesikari score, which may reflect 
lower diarrhea severity.  There has been scientific debate, whether fecal osmolarity has the 
potential to differentiate osmotic from secretory diarrhea by evaluation of the stool ion gap.62 
Diarrhea type was not subject of our study, but results showed that acute diarrheal episodes 
were characterized by increased fecal osmolarity suggestive for the osmotic type of 
diarrhea.61 Our fecal sample collection logistics were very strict to ensure quick cooling and 
storage of samples in freezers to prevent ex-vivo bacterial fermentation and thus artificial ex-
vivo osmolyte increases.  
The acute infection-induced changes in fecal mucin were not uni-directional among dietary 
treatment groups and less pronounced. The casei group showed a significant increase 
(P=.006), whereas fecal mucin in the regular calcium group tended to decrease (P=.09) 
during diarrheal. The mucus layer is an important contributor to  intestinal host defence and 
inhibits pathogens adhesion to epithelial cells and subsequent bacterial translocation of 
invasive strains.61,62 Mucin excretion is stimulated during infectious diseases.26,28 So far, 
studies on intestinal mucin merely focused on qualitative differences in mucin 
oligosaccharide composition during various intestinal diseases63,64 whereas quantitative 
aspects are understudied. Despite responsiveness of fecal calprotectin, osmolarity, and 
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mucin to less extent, to acute diarrhea, levels were not significantly modified by dietary 
treatment. The absence of supplement-induced differences in diarrhea severity markers 
corresponds with the equal Vesikari scores among groups. The relatively mild diarrheal 
episodes observed in our study population lead to a rather homogeneous dataset of fecal 
biomarker responses. Unfortunately, this hampers conclusions whether fecal calprotectin, 
osmolarity and mucin are truely quantitative indicators of diarrhea severity. Confirmation 
needs to come from future infection studies in subjects with a wider range of diarrhea 
severity.   
Conclusion 
L. reuteri DSM 17938 significantly reduced the total duration of diarrheal episodes, likely by 
mainly affecting rotavirus-positive diarrhea. L. reuteri, L. casei CRL 431 and calcium did not 
affect diarrhea severity in Indonesian children.     
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Abstract 
Objective 
Probiotics and milk calcium may increase intestinal infection resistance, but their effect 
on growth, iron and zinc status of Indonesian children is uncertain. We investigated 
whether milk supplemented with probiotics would improve growth, and iron and zinc 
status of Indonesian children, whereas milk calcium alone would improve growth, but 
reduce iron and zinc status.  
Methods 
A six-month randomized trial was conducted in low-socioeconomic urban communities 
of East Jakarta. Healthy children (n=494) were randomly assigned to receive low 
lactose milk: with low calcium content ≈50 mg Ca/d (LC; n=124), regular calcium 
content ≈440 mg Ca/d (RC; n=126), RC with 5x108 CFU/d Lactobacillus casei CRL 431 
(casei; n=120); or RC with 5x108 CFU/d Lactobacillus reuteri DSM 17938 (reuteri; 
n=124). Dietary intake, growth, anemia, iron and zinc status were assessed before and 
after the intervention.  
Results 
The increase in weight gain, weight-for-age z score (WAZ) changes and monthly weight 
and height velocities were significantly higher in the reuteri compared with RC group 
[0.22 (95% CI: 0.02, 0.42) kg, 0.09 (95% CI: 0.01, 0.17) Z, 0.03 (95% CI: 0.002, 0.05) 
kg and 0.03 (95% CI: 0.01, 0.05) cm, respectively]. Casei significantly increased 
average monthly weight velocity [0.03 kg (95% CI: 0.001, 0.05 kg), but not height. 
However, the changes in underweight and stunting prevalence, anemia prevalence and 
iron and zinc status were similar among groups. 
Conclusions 
L. reuteri DSM 17938 modestly improved growth, by increasing weight gain, WAZ 
changes, and weight and height velocity in Indonesian children. L. casei CRL 431 
modestly improved weight velocity. Independent from probiotics supplementation, 
regular milk calcium neither affected growth, nor iron and zinc status. This study was 
registered at clinicaltrials.gov (registration ID no. NCT00512824). 
 
 
 
 
 
  Effect of milk calcium with or without probiotics on growth, iron and zinc status Chapter 4 
   
 
65 
 
Introduction  
Undernutrition and multiple micronutrients (MMNs) deficiencies persist as the most serious 
nutritional problems among children <5 years in developing countries.1,2 The Indonesian 
national prevalence of stunting (37%) and wasting (14%) is higher, and underweight (18%) is 
similar compared to the estimated overall prevalence of undernutrition among under-five 
children in the developing world.3,4 Deficiencies in vitamin A, iron, zinc and iodine are the 
most prevalent in Indonesian children.5 Because intake of dairy products in these children is 
minimal during their growth period,6 calcium deficiency may also be prevalent.  
Studies reporting benefits of nutrition interventions on growth and micronutrient status of 
under-five children used different approaches of supplementations and, fortified foods, but 
results are conflicting.5, 7-11 In addition, some studies indicated that nutrient-dense foods may 
help to prevent stunting and wasting in young children, but more data are needed to identify 
the impact of this approach.12-14 Probiotics are often supplemented to dairy foods and both 
probiotics.15,16 and calcium in milk17 may strengthen intestinal infection resistance. However, 
the impact of probiotics on growth and micronutrient status is uncertain. In addition to a 
mice study with Lactobacillus casei CRL 431,18,19 several human studies showed a positive 
effect of probiotics on weight gain in children aged 5 mo to 5 y.20-23 Three reviews reported 
that calcium supplementation in healthy children has no effect on weight, height, body fat, or 
lean mass in randomized clinical trials (RCTs).24-26 However, such evidence in children in 
developing countries is scarce. 
The combination of regular calcium milk and probiotics may give synergistic benefits, but 
less is known about the effects on the absorption of iron and zinc. Probiotics are often used 
to improve digestibility and uptake of nutrients by intestinal cells27 and may be beneficial in 
malnutrition when gut function is impaired.28 Acute inhibitory effect of calcium to iron 
absorption in adults was shown in some studies,29-31 but not in others.32-34 Previous studies 
reported variable findings on the effects of milk or calcium supplementation on zinc 
absorptions in adults.35 The possibility that calcium interferes with iron and zinc absorption 
and thus affects iron and zinc status in children is an important concern,36,37 but very few 
studies were performed in a pediatric population. These studies were conducted mainly in 
developed countries involving children with adequate calcium and iron intake and showed 
contradictive results.36, 38-40 
Until now, evidence is inconclusive whether prolonged dietary supplementation with 
calcium and probiotics in children with low habitual calcium intakes in developing countries 
including Indonesia, affects growth, and iron and zinc status. Therefore, we investigated the 
hypothesis that milk supplemented with probiotics would improve growth, and iron and zinc 
status, whereas milk calcium alone would improve growth, but reduce iron and zinc status of 
Indonesian children.  
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Subjects and methods 
Study design  
A randomized, double-blind, placebo-controlled trial was conducted between August 2007 
and September 2008 in low socioeconomic urban communities representing flooding and 
nonflooding areas of East Jakarta, Indonesia.  
Subjects  
Detailed criteria of subjects has been described elsewhere.41 Briefly, we included children 
aged 1–6 years who were apparently healthy, not being breastfed, no symptoms of 
chronic/congenital diseases and disabilities, not having pulmonary tuberculosis, no history 
of allergy, not having diarrhea on admission, did not use antibiotics within 2 wk before study 
start, not severely wasting,  calcium intake ≤ 375 mg/d  according to a validated 
semiquantitative food-frequency questionnaire, capable or willing to drink liquid milk with a 
straw in a 2-d acceptance test,  did show allergy or intolerance to the products, and/or not a 
sibling of included child (twins excepted). All parents signed the informed consent. The 
protocol was approved by the Medical Ethics Committee of the Faculty of Medicine of the 
University of Indonesia and of Wageningen University, The Netherlands.  
Randomization and blinding 
Detailed procedure for randomization and blinding procedure has been described 
elsewhere.41 Eligible children were admitted to the study on enrollment basis and stratified 
according to area (flooding and non-flooding), age (<57 and ≥57 mo) and sex. The twin 
siblings of subjects (n=3) were allocated to the same treatment group.  Researchers, 
mothers, children, and laboratory personnel were unaware of the treatment until all 
biochemical and data analyses were finished and until after the blind review meeting. Fecal 
calcium at study end was kept blinded from the study team until all data were fully 
deblinded.  
Intervention 
Children were randomly assigned to receive low-lactose milk:  with a low-calcium content 
(≈50 mg Ca/day, LC); regular-calcium   (≈440 mg Ca/day, RC); RC plus Lactobacillus casei 
CRL 431 (5x108 CFU/day, casei); or RC plus Lactobacillus reuteri DSM 17938 (5x108 
CFU/day, reuteri). Milk was sweetened, chocolate-flavored, ambient stable (sterilized by 
using ultra high temperatures), and packed in tetra-paks (Frisian Flag Indonesia, Jakarta). 
Milk was consumed with straws coated inside with the oil drop as placebo (BioGaia AB, 
Sweden) or with either L. casei CRL 431 (Chr Hanssen, Hørsholm, Denmark) or L. reuteri 
DSM 17938 (an antibiotic resistance gene-depleted derivative daughter strain of  L. reuteri 
ATCC 55730, BioGaia AB)42 in vegetable oil. Probiotic dosage was based on supplier's 
information of efficacy, application in children, and safety concerns when dosed for longer 
time. The different milks and straws were indistinguishable for the investigators and 
participants. The composition of the milks and straws is described in Table 4.1. Milk and 
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straws were stored cooled (<100C) at all times until delivery. Viability of the probiotics was 
checked each month by using selective plating.  
Field workers distributed milk and straws twice a week to the parents, who were instructed 
to store products refrigerated and prevent sun exposure. Parents without refrigerators 
obtained the products from the field workers’ house on daily basis and/or children 
consumed the products directly at the field workers’ house. Mothers were instructed to 
provide the children 180 mL of milk twice daily (not with a meal) using the straws provided. 
Field workers observed the children drinking milk at least once a week and empty packages 
had to be shown during visits. During diarrheal episodes, children continued or restarted 
drinking milk as soon as possible but after being rehydrated with Oral Rehydration Solution 
according to WHO guidelines.43 Activities with creative and educational contents were 
implemented to maintain compliance of mothers and children.  
Table 4.1 Composition of LC and RC milk and probiotic straws 
Composition LC RC Casei Reuteri 
UHT Milk (per 100 ml) 
    
   Energy, kcal 93.8 98.0 98.0 98.0 
   Fat, ga 3.5 3.9 3.9 3.9 
   Protein, ga 3.9 3.8 3.8 3.8 
   Total carbohydrate, ga 11.7 12.0 12.0 12.0 
   Lactose, g 0.07 0.09 0.09 0.09 
   Vitamin A, µg 32 30 30 30 
   Calcium, mga 15 129 129 129 
   Phosphor, mg 32 77 77 77 
   Magnesium, mg 6 6 6 6 
   Iron, mg 0.30 0.30 0.30 0.30 
   Zinc, mg 0.14 0.14 0.14 0.14 
Straw probiotic (CFU/day)b 
    
  Lactobacillus casei CRL 431  - - 5x108 
   Lactobacillus reuteri DSM 17938 - - 
 
5x108 
UHT, ultra-high temperature; CFU, colony-forming unit. 
 a Based on chemical analyses.   
Data collection  
Field workers performed anthropometric measurements at baseline (month 0), during 
intervention (month 1st, 2nd, 3rd, 4th and 5th) and study end (month 6th). Lightly clothed 
children were weighed without shoes using an electronic scale (SECA model 890, SECA, 
Hamburg) with a precision of 0.1 kg. Body stature was measured using a microtoise with a 
precision of 0.1 cm.  Habitual dietary intake of the previous 2 months was assessed by using 
a semiquantitative food-frequency questionnaire (S-FFQ) as described elsewhere.41  
Before and at intervention end, non-fasting venous blood was drawn in the morning by 
trained phlebotomists. Four mL whole blood was collected in EDTA tubes for hematology 
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and plasma preparation, and 7 mL into non-anticoagulant tubes for determination of serum 
high-sensitivity C-reactive protein (hs-CRP) and alpha-1-acid glycoprotein (AGP). Blood 
samples were promptly stored and transported to the laboratories in cool boxes. Sera were 
stored at -70oC in regular microtubes. Procedure for fecal samples collection was described 
elsewhere.41  
Adverse events were recorded by using International Classification of Diseases, 10th Revision 
codes as described elsewhere.41 We followed the local standard for outpatient and hospital 
care for diarrhea and ARTI which were per WHO guidelines as described elsewhere.41 An 
independent expert monitored trial conduct and accordance to protocol. 
Laboratory measurements 
Routine hematology testing (ie. hemoglobin (Hb), hematocrite (HCT), red blood cell (RBC), 
red cell distribution width (RDW), mean corpuscular volume (MCV), mean corpuscular 
hemoglobin concentration (MCHC) was performed by using an automatic analyzer 
(ADVIA® 120; Bayer Diagnostics, Tarrytown, NY).44 A high-sensitivity chemiluminescent 
assay (Immulite® Dade-Behring, Los Angeles, CA) was used to measure serum high-
sensitivity C-reactive protein concentration.45 Serum α1-acid glycoprotein was measured by 
using an enzyme-linked immunosorbent assay (ELISA).46 Iron and zinc status were 
determined by analyses of serum ferritin, soluble transferrin receptor (sTfR)  and zinc 
concentration. Serum ferritin and sTfR were measured by ELISA.46 Serum zinc was analyzed 
by inductively-coupled plasma-optical emission spectrometry (ICP-OES) OPTIMA 2000TM 
DV (Perkin-Elmer, Norwalk, USA). Fecal calcium (base- and endline samples) was analyzed 
in freeze-dried feces by Inductively Coupled Plasma Atomic Emission Spectrometry (ICP-
AES; Varian, Mulgrave, Australia).17 
Outcomes 
The primary study endpoints concerned the intervention effects on the number and duration 
of diarrheal episodes as described elsewhere.41 In this paper, we present data on the 
secondary outcomes, notably the changes in growth, anemia, and iron and zinc status.  The 
study power calculation was based on the effects on diarrhea. 
The effect on growth was evaluated by calculating differences in weight, height, weight-for-
age z score (WAZ) and height-for-age z score (HAZ) at the study end (months 6th 
intervention) minus baseline (month 0). In addition, using the consecutive monthly 
anthropometric measurements, the mean change and difference of average monthly weight 
and height growth velocities as well as WAZ and HAZ were analyzed by using a longitudinal 
regression model (month 0, 1st 2nd, 3rd, 4th, 5th and 6th).  
The anthropometric aspects of nutritional status were determined based on nutritional 
indices of the WHO Child Growth Standard.47 The HAZ and WAZ were calculated using 
WHO anthropometric software 2005 and 2007. Stunting was defined as HAZ <-2 SD, and 
underweight as WAZ < -2 SD.2 The changes in the proportion of underweight and stunted 
children from baseline to study end were calculated. 
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Iron, and zinc status were assessed by estimating the difference between means at study end 
to baseline. Iron status was assessed at baseline and after 6 months of intervention by 
measuring haemoglobin, serum ferritin and sTfR concentrations.48 Changes in the 
proportion of anemic, iron deficient anemic and zinc deficient children were calculated. 
Anemia was defined according to WHO criteria as Hb <11.0 g/dL (children <5 y); Hb <11.5 
g/dL (children 5–11 y); iron deficiency was defined as serum ferritin <12 g/L in children <5 y 
and <15 g/L in children >5 y; and iron deficiency anemia was defined as iron deficiency with 
anemia.49 Zinc deficiency was defined as serum Zn concentration <65 mg/dL (9.9 
mmol/L).50 The 6-month changes in fecal calcium were used to verify the differences in 
calcium intake during the intervention.51 
Statistical analysis  
Intention-to-treat analysis was performed for all eligible children who had consumed the 
intervention products at least once. Analyses were carried out according to a predefined data 
analysis protocol. Normality of the data distribution was analyzed with the Kolmogorov-
Smirnov test. Chi-square test was used for comparison of categorical variables between 
treatment groups and Fisher exact test was used when expected count <5. Student’s t-test 
was used to identify differences in quantitative normally distributed data between 
predefined groups of comparison (between LC and RC; RC and casei; RC and reuteri). 
Within-treatment differences of status marker were assessed by paired t test. Mann-Whitney 
U test was applied when data were not normally distributed. Data are expressed as mean 
(SD) for normally distributed parameters and median and 25th─75th percentiles for non-
normally distributed parameters. We used PSAW Statistic 17.0.3 for windows (SPSS Inc. 
Chicago, USA 2009) for this analysis.  
Random intercept models were applied for statistical analyses of growth outcomes by using 
SAS version 9.2 (GLIMMIX procedure). We performed a repeated measures logistic 
regression model using STATA for windows release 11 (XTGEE procedure) for changes in the 
prevalence of underweight, stunting, anemia, iron and zinc deficiency, and iron deficiency 
anemia.  Growth parameters (weight, height, WAZ, HAZ) and status markers (Hb, serum 
ferritin, sTfR and zinc) were the dependent variable and treatment group and time of 
measurement were the independent variable. The variables area, age, sex, HAZ, WAZ, and 
status markers at baseline were included in the model as covariates dependent on the 
outcome studied. In additional analyses, potential effect modification by age, habitual 
calcium intake and baseline nutritional status were assessed by adding interaction terms to 
the regression model.  
 
Results 
A total of 3,150 children were screened in phase 1 and 1,343 in phase 2 (Figure 4.1). From 
the 497 eligible children, 3 refused to have baseline measurements. In total, 494 children 
were randomly allocated to four treatment groups and included in ITT analysis. 
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Figure 4.1 Flow diagram of study subjects.  
ITT, intention-to-treat; TB, tuberculosis. 
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Table 4.2 Baseline characteristics of the Indonesian children 
Characteristics 
 
LC 
(n = 124) 
RC 
(n = 126) 
Casei 
(n = 120) 
Reuteri 
(n = 124) 
Living in flooding area [n (%)] 81 (65) 82 (66) 78 (65) 82 (66) 
Sex (male) [n (%)] 67 (54) 68 (54) 66 (55) 68 (55) 
Age (mo) 59.3 ± 14.31 58.9 ± 14.2 60.3 ±13.7 58.9 ±15.1 
Family size 5.1 ± 1.7 5.4 ±1.7 5.2 ± 1.8 5.0 ±1.8 
Household  expenditure (US$/mo) 189 ± 97 194 ± 139 159 ± 69 203 ± 181 
Mother's education <6 y [n (%)] 43 (36) 43 (35) 52 (42) 50 (40) 
Diarrhea 2-wk before study [n (%)] 20 (16) 13 (10) 24 (20) 15 (12) 
ARTI 2-wk before study [n (%)] 48 (39) 51 (41) 52 (43) 56 (45) 
Serum hs-CRP (mg/L) 0.79 (0.23, 1.82)2 0.75 (0.28, 2.90) 0.75 (0.30, 2.50) 0.66 (0.25, 3.03) 
Serum AGP (g/L) 0.79 (0.69, 0.93) 0.82 (0.70, 0.95) 0.83 (0.70, 0.97) 0.81 (0.71, 0.94) 
Serum ferritin, µg/L 16.2 (9.56, 27.7) 18.4 (9.2, 36.4) 18.9 (10.6, 34.3) 16.5 (10.9, 30.4) 
Serum Transferrin receptor (µg/L) 9.3 (5.2) 9.3 (4.3) 9.2 (3.8) 9.2 (4.1) 
Serum Zinc concentration (µg/dL) 56.0 (16.3) 55.3 (14.6) 57.4 (17.8) 57.1 (14.8) 
Anemia3 [n (%)] 24 (19) 33 (26) 24 (20) 24 (19) 
Iron deficiency4 [n (%)] 40 (32) 41 (33) 32 (27) 37 (30) 
Iron deficiency anemia5 [n (%)] 12 (10) 17 (14) 13 (11) 14 (11) 
Zinc deficiency6 [n (%)] 85 (71) 93 (78) 75 (65) 82 (68) 
Anthropometric parameters     
   Weight 15.5 ± 3.36 15.3 ± 3.18 16.0 ± 3.66 15.6 ± 4.00 
   Height 101.7 ± 8.87 101.2 ± 8.94 103.0 ± 8.94 101.9 ± 9.70 
   Weight-for-age z score -1.27 ± 1.05 -1.39 ± 0.94 -1.15 ± 1.07 -1.26 ±1.24 
   Height-for-age z score -1.53 ± 0.98 -1.65 ± 0.94 -1.39 ± 1.00 -1.46 ± 1.09 
Underweight [n (%)]7 24 (19) 36 (29) 21 (18) 34 (27) 
Stunted [n (%)]8 38 (31) 44 (35) 34 (28) 37 (30) 
Habitual dietary intake      
   Energy (kcal/d) 1,033 ± 368 1,066 ± 329 1,024 ± 369 976 ± 310 
   Protein (g/d) 34.3 ± 13.5 36.3 ± 12.9 33.5 ± 13.6 32.9 ± 11.0 
   Carbohydrate (g/d)  155 ± 58 157 ± 48 156 ± 58 146 ± 49 
   Fat (g/d)  32.2 ± 13.2 34.5 ± 13.9 31.8 ± 13.7 30.9 ± 11.4 
   Fiber (g/d)  4.5 ± 3.1 5.1 ± 3.5 4.9 ± 3.7 4.6± 2.8 
   Calcium (mg/d)  235 ± 95 241 ± 97 228 ± 105 228 ± 94 
   Iron (mg/d)  6.1 ± 2.7 6.6 ± 2.6 6.2 ± 2.7 6.1 ± 2.4 
   Zinc (mg/d) 4.4 ± 2.0 4.8 ± 1.9 4.4 ± 2.0 4.4 ± 1.6 
Note: ARTIs, acute respiratory tract infection; hs-CRP, high sensitivity C-reactive protein; AGP, alpha 1-acid glycoprotein. 
1 Mean ± SD (all such values). 
2 Median (IQR) (all such values).  
3 Defined as a hemoglobin concentration <11 g/dL (children < 5 y) or < 11.5 g/ dL (children 5–11 y). 
4 Defined as a serum ferritin <12 µg/L (children <5 y) or <15 µg/L (children >5 y). 
5 Defined as an iron deficiency with anemia (see above). 
6 Defined as serum zinc concentration < 65mg/dL (9.9 mmol/L) at morning non-fasting . 
7 Defined as a weight-for-age z score < -2 SD. 
8 Defined as a height-for-age z score < -2 SD. 
At admission, all study groups were comparable regarding socio-demographic characteristics 
(including environment, and maternal hygiene and caring), health and hematologic status 
and habitual dietary intake (Table 4.2). About 21% of all children were anemic, 68% zinc 
deficient, 23% underweight and 31% stunted at baseline. The compliance to study products 
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use was high (94%) and similar among groups. Both probiotic strains remained >90% viable 
over the intervention period. As expected, fecal calcium excretion increased significantly in 
the three groups supplemented with regular calcium milk (P<0.001) (Table 4.6) indicating 
good compliance to the study product. 
Changes in energy and nutrient intake between baseline and endline were not significantly 
different among the groups (Table 4.3), except for calcium. Regular milk supplementation 
augmented the daily Ca intake of these children to the RDA (≈500 mg/day) of Indonesian 
children in this age group, whereas it remained 50% in the LC group (230 mg/day) (P<0.05). 
In addition, daily intake of energy and protein increased by 20% and 30% (up to 11 g), 
respectively.  
Table 4.3 Habitual daily intake of energy and nutrients measured at study baseline and at 
endline1,2,3 
Variables 
 
LC 
(n = 123) 
RC 
(n = 126) 
Casei 
(n = 120) 
Reuteri 
(n = 123) 
Energy Intake, kcal/d4     
      Baseline  1026 ± 365 1066 ± 329 1024 ± 369 977 ± 311 
      Endline 1240 ± 355 1257 ± 336 1277 ± 380 1238 ± 324 
      Changes +212 ± 389 +191 ± 356 +253 ± 414 +261 ± 397 
Protein Intake, g/d     
      Baseline  34.2 ± 13.5 36.3 ± 12.9 33.5 ± 13.6 32.9 ± 11.0 
      Endline 45.5 ± 12.3 45.4 ± 12.2 46.2 ± 14.2 44.7 ± 11.6 
      Changes +11.4 ± 13.0 +9.1 ± 13.7 +12.8 ± 15.0 +11.8 ± 14.1 
Vitamin A, IU/d5     
      Baseline  286 (127, 533) 283 (154, 283) 231 (119, 563) 268 (140, 606) 
      Endline 318 (210, 499) 294 (226, 417) 291 (211, 479) 295 (219, 576) 
      Changes +70 (-91, 193) +35 (-242, 164) +57 (-150, 182) +62 (-243, 188) 
Calcium Intake, mg/d     
      Baseline  231(161, 230) 232 (165, 335) 205 (148, 305) 220 (158, 304) 
      Endline 206 (162, 249)6 592 (541, 648) 602 (545, 662) 589 (538, 647) 
      Changes +1.25 (-101, 49)6 +354 (267, 440) +394 (292, 458) +382 (275, 455) 
Iron Intake, mg/d     
      Baseline  5.9 (4.0, 7.6) 6.1 (4.7, 8.0) 5.5 (4.2, 7.3) 6.0 (4.6, 7.4) 
      Endline 6.2 (5.0, 8.6) 6.3 (5.0, 8.4) 6.7 (4.9, 8.2) 6.0 (5.1, 7.9) 
      Changes +0.9 (-1.1, 2.5) +0.4 (-1.3, 1.8) +1.1(-0.9, 3.0) +0.2 (-1.3, 2.3) 
Zinc Intake, mg/d     
      Baseline  4.0 (2.9, 5.5) 4.8 (3.5, 5.7) 3.6 (2.9, 5.9) 4.3 (3.1, 5.4) 
      Endline 4.0 (3.0, 5.0) 4.0 (3.1, 5.4) 4.0 (3.0, 5.1) 3.8 (3.2, 4.9) 
      Changes +0.1 (-1.3, 1.0) -0.5 (-1.5, 0.8) +0.1 (-1.0, 1.4) -0.1(-1.6, 1,1) 
     
1 Assessed by Semi-Food Frequency Questionnaire (SFFQ). 
2 Two children did not complete endline measurement (1 in reuteri and 1 in LC group). 
3 Milk supplements were included at mean endline and changes. 
4 Mean ± SD (all such values).  
5 Median (IQR) (all such values).  
6 Significantly different from RC group, P<0.001 (Mann-Witney U test analysis) for calcium intake changes. 
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Figure 4.1 Treatment group-specific changes of (A) Weight-for-age z score; 
(B) Height-for-age z score during the 6-months period of intervention. 
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Table 4.5 Changes in the prevalence of underweight and stunting 
Outcomes Baseline  Month 6 Change Adjusted change Adjusted differences 
  [n (%)] [n (%)] [n (%)] OR (95% CI) OR (95% CI) OR (95% CI) 
Underweight              
   LC (n = 124) 24 (19) 25 (20) 1 (1) 1.09 (0.71, 1.67) 1.00 - 
   RC (n = 126) 36 (29) 29 (23) -7 (-5) 0.67 (0.45, 0.99)5 0.49 (0.23, 1.04) 1.00 
   Casei (n = 120) 21 (18) 23 (20) 2 (2) 1.20 (0.76, 1.88) - 1.71 (0.78, 3.74) 
   Reuteri (n = 124) 34 (27) 27 (22) -7 (-5) 0.63 (0.43, 0.93) 5 - 0.77 (0.39, 1.55) 
Stunting             
   LC (n = 124) 38 (31) 32 (26) -6 (-5) 0.67 (0.45, 0.99) 5 1.00 - 
   RC (n = 126) 44 (35) 38 (31) -6 (-4) 0.72 (0.49, 1.06) 1.06 (0.53, 2.13) 1.00 
   Casei (n = 120) 34 (28) 26 (22) -8 (-7) 0.55 (0.36, 0.83)6 - 1.15 (0.56, 2.34) 
   Reuteri (n = 124) 37 (30) 25 (20) -12 (-10) 0.44 (0.29, 0.68) 6 - 0.70 (0.34, 1.41) 
       
Note: OR, odd ratio; CI, confidence interval. 
1 Defined as a weight-for-age z score < -2 SD. 
2 Adjusted for area, age, sex and HAZ at baseline. 
3 Defined as a height-for-age z score < -2 SD. 
4 Adjusted for area, age, sex and WAZ at baseline. 
Statistically significant in changes between baseline and month 6: 5P< 0.05;  6P< 0.01 (repeated measures logistic regression). 
Weight, height, WAZ and HAZ increased in all intervention groups over time (Table 4.4). 
Overall, the weight and height velocity of children was 178 g/mo and 0.56 cm/mo (≈7 cm/y), 
respectively. On average the total group was 1,070 g heavier (0.10 WAZ) and grew up to 3.4 
cm taller (0.15 HAZ) during the 6 month intervention (data not shown).The reuteri group 
experienced significantly higher weight gain (1160± 650 g; P=0.03) and WAZ change (0.14 Z 
± 0.28; P=0.03) after 6 months of intervention as compared to the RC group (960 ± 740 g 
and 0.06 ± 0.31 Z, respectively). The difference in weight and height gain between reuteri 
and RC was 220 g (0.09 Z) and 0.19 cm (0.04 Z), respectively. Compared to RC, the average 
monthly weight velocity was significantly higher in the reuteri group [adjusted difference:  
0.03 (95% CI: 0.002, 0.05) kg; P=0.04]. Similar significant result was observed for the 
average monthly height velocity in the reuteri group. In the casei group, the average monthly 
weight velocity was significantly higher compared to RC [adjusted difference: 0.03 [(95% CI: 
0.001, 0.05) kg; P=0.04]. However, compared to the RC group, the difference in reductions  
in underweight (23%) and stunting (30%) in the reuteri group were not significantly 
different after adjusting for area of living, sex, age and WAZ at baseline (Table 4.5). The 
crude data (Figure 4.2) and model results of WAZ (Table 4.4) showed that the increases 
in z score of the reuteri group were most prominent in the first and sixth intervention month. 
HAZ increased more linearly.    
During intervention, Hb, HCT, other hematologic parameters (RBC, RDW, MCV, MCHC), 
and serum ferritin significantly declined, and the serum transferrin receptor significantly 
increased in all groups (P<0.001). Serum zinc showed a more variable response between 
groups. However, none of the changes in blood parameters were significantly different 
among the groups, neither when the RC group was pooled with the probiotic groups as one 
calcium supplemented group versus the LC group (Table 4.6). Because acute or chronic 
inflammation and infection are potential confounders of serum ferritin, an indicator of iron 
stores, we repeated the analysis excluding children with hs-CRP concentrations >5 mg/L. 
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Serum ferritin values were also corrected using both hs-CRP concentration >5 mg/L and/or 
AGP > 1 g/L, to classify children into incubation, early, or late convalescence groups.52 
However, results were not different when children with elevated CRP and/or AGP were in-or 
excluded or when serum ferritin was corrected. 
Table 4.6 Hematology parameters, serum inflammation biomarkers and the iron, zinc and 
calcium status changes of children during the 6 months intervention.  
Variables 
LC 
(n=123) 
RC  
(n=124) 
Casei  
(n=120) 
Reuteri  
(n=122) 
Hemoglobin, g/L           
   Baseline 12.0 ± 1.121 11.8 ± 1.35 12.0 ± 1.07 11.9 ± 1.04 
   Changes -0.19 ± 0.77 -0.15 ± 0.88 -0.25 ± 0.77 -0.14 ± 0.75 
Hematocryte %     
   Baseline 37.0 ± 2.67 36.2 ± 3.30 36.8 ± 3.00 36.7 ± 2.76 
   Changes -1.00 ± 2.97 -0.55 ± 2.98 -0.93 ± 2.74 -0.62 ± 2.86 
RBC, 106/µl     
   Baseline 4.80 ± 0.39 4.70 ± 0.40 4.76 ± 0.43 4.75 ± 0.41 
   Changes    0.11 ± 0.33 0.14 ± 0.31 0.12 ± 0.30 0.15 ± 0.28 
MCV, fl     
   Baseline  77.2 ± 6.1 77.3 ± 6.3 77.6 ± 6.2 77.7 ± 6.2 
   Changes   -3.8 ± 3.8 -3.4 ± 3.5 -4.0 ± 3.6 -3.7 ± 3.5 
RDW, %     
   Baseline 14.9 ± 1.5 14.9 ± 1.6 14.9 ± 1.4 14.9 ± 1.4 
   Changes    -1.2 ± 0.9 -1.2 ± 0.9 -1.1 ± 1.1 -1.3 ± 0.9 
Hs-CRP, mg/L     
   Baseline  0.79 (0.23, 1.82)2 0.75 (0.28, 2.9) 0.75 (0.30, 2.5) 0.66 (0.25, 3.03) 
   Changes    -0.01 (-1.03, 0.61) -0.09 (-0.89, 1.0) -0.05 (-1.42, 0.40) 0 (-1.65, 0.51) 
AGP, g/L     
   Baseline  0.81 ± 0.18 0.84 ± 0.20 0.84 ± 0.19 0.82 ± 0.17 
   Changes    -0.01 ± 0.25 -0.02 ± 0.24 -0.03 ± 0.22 -0.02 ± 0.24 
sTfR, µg/L3     
   Baseline  8.07 (6.54, 10.4) 8.46 (6.64, 10.4) 8.44 (6.89, 10.6) 8.54 (6.76, 10.2) 
   Changes    0.90 (-0.35, 1.69) 0.87 (-0.64, 2.23) 0.38 (-0.61, 1.89) 0.67 (-0.26, 2.02) 
Ferritin, µg/L4 n = 109 n = 109 n = 108 n = 102 
   Baseline 18.3 (9.65, 30.7) 24.4 (9.27, 39.1) 22.8 (12.0, 35.3) 19.5 (11.6, 32.4) 
   Changes -3.96 (-11.1, 1.03) -4.35 (-15.7, 1.58) -4.21 (-13.5, -0.35) -3.66 (-11.5, 0.87) 
Zinc, umol/L5 n = 115 n = 116 n = 116 n = 117 
   Baseline 8.50 ± 2.47 8.42 ± 2.24 8.78 ± 2.72 8.70 ± 2.28 
   Changes 0.34 ± 2.01 0.30 ± 2.45 -0.03 ± 2.23 -0.04 ± 1.95 
Fecal calcium, mg/g6 n = 124 n = 123 n = 120 n = 122 
   Baseline 7.6 (4.7, 11.1) 7.5 (4.8, 10.4) 6.6 (4.8, 9.3) 7.8 (5.1, 11.4) 
   Changes  0.37 (-2.00, 4.26)7 15.9 (6.48, 23.9) 14.9 (7.14, 23.4) 15.1 (6.68, 20.7) 
Note: RBC, red blood cell, RDW; red  cell distribution width, MCV; mean corpuscular volume (MCV); hs-CRP, high sensitivity C-reactive protein; 
AGP, alpha 1-acid glycoprotein; sTfR, soluble transferrin receptor. 
1 Mean ± SD (all such values).  
2 Median (IQR) (all such values).  
3  Five children did not complete endline measurement (2 in reuteri, 2 in RC and 1 in LC group).  
4  Sixty Six children were not included in the analysis: 5 children did not complete endline measurement (2 in reuteri, 2 in RC and 1 in LC group) 
and 61 children had hs-CRP baseline and endline > 5mg/L. 
5  Measurement at study end of 30 children were not available (4 in casei, 7 in reuteri, 8 in RC and 9 in LC group). 
6  Four children did not complete endline measurement (2 in reuteri, 2 in RC and 1 in LC group). 
7 Mann-Whitney test, statistically significant between RC vs LC, P<0.001. 
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During the 6-month intervention, the percentage of children with iron deficiency and iron 
deficiency anemia increased significantly (P<0.05) in all groups (Table 4.7). Again no 
significant differences among treatment groups were observed even after adjusting for area 
of living, seasons and other covariates.  So, milk calcium alone or with supplemented 
probiotic strains did not significantly affect iron status during the 6 months intervention.  
 
Discussion  
Our study showed that supplementing the habitual diet of Indonesian children aged 1 to 6 y 
with regular calcium milk combined with L. reuteri DSM 17938 modestly  improved growth, 
by increasing weight gain, WAZ changes over 6 months and monthly weight and height 
velocity compared to regular calcium milk alone. Regular calcium milk with L. casei CRL 431 
modestly improved monthly weight velocity compared to regular calcium milk. Regular 
calcium milk did not significantly affect any of the growth parameters as compared to low 
calcium milk. None of the treatments affected iron and zinc status. 
 The weight velocity (178 g/mo) of all treatments in our study children falls within the 50th 
percentile of the weight velocity (138-192 g/mo) of children in this age group on the CDC 
growth chart.53 The height velocity (≈7 cm/y) of all children is also within the upper expected 
average velocity (5-6 cm/y).54 Overall, all treatments resulted in normal growth in weight 
and height in our children.  
The modest effect sizes (calculated by dividing the difference between the mean change in 
treatment and control groups by the pooled SD for the 2 groups)7 of L. reuteri in all weight 
parameters (0.24 – 0.40) and casei in weight velocity (0.3) are larger than the results of a 
meta-analysis and review on MMNs supplementation  (<0.15) in under-five children over 1 
year period.7, 8 A few studies  have investigated probiotic effects on children's growth.55 These 
studies showed inconsistent effects and differed in probiotic strain and dose, intervention 
duration and children’s age. Our  reuteri and casei results in weight gain (effect size 0.29 and 
0.23, respectively) are slightly larger compared to a study  in Indian children of similar age 
(effect size 0.22) supplemented with milk fortified with Bifidobacterium lactis HN019 and 
prebiotic oligosaccharide versus control milk alone 23 and a study in Indonesian 12-mo-old 
toddlers (effect size 0.23)  supplemented with a combination of B. longum, L. rhamnosus, 
prebiotics and polyunsaturated fatty acid versus control milk.56 However, differences in 
growth outcomes did not affect prevalence of stunting and underweight in the reuteri and 
other groups. This may implicate that 6-mo intervention is too short to observe reduction of 
malnutrition prevalences.57 It may also be that the actual increment of 0.09 for WAZ and 
0.05 for HAZ, albeit statistically significant, were still too small, especially taking the average 
growth deficit of Asian and African children into account (~–2.0 Z).58 In contrast to our 
results, several other studies in infants receiving various probiotic strains, either alone or 
combined with prebiotics,28, 59  did not find any growth effects. Overall, our probiotics 
interventions, but not milk calcium,  showed larger effects on growth than other nutritional 
interventions.  
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In our trial, the changes of WAZ sharply increased in the first intervention month. This may 
reflect a rapid catch-up growth due to the extra energy and protein in the supplied milks.60 
The stasis of WAZ in all groups between the 2nd and 5th intervention month may reflect the 
inability to continue the catch-up. Growth is a nonlinear process within short periods, which 
are  characterized by periods of weight gain separated by periods of weight loss.61 This 
irregular pattern was not seen for HAZ that consistently increased in all intervention 
months. The beneficial effects observed on growth could be due to enhanced mucosal 
integrity62 and reduced intestinal infections in our children.41 
No effect on growth was observed in the RC (without probiotics) compared to the LC group. 
This is in line with three reviews of randomized clinical trials (RCT’s) in children of mainly 
developed countries, also reporting no benefit of calcium supplementation on weight, height, 
body fat, or lean mass.24-26  
The present study showed that the probiotics did not affect iron and zinc status. Probiotics 
are claimed to improve digestibility and nutrient uptake by intestinal cells.27 A study in 
infant rhesus monkeys given L. reuteri showed an improved  haematocrite,63  but so far no 
information is available about more relevant iron status markers (eg. ferritin, sTfR).  
Levels of iron parameters, eg. Hb, HCT and serum ferritin, decreased and sTfR increased 
over the 6-mo intervention in all groups, whereas serum zinc remained constant. No 
treatment-specific differences were observed in mean change of iron parameters and 
prevalence rate changes of anemia, iron-deficiency, and iron-deficiency anemia, or in zinc 
status. The reduced iron status over 6 months, independent of intervention type, may be due 
to insufficient iron homeostasis to compensate the fast iron mobilization from storage 
needed during growth.22 Chronic  blood loss may also contribute to iron deficiencies and 
anemia in children in developing countries and can be caused by gastrointestinal parasites,48  
Helicobacter pylori64 or allergy to cow’s milk protein.65 No information was available on the 
parasitic infestation or Helicobacter pylori prevalence, neither a deworming program was 
applied in our study population. No adverse events related to cow’s milk protein were 
present in our study. Also, the considerable prevalence of respiratory (90%) and 
gastrointestinal infections (27%) in our study children may have negatively affected iron 
metabolism,66 known as the anemia of infectious disease.67 In addition, the polyphenolic 
compounds of cocoa powder added to our study milk may have inhibited iron absorption.68, 
69  
Conflicting results have been reported on the effect of calcium on iron absorption in adults 
and children with great variability in study design, type and duration of supplementation, 
study population’s age and country.30, 31, 34, 36, 39, 40 Most studies evaluating iron status were 
conducted in developed countries involving children and adolescent with adequate iron and 
calcium intakes and reported  no or a small effects on iron status.36, 39, 40 No difference in iron  
status of preschool children aged 3-5 y was observed after a 5 wk adaptation to a low- (502 
mg/day) versus high- (1180 mg) calcium diet.39 Also, an RCT in pre-pubertal children found 
that low or moderate amounts of calcium (78 mg/d or 312 mg/d) of 2 wk did not interfere 
with iron absorption.36 A long-term, 1-year-intervention study in adolescent girls showed 
that daily calcium supplementation of 500 mg did not compromise iron status.40 With regard 
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to zinc, calcium per se does not impair  zinc absorption in premenopausal women70 but 
reduce net zinc absorption in postmenopausal women.71 So far, evidence from studies in 
children were missing. In our study children, with a low iron and calcium intake, regular 
calcium milk did not adversely affect iron and zinc status as compared to low calcium milk.  
Strengths of our study were its double-blind design, long intervention duration, the excellent 
compliance and high response rate, the strict adherence to a rigorous protocol, and duplo 
assessment of supervised anthropometric measurements by well-trained field workers. Per-
protocol analysis, excluding the few non-compliant subjects (6%) and subjects having 
chronic antibiotic usage, did not change the outcomes. A study drawback is its primary 
design to detect differences in intestinal infection incidence and therefore, sample size may 
have been inadequate to detect group differences in growth or micronutrient status.  
Conclusions 
L. reuteri DSM 17938 modestly improved growth, by increasing weight gain and WAZ 
changes over 6 months and monthly weight and height velocity in Indonesian children.  L. 
casei CRL 431 modestly improved monthly weight velocity.  Regular calcium milk did not 
affect any growth outcome. Neither the probiotics nor regular calcium milk affected iron and 
zinc status. 
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Abstract 
Background 
In contrast to determinants such as malnutrition, mother’s education, and inadequate 
sanitation, the role of poor food-hygiene in the development of diarrhea in low 
socioeconomic urban communities is lacking. This study therefore aimed to assess the 
contribution of food-hygiene practice to the prevalence of diarrhea among children in 
Indonesia.  
Methods 
A cross-sectional study was conducted among 274 randomly selected children aged 12-59 
months in selected low socioeconomic urban areas of East Jakarta. The prevalence of 
diarrhea was assessed during the 7-day record on frequency and consistency of the child’s 
defecation pattern. Food-hygiene practices including mother’s and child’s hand washing, 
food preparation, cleanliness of utensils, water source and safe drinking water, habits of 
buying cooked food, child’s bottle feeding hygiene, and housing and environmental 
condition were obtained through home visit interview and observation by field workers. 
Thirty six practices were scored and classified into poor (median and below) and better 
(above median) food-hygiene practices. Nutritional status of children, defined 
anthropometrically, was measured through height and weight.  
Results 
Factors found to be significantly associated with diarrhea were age, nutritional and 
immunization status, family size and number of under-five children living under 
the same roof.  Among the individual food-hygiene practices, children  living in  a 
house with clean sewage had a significantly lower diarrhea prevalence compared to 
those who did not have one and/or had dirty sewage [adjusted odds ratio (OR): 
0.16, 95% confidence interval (CI): 0.03-0.73]. The overall food-hygiene practice 
score was not significantly associated with diarrhea in the total group, but it was in 
children aged < 2 years (adjusted OR: 4.55, 95% CI: 1.08-19.1). 
Conclusions 
In addition to other major determinants, poor mother’s food-hygiene practices 
contributed to the occurrence of diarrhea in Indonesian children < 2 years from 
low socioeconomic urban areas.   
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Introduction 
 
Despite the substantially declining mortality rate from diarrhea in developing countries,1 
diarrhea still accounts for approximately one-ﬁfth of all mortality in children <5 years, 
annually.2,3 Similar to other developing countries,  diarrhea contributes to 25% of the 
mortality rate and 14% of morbidity among children under five in Indonesia.4,5 The overall 
incidence of diarrhea in developing countries has remained high due to multiple 
determinants6 such as malnutrition,7 low socioeconomic status and education of mothers,8,9 
lack of safe drinking-water, inadequate sanitation and poor hygiene,10,11 crowding12 and low 
maternal age.13 These determinants of diarrheal disease are strongly linked to poverty and 
social inequities.14 Furthermore, diarrheal incidence  differs greatly with the seasons and is 
highest in the first two years of life and declines as a child grows older.2   
Although the determinants of diarrhea among children are well described, information on 
the role of food-hygiene practice in the development of diarrhea and malnutrition among 
children in low socioeconomic urban communities is lacking.15 Many studies conducted in 
this urban settings of developing countries focused on the risk factors of diarrhea related to 
environmental conditions and utilization of sanitation facilities.16-18 A previous study on 
food-hygiene missed some important practices such as food storage, thorough cooking and 
adequate holding temperature15 as recommended by World Health Organization (WHO).19 
Mothers and children in low socioeconomic urban areas in East Jakarta with limited hygiene 
and sanitation facilities tend to have poor hygiene practices such as using dirty cooking or 
eating utensils for their children.20 While poor hygiene practices, especially in food 
preparation and feeding practices, may increase the risk of having diarrhea, up to 70% of 
diarrhea episodes are actually caused by water and food contaminated with pathogens.21 
Therefore, we hypothesized that the prevalence of diarrhea and malnutrition among children 
in low socioeconomic urban areas of East Jakarta is high, not only because children and 
mothers are exposed to the environmental factors that cause diarrhea such as unsafe water, 
and poor sanitation and hygiene, but also due to poor food-hygiene practice. To address this 
hypothesis, we assessed the association of food-hygiene practice with the occurrence of 
diarrheal disease among under-five children in selected urban low socioeconomic areas of 
East Jakarta, Indonesia. The results of this study can be useful in designing an intervention 
study, health plans and policies related to mother and child hygienic behavior. 
 
Methods  
Study design 
A cross sectional study was carried out from October 2004 to February 2005 in an urban 
area of Jatinegara, East Jakarta district, Indonesia. This district was selected because it has 
the highest prevalence of diarrhea and underweight (24%) in under-five children in Jakarta 
province, based on passive surveillance of the local government.  In this urban area, 
purposive sampling was used to target low socioeconomic households: those in which the 
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housing location was along the river side (flooding area) and households within specific low 
socioeconomic areas of city centre (non-flooding area).  
Subjects 
A total of 274 children aged 12 – 59 months were selected randomly from the community 
health post registry. Only one child was selected for the study if a family had more than one 
child at this age category. At the time of selection, the children had been living in this district 
for at least 6 months. Informed consent was obtained from mothers or caregivers after they 
had received an explanation about the study’s objective and method. The study protocol was 
reviewed and approved by the Ethical Committee of the Faculty of Medicine, University of 
Indonesia and National Center for Research and Development, Ministry of Health Republic 
of Indonesia. 
Data collection 
Data collection in this study was divided into three phases: (a) interview of socio-
demographic factors of the family, diarrhea prevalence, food-hygiene practices, (b)  
observation of environment housing condition and the child's defecation and diarrhea 
pattern, and (c) anthropometric measurements.   
A structured questionnaire, used for conducting interviews, consisted of four sections: (a) 
general information, (b) diarrhea prevalence, (c) food-hygiene practice, and (d) nutritional 
status. The questionnaire was developed based on a similar survey,  the guidelines set by the 
WHO, information from staff members of the community health centers and voluntary 
mothers,  and two group discussions in two chosen villages with 8-10 mothers aged less than 
45 years old, having children between 1-5 years of age, living in the study area. 
The interview was conducted with the mothers or caretakers in their house after 
anthropometric measurement of their child. During interview, the enumerator observed the 
environment housing condition. Mothers were asked to fill in the form according to what she 
had observed in her child's defecation pattern (time, frequency and stool’s visual 
appearance)22 for seven days, starting at 8.00 AM each day. Every day one enumerator 
collected the observation form. The enumerator checked whether the child being observed 
had diarrhea or not based on mother’s record presence of three or more watery stools per 
day.  
In addition, mothers or caregivers were interviewed on mother’s and child’s hand washing, 
food preparation, cleanliness of utensils, water source and safe drinking water, habits of 
buying cooked food, child’s bottle feeding hygiene and housing and environmental condition, 
using a structured questionnaire. House and surrounding condition, sewage condition, 
availability of a latrine, and water source were also observed during interview.   
Diarrhea prevalence 
Diarrhea was defined as defecation frequency of three or more loose/liquid stools in a day.23 
We calculated the period prevalence of diarrhea as the percentage of children suffering from 
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diarrhea for three alternative periods: the past 3 months, the past 2 weeks and during a 7-
day recording period. Recall periods of more than 48 hours may lead to underreporting of 
diarrhea cases24  therefore only the prevalence of diarrhea based on the percentage of 
children who suffered from diarrhea during the 7-day recording period was used in the 
analysis.  
Food-hygiene practice 
All 36 variables that may contribute to food-hygiene practices, i.e. mother’s hand washing 
before preparing food and feeding the child, child’s hand washing before eating a meal and 
after defecating/urinating, food preparation, cleanliness of utensils, water source and safe 
drinking water, habits of buying cooked food, child’s bottle feeding hygiene and housing and 
environmental condition, were summed up into a total of 36 scores. Each variable was 
scored as 0 or 1, with 1 representing a positive practice.25 All individual variables were 
assigned equal importance. Total score was classified into poor and better food-hygiene 
practice based on the median score of the population, i.e. food-hygiene practice score  ≤ 19 
was considered as being poor  (n=168), while a score > 19 was considered as being better 
practice (n=168) (Table 5.5).  
Nutritional status 
Wasted, underweight and stunted were defined as weight-for-height z-score (WHZ), weight-
for-age z-score (WAZ), and height-for-age z-score (HAZ) of  less than – 2 SD  based on 
nutritional indices of the WHO Child Growth Standard, respectively.26 Children were 
weighed lightly clothed without shoes using an electronic scale (SECA platform 770, SECA, 
Hamburg) with a precision of 0.1 kg. For children who were not able to stand, the child’s 
weight was obtained by subtracting the mother’s weight from the measured weight. Body 
stature was measured using a microtoise for children who could stand erectly, with a 
precision of 0.1 cm.27 While for children who could not stand, a SECA length board was used. 
Statistical analysis  
The minimum study sample size was calculated for estimating the actual prevalence of 
diarrhea among areas under study. The anticipated proportion of 15% was chosen as average 
diarrheal prevalence in East Jakarta. With 5% precision and anticipating on 20% missing 
data, the minimal sample was 245 children.  
We used STATA for windows release 11 (College Station, Texas 2009) for data analyses.  
Data on weight and height of the children were transferred into z-scores using WHO 
software.26 
Variables, such as child’s age, sex, area of living, nutritional status, breastfeeding practices, 
utilization of health services, maternal schooling, socioeconomic status (SES), family size 
and number of under-five children living under the same roof that had a p<0.25  based on 
bivariate analysis by X2 test were considered as potential confounders.28 SES was categorised 
based on the criteria of the local government (ownership of the house, monthly income, 
Chapter 5 Association of food-hygiene practices and diarrhea prevalence  
 
90 
 
monthly expenditure, type of floor, and availability of latrine). The average score of SES in 
the study population was 15. SES was classified into binary category as described in other 
study:29 households with median score or lower (≤15) as very low SES; or above median  
score (>15) as medium-low SES. 
We next performed single and multiple logistic regression models and used these models to 
assess the association between diarrhea and food-hygiene practices. First, we calculated the 
unadjusted odds ratio (OR) and 95% confidence intervals (CI) of each variable using 
bivariate analysis. Only if the 95% CI did not include one, i.e. p< 0.05, we considered the 
result statistically significant. Secondly, all potential covariates were included in logistic 
analysis to estimate the adjusted OR and 95% CI. Thus, a multiple logistic regression model 
was used to account for the effect of several potential confounding factors, i.e., age, weight-
for-height z-score, immunization status, family size and number of under-five living under 
the same roof. Logistic regression was also used to assess whether there was any effect 
modification (p< 0.05, test homogeneity of the OR). Finally, we assessed the unadjusted and 
adjusted OR and 95% CI of two classifications of food-hygiene practices versus prevalence of 
diarrhea.   
 
Results 
More than half of children resided in the flooding area along the river side. The median age 
of children was 31 months (12.1 – 59.8 months) with an almost equal number of boys and 
girls (Table 5.1).  Half of the children belonged to very low SES families and one third of 
them were from families consisting of six members. Median age of the fathers was 34 years 
(range 20 – 66 years) while the mothers had an average age of 30 years (range 17 – 50 
years).  More than half of mothers had length of schooling ≤ 9 years. The main occupation of 
fathers was private sectors employee (34%), street vendor and small-scale trader or self-
employed (29%), taxi and public transportation driver (12%), construction laborer (10%), 
factory and day laborer (7%), government employee (3%), while 5% was unemployed. The 
majority of mothers (83%) were housewives. A few mothers worked as small traders, street 
vendors, laborers and launderers.  
The minimum labor salary rate of Rp. 600,000 (<US$ 65) per month was used to determine 
the level of family income and expenditure. In one third of the families, the monthly income 
was less than <US$ 65 indicating that they belonged to a very low-income group. In a second 
third of the families, the monthly income ranged between US$ 65 – 110, indicating the low 
income and expenditure group. The last third belonged to the medium income and 
expenditure group, with a monthly income > US$ 110. 
 
Diarrhea prevalences of 40%, 18% and 10% were observed within the time frames of three 
months, two weeks preceding the study and during a 7-day record, respectively (Table 5.2). 
There was no significant difference in diarrhea prevalence between children living in 
flooding and non-flooding areas. The highest diarrhea prevalence was found in children aged 
12 to 23 months: 17% of 7-day diarrhea records. Prevalence tended to decrease as child’s age 
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increased, and the difference in the prevalence was significant between children aged 12 to 
23 months and older. Diarrhea prevalence was not significantly different between sexes. The 
prevalence of stunting, wasting and underweight  among children aged 12 – 59 months was 
32%, 19% and 12%, respectively, and not different between age groups, sexes and living 
areas.  
 
Table 5.1  General characteristics of the study population in Jatinegara sub-district, East 
Jakarta (n=274) 
Variables n (%) or median (min-max) 
    Area of living   
         Flooding site 168 (61%) 
         Non Flooding site 106 (39%) 
    Children  
           Median age (months) 31.1 (12.1 – 59.8) 
           Age group (months)  
                12 – 23 93 (34%) 
                24 – 35 71 (26%) 
                36 – 47 65 (24%) 
                48 – 59 45 (16%) 
           Gender   
                Boy 151 (55%) 
                Girl 123 (45%) 
    Mother  
           Median age (years)  30 (17-50) 
           Length of schooling (n=273) a  
                ≤9 years 156 (57%) 
                >9 years 116 (43%) 
    Household  
           Nuclear/extended familyb 143 (52%)/131 (48%) 
           Family size 6 (3-22) 
    Socioeconomic statusc  
           Medium – low 125 (46%) 
           Very low 149 (54%) 
a One mother was illiterate. 
b Nuclear family consists of only father, mother and children; extended family consisted of a nuclear family and 
their close relatives living under the same roof 
c Categorised based on total score of socioeconomic status (SES) criteria of local government (ownership of the 
house, monthly income, monthly expenditure, type of floor, and availability of latrine).  
 
 
Factors found to be significantly associated with diarrhea were age, weight-for-height z-
score, immunization status, family size and number of under-five children living under the 
same roof (Table 5.3).  The odds ratio for children aged < 2 years was 2.9 times (95% CI: 
1.32-6.48). Children with complete immunization were protected from diarrhea (OR 0.35 
95% CI: 0.16-0.78). Children belonging to families with ≥6 household members had 2.3 
times higher risk of suffering from diarrhea (95% CI: 1.03-4.98). Presence of ˃1 child under 
five years of age living in the same household increased the risk of suffering from diarrhea 
2.8 times (95% CI: 1.26-6.16). The risk of diarrhea was 1.6 times higher when children had  a 
Chapter 5 Association of food-hygiene practices and diarrhea prevalence  
 
92 
 
mother with low education level and family with very low socioeconomic conditions, but this 
was not significantly different, nor was the association with wasting  (OR 2.3 95% CI: 0.70-
6.73). 
 
Table 5.2 Prevalence of diarrhea and malnutrition by age and sex of under-five children in 
Jatinegara sub-district, East Jakarta 
Variables n 
Diarrhea prevalence (%) Undernutrition prevalence (%) 
Past 3 
months 
Past 2 
weeks 
During  
7-day 
record 
Stunted 
(HAZ<-2) 
Underweight 
(WAZ<-2) 
Wasted 
(WHZ<-2) 
Area of living 
Flooding 168 38.1 19.6 10.1 36.3 26.8 9.5 
Non flooding 106 42.5 15.1 10.4 25.5 17.9 9.5 
        
Age group (months) 
12 - 23 93 58.1* 29.0* 17.2* 32.3 19.4 11.8 
24 - 35 71 32.4 11.3 8.5 32.4 25.4 8.6 
36 - 47 65 30.8 15.4 6.2 33.8 24.6 6.2 
48 - 59 45 26.7   8.9 4.4 28.9 26.7 11.1 
All ages 274 39.8 17.9 10.2 32.1 23.4 9.5 
        
Gender 
       
Boy 151 41.7 16.6 9.9 35.8 25.2 11.9 
Girl 123 37.4 19.5 10.6 27.6 21.1 6.6 
HAZ, height-for-age z-score; WAZ, weight-for-age z-score; and WHZ, weight-for-height z-score.  
* Significantly different between ages, p< 0.05, X2 test. 
    
Among the individual food-hygiene variables, children who lived in the house with clean 
sewage significantly had lower diarrhea prevalence compared to those who did not have one 
and/or had dirty sewage (adjusted OR 0.17; 95% CI: 0.04-0.75) (Table 5.4). Children whose 
mother had habits of buying package snacks  showed significantly higher diarrhea 
prevalence compared to those who did not (unadjusted OR 3.00; 95% CI: 1.01-8.93).  
However, the risk of diarrhea became non-significant after adjustment for age, weight-for-
height z-score, immunization status, family size and number of under-five children living 
under the same roof.    
A number of other single food hygiene practices such as mother’s and child’s hand washing, 
food holding time <1 hour before eaten, reheating food before eaten, the use of clean 
utensils, availability of safe water, not frequently buying street food, food bought when were 
still hot and directly eaten, and proper child’s bottle feeding practices seemed to be 
protective for diarrhea, however, the associations were not statistically significant.     
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Table 5.3 Risk factors associated with the occurrence of diarrhea in children aged 12 – 59 
months (n=274) 
Risk factors 
 Diarrhea 
Number 
of cases 
% 
Unadjusted 
OR (95% CI) 
Children 
   General characteristic    
   Living in flooding area 168 10 0.97 (0.44-2.17) 
   Age ≤ 2 years 93 17 2.93 (1.32-6.48)*a 
   Age ≤ 3 years 164 13 2.69 (1.05-6.86)*a 
   Boy 151 10 0.93 (0.43-2.04) 
Nutritional status 
   
   Wasted 36 19 2.32 (0.70-6.73) 
   Underweight 63 14 1.67 (0.71-3.89) 
   Stunted 88 8 0.68 (0.28-1.66) 
Breastfeeding practice history 
   
   Received breastfeeding after birth (n=273) 170 12 1.58 (0.67-3.74) 
   Received colostrum at birth 215 10 1.01 (0.39-2.61) 
   Received exclusive breastfeeding/ 
   No pre-lacteal feeding at birth† 
103 8 0.64 (0.27-1.50) 
   Breastfeeding duration ≥12 months (n=273) 224 9 0.62 (0.25-1.55) 
Utilization of health services    
   Received vitamin A supplementation (n=273) 224 9 0.62 (0.25-1.55) 
   Received complete immunization 188 7 0.35 (0.16-0.78)*a 
Mother 
   
   Maternal schooling ≤ 9 years (less or equal to   
   junior high school) (n=273) 
157 12 1.64 (0.71-3.76) 
Household condition 
   
   Socioeconomic status: very low 149 12 1.58 (0.70-3.56) 
   Family size ≥ 6 persons 98 15 2.27 (1.03-4.98)*b 
   Under-five children  living under the same  roof >1 79 18 2.78 (1.26-6.16)*b 
    † Prelacteal feeding was any nonhuman milk food or fluids provided to the new-borns before breastfeeding on the 
first day of life.58 
*a Statistical significant at p< 0.05, X2 test. 
*b Statistical significant at p< 0.05, Fisher’s exact test. 
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Table 5.4 Distribution of diarrhea prevalence by determinant factors of food-hygiene 
practices among children aged 12 – 59 months  
Food-hygiene practices 
No. 
of 
cases 
Diarrhea 
% 
Unadjusted  p-
value 
Adjusted  p-
value OR (95% CI) OR (95% CI)a 
House and environmental condition (n=274) 
        Clean inside the house 134 7 0.46 (0.20-1.05) 0.07 0.68 (0.27-1.68) 0.40 
   Clean surrounding the house 139 8 0.60 (0.27-1.33) 0.21 0.69 (0.29-1.64) 0.40 
   Existence and clean sewage 74 3 0.19 (0.04-0.80)* 0.02* 0.16 (0.03-0.73)* 0.02* 
   Existence of latrine 172 12 1.89 (0.77-4.61) 0.16 1.53 (0.62-3.92) 0.37 
   Latrine with closet and septic tank 105 13 1.70 (0.78-3.73) 0.18 1.43 (0.62-3.29) 0.41 
   Child’s faeces was thrown in latrine 138 7 0.51 (0.23-1.15) 0.11 0.62 (0.27-1.46) 0.28 
   Other family defecated in latrine 241 11 1.87 (0.42-8.29) 0.41 1.63 (0.35-7.58) 0.53 
   Closed domestic waste disposal 145 10 0.87 (0.40-1.90) 0.73 0.96 (0.42-2.21) 0.93 
Mother’s hand washing (n=274) 
         Before preparing food 80 9 0.79 (0.32-1.94) 0.61 0.79 (0.31-2.04) 0.62 
   Before feeding the child 240 11 4.18 (0.55-31.8) 0.17 4.16 (0.53-32.8) 0.18 
   Using water and soap 193 9 0.73 (0.32-1.66) 0.45 0.71 (0.30-1.70)                                                                                         0.45
Child’s hand washing (n=274) 
         Before eating a meal 185 10 1.02 (0.44-2.35) 0.97 1.08 (0.45-2.61) 0.86 
   After defecating/urinating 49 10 1.00 (0.36-2.77) 0.99 1.14 (0.39-3.32) 0.81  
   Using water and soap 154 10 0.89 (0.41-1.95) 0.77 0.87 (0.38-1.99) 0.74 
Food preparation (n=274) 
         Food cooked by mother 201 10 1.10 (0.45-2.71) 0.84 1.00 (0.38-2.62) 0.99 
   Cooked special food for childb 75 16 2.48 (0.99-6.19) 0.05 2.56 (0.88-7.58) 0.08 
   Food holding time before eaten <1 hour 151 10 0.93 (0.43-2.04) 0.86 0.78 (0.34-1.78) 0.55 
   Reheating the food before child eatingc 191 9 0.46 (1.18-1.13) 0.09 0.48 (0.18-1.28) 0.14 
   Feeding child with warm/hot food 150 11 1.31 (0.59-2.92) 0.50 1.16 (0.49-2.74) 0.74 
   Store food covered/closed 254 10 1.03 (0.23-4.67) 0.97 0.93 (0.19-4.41) 0.92 
Cleanliness of utensils (n=274) 
         Wash utensils inside house 236 11 2.23 (0.51-9.80) 0.29 1.97 (0.43-9.11) 0.38 
   Wash utensils with flowing tap water 76 9 0.86 (0.35-2.10) 0.73 0.86 (0.33-2.21) 0.75 
   Change water in the pail 225 9 0.50 (0.21-1.21) 0.13 0.48 (0.18-1.26) 0.14 
Water source and safe drinking water(n=274) 
       Piped water source 72 10 0.93 (0.38-2.29) 0.87 0.97 (0.37-2.51) 0.94 
   Existence of septic tank  106 13 1.67 (0.76-3.67) 0.20 1.41 (0.61-3.25) 0.42 
   Refill/branded drinking water source 57 11 1.04 (0.40-2.71) 0.93 1.02 (0.37-2.80) 0.98 
   Cover on water storage 270 10 1.32 (0.37-4.76) 0.67 1.06 (0.28-4.07) 0.93 
Habits of buying cooked food (n=274) 
         Not Frequently bought street food 109 7 0.57 (0.24-1.35) 0.21 0.52 (0.21-1.29) 0.16 
   Bought hot food from outside 159 13 1.92 (0.82-4.54) 0.14 1.71 (0.69-4.26) 0.25 
   Food given to child were still hot 235 11 1.43 (0.41-4.98) 0.58 1.48 (0.38-5.73) 0.57 
   If the food still hot, food directly eaten 193 9 0.61 (0.27-1.38) 0.24 0.71 (0.30-1.67) 0.43 
   Not frequently bought snack  29 17 2.01 (0.70-5.77) 0.19 1.43 (0.43-4.75) 0.56 
   Bought package snack 188 13 3.00 (1.01-8.93)* 0.048 2.37 (0.76-7.35) 0.14 
Child’s bottle feeding hygiene 
         Using bottle feeding (n=155) 96 13 2.67 (0.71-9.88) 0.14 3.33 (0.78-14.2) 0.10 
   Bottle was washed and boiled (n=96) 24 8 0.56 (0.11-2.78) 0.48 0.67 (0.11-3.97) 0.66 
   Clean bottle milk (n=95) 32 6 0.35 (0.07-1.72) 0.20 0.22 (0.03-1.53) 0.13 
Note: OR, odd ratio. 
a Adjusted for age, weight-for-height z-score, immunization status, family size and number of under-five children  living under 
the same roof.  
b n=201 ; c n=234;  
* Statistical significant at p< 0.05, X2 test. 
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The association between the overall food-hygiene practice score and diarrhea among 
children aged 12 – 59 months was not significant, neither in the crude nor in the adjusted 
analyses (Table 5.5).  However, a significant interaction with age and food-hygiene 
practices was observed (p < .001). Stratified analysis by age showed that a poor food hygiene 
score was independently associated with diarrhea in children < 2 years, although the 
confidence interval was very wide. 
 
Table 5.5 Association between food-hygiene practices and diarrhea among children aged 12 
– 59 months (n=274)  
Determinants 
Food-hygiene 
practice 
Diarrhea  
% 
Unadjusted 
OR (95% CI) 
Adjusteda 
OR (95% CI) 
 
All children  
    Poor 11 1.15 (0.51-2.60) 1.33 (0.57-3.14)  
     Better 9 1.00 1.00 
 p-value  0.73 0.51 
Stratified by age group    
   ≤ 2 y (n=93)     Poor 23 2.63 (0.78-8.89) 4.55 (1.08-19.1)*  
                        Better 10 1.00 1.00 
 p-value  0.12 0.04* 
   > 2 y (n=181)     Poor 5 0.55 (0.17-1.78) 0.62 (0.18-2.14)  
                        Better 9 1.00 1.00 
 p-value  0.32 0.38 
Note: Poor food-hygiene practice (score ≤19 of 36 score); good practice (score >19 of 36 score).  
a Adjusted for age (continuous), weight-for-height z-score (continuous) and number of under-five children  living 
under the same roof (>1/1). 
*Statistical significant at p< 0.05, X2 test. 
 
 
Discussion 
 
Our study indicates that the risk of having diarrhea is increased in children aged <2 years 
whose mother had poor food-hygiene practices. Children who lived in the house with clean 
sewage had a lower risk of diarrhea.  
We found that children aged <2 years were more vulnerable to suffer from diarrhea  as 
supported by previous studies in Vietnam15 and Bangladesh30. This finding is also in line 
with the previous review that diarrheal diseases were extremely high during the weaning 
period (6-24 months).21 The higher prevalence may be explained by the fact that weaning 
foods prepared under unhygienic conditions to our children are frequently contaminated 
with pathogens and are an important risk factor in the transmission of diarrhea.21 Up to 70% 
of diarrhea episodes were caused by water and food contaminated with pathogens.21 
Enterotoxigenic Escherichia coli (ETEC) was the most common identified pathogen 
constituting about 14% of diarrhea among children in community-based studies.31 While 
Enteropathogenic E. coli (EPEC), rotavirus, Campylobacter, Cryptosporodium and Shigella 
(5-9%) were the next common pathogens identified in these studies. Transmission of E. coli 
especially ETEC is known to be specifically associated with contaminated weaning foods 
among younger children in developing countries.32,33 Moreover, this pathogen was 
considered to be responsible for the diarrhea-induced weight faltering.21 Younger children 
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are also at risk to be infected by rotavirus because the specific immunity has not yet been 
developed to fight against this pathogen entering the digestive system.  Rotavirus is 
transmitted primarily person-to-person through the fecal-oral route.34 Children are infected 
with rotavirus through their contact with an infected person outside the household and poor 
food-handling hygiene practice such as contamination of mother’s hands by infected fomites 
or surfaces.35, 36 Improved water and sanitation is not sufficient to reduce the spread of this 
virus, as indicated by similar rates of illness in developed and developing countries.37, 38 
Our study confirmed that children who lived in a house with clean sewage had significant 
lower risk of having diarrhea than children who did not have one. A previous study 
conducted in an urban poor setting in Indonesia  also reported an increased  risk of having 
diarrhea in children with unavailability of sewage and/or place to dispose the child’s stools.39 
Living conditions such as type of housing, population density, sanitation facilities, and water 
source were observed earlier as the major determinants for enteropathogen 
contamination.40-43 Pathogens in feces disposed in sewage near the house can harm the 
environment and it could contaminate the food eaten by children.40-43 In developing 
countries, both E. coli and rotavirus were the common pathogens associated with 
waterborne disease especially for children who live in poor environmental conditions. 
Outbreaks of viral gastroenteritis resulting from sewage contamination of water supplies 
have been well described.44,45 Contamination of drinking water by sewage through pump 
failure or blockage of a sewage system has been previously described.46 Unfortunately, 
information on diarrhea-causing pathogens could not be obtained in our study.  
In our study we included a complete set of food-hygiene practices identified in our 
community. This approach may give advantages because important and specific local 
practices are not missed. However, we had to rely on recall methods to investigate food-
hygiene practices. This may be the reason why we could not observe significant associations 
between overall and some of single food-hygiene practices Mothers may report social 
desirable practices which they do not perform.47  Mothers may also forget some of the 
practices. For instance, the assessment of handwashing practices seems to require 
repeatability observations to avoid risks of misclassifying exposure, which reduces the 
statistical power to identify associations.48 
Some data in this study which were derived from direct observation, such as observations in 
the house and its environment, were significantly associated with diarrhea prevalence. Direct 
observation is most preferred because it allows first hand data collection in a natural setting, 
and this was used in prospective cohort studies in Nigeria and Brazil.49, 50 Although there can 
be potential bias in (any) recall method, this way of data collection is less expensive and 
relatively fast, and is still  considered as a way to find out the extend of the problem in a poor 
community.25        
Studies on the effect of seasonal variation on diarrhea prevalence are contradictive. Our 
study was conducted in a rainy season which was assumed to be the peak of diarrhea 
prevalence as described in a previous study within a similar community.51 However, some 
recent studies in developing countries observed high diarrhea prevalence in dry seasons.52-56 
Another study reported that in a tropical area, rotavirus diarrhea occurs throughout the year, 
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increasing frequency during the dry season whereas bacterial diarrhea peaks during rainy 
season.57  
 
Conclusions 
In conclusion, the poor food-hygiene practice score was not associated with the prevalence of 
diarrhea among children under five, but was significantly associated with more diarrhea 
among children aged <2 years. Therefore, food safety education should be especially targeted 
to this age group, focusing on clean sewage and good food-hygiene practices. Direct 
observation methods are preferred for future studies to avoid over- or under-reporting by the 
mothers on their child's feeding practice. 
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Acute diarrhea and acute respiratory tract infections (ARTIs) continue to lead the infectious 
cause of morbidity and mortality among children <5 years of age in developing countries.1-3 
The burden of this problem calls for effective public health intervention as the preventive 
strategies (including provision of safe water and sanitation, exclusive breastfeeding, hand 
washing, vitamin A and zinc supplementation, and vaccinations) are available in developing 
countries, but are not always effective to reduce the burden of these diseases.3 Efforts to 
prevent diarrheal disease by probiotics and milk calcium supplementation as alternative 
strategy are promising.4 Probiotics are often supplemented to dairy foods and both 
probiotics5-7  and calcium in milk4 may strengthen intestinal infection resistance. Research 
presented in this thesis consists of an intervention study and a cross sectional study. As 
presented in the general introduction, the research described in this thesis focused on four 
major research questions as follows:  
What are the effects of an intervention using probiotics and calcium on reducing the 
incidence and duration of diarrhea and ARTIs among Indonesian children aged 1-6 years?  
What are the effects of probiotics and calcium supplementation on severity of diarrhea 
based on Modified Vesikari Scale and fecal markers?  
What are the potential effects of probiotics and calcium on growth, iron and zinc status?   
What is the association between food-hygiene practices and prevalence of diarrhea among 
children in low socioeconomic urban areas of East Jakarta? 
The next section presents the main findings of the thesis, methodological issues are 
discussed and results are placed in a broader perspective. Moreover, implications for public 
health and future research are given. 
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6.1. Main Findings 
The main findings of this thesis are summarized in Table 6.1.  
Our community-based RCT involving 494 Indonesian children who were randomized to 
receive milk with either low or regular calcium as well as two different types of probiotics 
revealed mixed results (chapter 2-4).   
We observed a consistent benefit of the probiotic strain Lactobacillus reuteri DSM 17938 for 
many different outcomes. L. reuteri may prevent diarrhea especially in children with lower 
nutritional status (chapter 2) and reduce total duration of diarrheal episodes (chapter 3). 
This probiotic modestly improved growth, by increasing weight gain and WAZ changes over 
6 months and monthly weight and height velocity in Indonesian children (chapter 4). 
However, L. reuteri did not affect diarrhea severity.  
The other probiotic strain, L. casei CRL 431 modestly improved monthly weight velocity 
(chapter 4), but this strain did not reduce diarrhea incidence (chapter 2) and duration or 
severity of episodes (chapter 3).  
In contrast to these findings, milk calcium alone did not affect any of the outcomes (chapter 
2-4). Also, none of the dietary treatments affected incidence and duration of ARTIs 
(chapter 2) and iron and zinc status in Indonesian children (chapter 4).  
Our cross sectional study showed that in addition to other major determinants, poor 
mother’s food-hygiene practices contributed to the occurrence of diarrhea in Indonesian 
children <2 years from low socioeconomic urban areas of East Jakarta (chapter 5).
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6.2. Internal and external validity 
This section presents a number of methodological considerations and puts findings in a 
broader perspective. We first discuss the intervention study and subsequently address the 
cross sectional study.  
6.2.1. Intervention study 
A major part of this thesis is based on an intervention study that is subject to certain 
limitations. 
Study population 
Apparently healthy children 
Because the study aim was to prevent the incidence of diarrhea and ARTIs, we included 
apparently healthy children without severe illness, pulmonary tuberculosis and severe 
malnutrition, which have the advantage of less interference with (co) morbidity or drug 
treatment (e.g. antibiotics). We involved mild and moderately (but not severely) 
malnourished children that gave the advantage that an additional beneficial effect of 
probiotics and calcium in malnourished subjects can be observed. Primary and secondary 
outcomes of this study were adjusted for nutritional status to eliminate the influence of 
confounding. Moreover, we checked interaction of nutritional status (effect modification).  
Subjects with increased susceptibility to infections 
We selected young children because the prevalence of infections and malnutrition among 
children aged <5 years in low socioeconomic urban communities in Indonesia remains 
high.8, 9 During our acceptance study, which was conducted before the trial, we observed that 
the age of children who entered the study was mainly between 2 and 5 years. The main 
underlying reason was that we included only non-breastfed children in the study. We 
excluded breastfed children because of the well-known protective effect of breast milk 
against infection, which may affect the intestinal microbiota,10 and thus may result in 
confounding. In addition, for ethical reasons, the intervention must not interfere with the 
national breastfeeding program for young children. We, therefore, prioritized children with 
this age range to be included in the intervention study. However, due to the tight eligibility 
criteria of the study, but to prevent insufficient numbers of children entering and having an 
underpowered study, children between 1 and 6 years of age were recruited for the study. 
Higher morbidity of diarrhea in children from families with lower socioeconomic status has 
been observed in urban areas of some developing countries e.g. Jakarta, Indonesia;11 
Gaziantep, Turkey;12 Accra, Ghana.13 It is therefore, that our study was conducted in a low 
socioeconomic urban area of East Jakarta.  
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Children with low calcium intake 
We chose a study population with a low habitual calcium intake because the assumable 
benefit of calcium supplementation on resistance to the intestinal infection is likely higher in 
this population. Therefore, children with daily calcium intake of >75% recommended daily 
allowances (RDA) (> 375 mg) were excluded. Calcium intake status was assessed during the 
screening phase by means of a semi-quantitative food-frequency questionnaire (S-FFQ) that 
was validated and specifically designed to measure calcium intake in less affluent children 
(unpublished results). Furthermore, we assessed calcium intake from analysis of fecal 
calcium excretion, which reflects calcium intake over the past days. Both measurements of 
calcium from S-FFQ and fecal excretion confirmed that our subjects had a low calcium 
intake as expected, mainly because of low consumption of milk and dairy among children in 
low socioeconomic urban areas of Indonesia. There are no published data available yet at 
national scale for calcium intake. Available data suggest that Indonesian children <5 years 
have a low dietary calcium intake not meeting their age-specific RDA 14-16 with an average 
intake as low as ≈80 and ≈190 mg/d for non- and breastfed children aged 1-3 years, 
respectively.15 Our previous survey in selected urban low socioeconomic East Jakarta 
revealed that 46% and 61% of the children had a calcium intake less than 75% and 100% of 
RDA (Figure 6.1; unpublished results).  This is in line with the reported ≥70% prevalence of 
inadequate calcium intakes the Filipino, Cambodian and Mongolia children.17 
 
Figure 6.1 Percentage children who had calcium intake meeting 25%, 50%, 75% and 100% 
of recommended daily of allowances in children aged 1-5 years of selected urban low 
socioeconomic area of East Jakarta, Indonesia. 
Study design 
The major strength of our study was our focus on prevention in contrast to most previous 
studies on probiotics, which aimed at treatment of institutionalized or hospitalized children. 
There is a difference between hospitalized and community cases in disease severity and it 
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can be hypothesized that the public health impact of nutritional interventions is expected to 
be higher in milder, and thus community, cases. Additional strengths were the double-blind, 
placebo-controlled design: characterized by strict adherence to a rigorous protocol, use of 
validated instruments in the assessment of outcomes, long duration of the intervention, and 
excellent compliance rate.  
Blinding 
RCTs should preferably be double-blind, i.e. subjects and research staff must be unaware 
about the type of treatment until data-analysis is completed. Studies of probiotics often lack 
a control group, blinding, validated outcomes, or standards for reporting adverse events.18 A 
lack of proper blinding is the most common bias. Our study carefully considered this 
potential bias by having researchers, mothers, children, and laboratory personnel unaware of 
the treatment until all biochemical and data analyses were finished, and until after the blind 
review meeting. Also, the data safety monitoring board (DSMB) and an independent person 
at SEAMEO RECFON kept three sets of sealed envelopes allowing deblinding per subject 
without disclosing other children’s treatments. 
Randomization 
To prevent selection bias in a RCT, subjects should be randomly divided over the 
intervention and placebo groups. To ensure an equal balance of baseline values that may be 
of influence on the response of subjects to probiotic and calcium supplementation, eligible 
children were admitted to the study on enrolment basis and stratified according to area of 
living (flooding and non-flooding), age (<57 and ≥57 months) and gender. A randomization 
table with treatment codes and block size of eight was generated using SAS version 9.1 (SAS 
Institute, Inc, Cary, NC) by an independent person at Wageningen University. 
Randomization in our study was successful, because demographic, anthropometric and 
lifestyle characteristics of the subjects were well balanced over the four intervention groups. 
Randomization was maintained throughout the study period since there was no selective 
drop-out related to the interventions. 
Intervention 
Important factors concerning our intervention were dose of calcium and probiotics, type of 
probiotic strains, intervention duration and compliance. 
Dosage of calcium 
We used a low (50 mg) as well as a high (440 mg) daily dose of calcium. The dosage of 50 mg 
of calcium per day by providing low calcium milk seems very low. However, to be able to 
obtain a difference in calcium intake between the control (Low calcium milk, LC) and 
experimental (Regular milk calcium, RC) group, subjects were asked to exclude dairy from 
their habitual diet. Normally, milk and milk-based foods are the major sources of calcium in 
children’s diets. However, milk is not the only important dietary calcium source in our study 
population because milk is considered as an expensive commodity for less fortunate 
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communities. Local calcium-rich food sources (e.g. tofu and tempeh) are frequently 
consumed by the children. These common foods could not be excluded from the children’s 
daily diet for ethical reasons. By allowing these non-dairy calcium-rich habitual foods, 
besides providing LC milk resulting in additional 50 mg calcium/day, the median total daily 
calcium intake of subjects in the LC group was 206 (interquartile range 162, 249) mg/day. 
This amount was largely comparable with that provided by their habitual intake (generally 
low in calcium) as mentioned above (Figure 6.1). The Indonesian RDA for calcium for 
children aged 1-6 y old is set at 500 mg per day,19 which is roughly equivalent to having two 
servings of milk per day20, 21 as part of the existing habitual eating pattern. Calcium is not 
widely distributed in the food groups and milk as well as milk products are excellent source 
of calcium.22 Therefore, an adequately high calcium intake is hardly achievable via dietary 
intake in the usual eating pattern of our children when dairy is not included.16 By 
supplementing regular calcium milk, the median calcium intake of the children increased to 
589-602 mg per day, which was presumed of sufficient contrast with the LC group 
consuming ≈200 mg calcium in total per day.  
Probiotic Strains 
 
Food microbes should have a Generally Regarded As Safe (GRAS) status. They have a long 
history of safe use in foods, are non-pathogenic, and are preferably acid and bile tolerant.23 
Lactobacilli are generally regarded as safe and they have a long history of safe use in foods.23, 
24 The applied L. reuteri and L. casei strain were selected because of their suggested anti-
diarrheal potential in young children in previous studies.25-28 L. reuteri DSM 17938 has been 
derived from the original strain of L. reuteri (American Type Culture Collection strain 
55730), by removal of antibiotic resistance gene-carrying plasmids.29 This strain has over 
recent years been accepted in the US as GRAS for their intended use.30 A recent randomized 
controlled trial indicated that the use of L. casei CRL 431 in early infancy is safe, well 
tolerated and has no adverse effects on growth and infant behavior.31 
The Food and Agriculture Organization (FAO)/WHO defined in 2001 probiotics as ‘‘live 
microorganisms which, when administrated in adequate amounts, confer a health beneﬁt on 
the host.’’24 It implicates that probiotic strains should remain alive in the product and should 
survive passage through the human gastrointestinal tract.32 Also, probiotics must be 
provided in an adequate dose in order to exert the desirable effects.24 For a strain to be 
selected as probiotic, it should preferably meet certain criteria i.e., resistance to gastric and 
bile acids, adherence to mucus and/or human epithelial cell and cell lines, possess 
antimicrobial activity against potentially pathogenic bacteria and/or possess the ability to 
reduce pathogen adhesion to surfaces.33, 34 Probiotics must be able to exert their benefits to 
the host through growth and/or activity in the human body.34, 35 It is the ability to remain 
viable at the target site and to be effective that should be verified for each potentially 
probiotic strain. The WHO recommends all strains to be deposited in an internationally 
recognized culture collection.33 Many probiotic products were originally developed by and 
for the dairy industry, but nowadays probiotics are included in a wide range of foods, drinks 
and supplements. 
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It is important to maintain high viable survival rates of probiotics during delivery through 
the gastrointestinal tract. To ensure high survival rates of the probiotic strains, straws 
containing probiotics in our study were stored cooled (<100C) at all times until delivery. 
Viability of the probiotics cq shelf-life of the probiotic straws was checked each month by 
selective plating. Both probiotic strains in the straws remained >90% viable during the 
intervention period. Regarding the ability to survive within the gastrointestinal tract, it is 
reported that L. reuteri DSM 17938 can survive passage through the human gastrointestinal 
tract after the consumption of a low-fat probiotic spread.32 
Dosage of probiotics 
The probiotic dose is important to achieve clinical effects. The importance of the dose used 
has been underlined in many studies, it is therefore that we should be more cautious on this 
aspect. In the past many commercial products claimed to have e.g. 109 colony-forming unit 
(CFU) of probiotics whereas in reality probiotic viability had declined significantly during 
shelf-life.36 To prevent consumer misleading, probiotic doses and viable concentration of 
each probiotic present at the end of shelf-life are necessary to be clearly stated in the labeling 
of the probiotic product, which can be better monitored and guaranteed.33,37 The probiotic 
dosage selected for our intervention was based on supplier's information of efficacy, 
application in children and safety concerns when dosed for longer periods of time. 
There is no single cut-off value for the probiotic dose beyond which clinical effects start to 
occur. A recent Cochrane review reported the efficacy of probiotics to treat diarrhea: 15 
studies used a high probiotic dose (>1010 CFU/day) and 26 used a low dose (<1010 
CFU/day).5 However, they concluded that the beneficial effects of probiotics to treat acute 
infectious diarrhea were dependent on the bacterial strain and the dose. Different probiotic 
strains have different effective dosages. It should be noted that our study was in a 
community setting and had diarrhea prevention as outcome, which is clearly different from 
studies in hospital settings applying probiotics for treatment purposes as reviewed by 
Cochrane. Higher dosages may be needed for treatment of hospitalized severe cases than for 
occasional and generally milder cases in the community. However, until now, there are no 
data available indicating “the effective probiotic dose” for prevention of diarrhea in 
otherwise healthy children given probiotics for a longer time period. Moreover, it can be 
questioned whether there will be a substantiated single probiotic dose advise in the future. 
Weizman et al documented that child care-visiting infants fed a formula supplemented with 
L. reuteri ATCC 55730 (sister strain of our study strain) at a dose of 1.2 x 109 CFU/day or 
Bifidobacterium lactis 1.2 x 109 CFU/day had fewer and shorter episodes of diarrhea, with 
no effects on respiratory illnesses.25 They found that effects were more prominent with L. 
reuteri than B. lactis.25 This dosage is within the range of the dose applied in our study as we 
used a dose of 5 x 108 CFU/day for both L. reuteri and L. casei. The dosage of our probiotics 
strains is also within the effective dosage recommended by FAO/WHO during their 
consultation meeting in 2001.38 As stated in the Introduction section of this thesis, in this 
consultation, the minimum effective dose of ≥108 CFU/day has been recommended for 
therapeutic effects.38 The rationale of this recommendation was derived from the reported 
minimum effective dose for therapeutic cultures from some studies to be 106-109 viable 
CFU/day.39 However, some other studies showed that the minimum dose of some strains 
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such as L. rhamnosus GG to yield fecal recovery was 1010 CFU/day,40, 41 and L. johnsonii LJ1 
to elicit immune effects was 109 CFU/day, whereas dose of <108 CFU did not.42 The minimum 
dose of 109 CFU/day and consumption of 100 g or ml (a food containing at least 107 cells per 
gram or milliliter) was recommended for dairy products as this dosage was also 
recommended by the Japanese Fermented Milk and Lactic Acid Bacteria Beverages 
Association.38, 43, 44  
Study duration 
When we designed our 6-month community-based RCT (2006), several meta-analyses, 
systematic reviews and trials on probiotics and diarrhea were published. These studies 
reported beneficial effects after respectively very short study durations (<2 weeks) and 
mainly in hospital-based settings aiming at treatment of diarrhea.5 Studies on the prevention 
of diarrhea in healthy children living in the community were mainly in day-care center based 
studies (6 studies) in Western countries with study duration between 3 to 18 months.25, 45-53 
Thus far, only 1 randomized trial has focused on the role of probiotics in prevention of acute 
diarrhea in a community setting in a developing country. This study using LGG strain 
suggested a significant reduction of acute diarrhea with duration of 15 months.54, 55 However, 
there is no data available indicating minimal study duration for diarrhea prevention by 
supplementation with the probiotic strains, L. reuteri and L. casei, used in our study. 
Considering the safety aspects and based on our feasibility in predicting the prevalence of 
diarrhea in the community, we decided for study duration of 6 months. We also considered 
the logistics arrangement, long holiday after Ramadan (Islamic holiday) and possibility of 
flooding study sites leading to impaired access. To support our prediction, the sample size 
was calculated thoroughly on the basis of the expected effect size of 21% reduction of mean 
number of diarrheal episodes and 0.7 day reduction of mean diarrhea duration over a 6-
month intervention period. Effect sizes were based on meta-analyses of probiotics.7, 56 With a 
minimum 480 children, we assumed that the 6 months would be sufficient to detect this 
effect size.  
RCTs on probiotics and growth and on other constituents such as prebiotics and LC PUFA 
showed effects on child growth after 12 months. With a study duration of 6 months we were 
only able to examine relatively short-term changes in growth outcomes. Therefore, we 
cannot exclude a possible beneficial effect of long-term intake of probiotics and calcium on 
growth. 
In a small proof-of-concept RCT on calcium supplementation and diarrhea in adults, anti-
diarrheal effects were already visible within 3 weeks. In that study all subjects were orally 
infected with a live but attenuated enterotoxigenic E. coli vaccine strain leading to 100% 
infectivity.4 This is not the case in a community trial, where the number of diarrheal cases 
follows less predictable ‘natural’ incidence rates. Based on the above-mentioned study, an 
intervention duration as short as a few weeks for calcium might be already effective and it is 
difficult to think of physiological arguments why efficacy would disappear after (much) 
longer study duration. 
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Compliance 
Our double-blind randomized placebo-controlled study was conducted with an excellent 
compliance rate. Subjects in our RCT consumed 180 mL of milk twice daily (not together 
with a meal) by using the straws provided. Mothers were requested to maintain the child's 
habitual diet but to exclude probiotic, prebiotic or high calcium foods/drinks other than the 
supplied ones. Compliance was checked by measuring the amount of milk consumed by 
using a calibrated stick put into the tetra-packs to score the remaining volume by using a 
pretested 5-point scale. The field workers observed the children drinking milk at least once a 
week and empty packages had to be shown during visits. Activities with creative and 
educational contents were implemented to maintain compliance of both mothers and 
children. A small acceptance test (n=65 children aged 1-6 years) was conducted before the 
intervention study to check the acceptance of regular milk and (placebo) straws supplied for 
7 days. The acceptance of liquid milk and straw usage was high (83% and 98%, respectively). 
A 2-day milk drinking acceptance test was part of the screening procedure (to identify 
potential non-compliant subjects) and only children that didn’t refuse to drink milk and did 
not show allergy or intolerance to the products were included in the intervention. 
All measures reflected an excellent compliance rate of 94%; apart from the few subjects who 
stopped prematurely (n=3 from total n=494), only 6% of subjects consumed less than 70% of 
the total frequencies (2 consumption units per day x 168 days intervention) for at least ¾ 
empty packages of 180 ml milk. We performed our primary analysis of the results according 
to the intention-to-treat (ITT) principle. Intention-to-treat analysis was performed for all 
outcomes and for all eligible children who were randomly allocated to treatment and had 
consumed the intervention products at least once. Per-protocol analysis, excluding the few 
noncompliant subjects (6%) and subjects having chronic antibiotic usage, did not change the 
results. 
Outcomes  
Definition of diarrhea 
There is large variability in defining the outcome measures in probiotic studies on diarrhea.5, 
57 In our study, diarrhea was defined according to the WHO definition (≥3 loose/liquid stools 
in 24 hours).58 In addition, all reported diarrhea (broader definition: ≥2 loose/liquid stools 
in 24 hours) was evaluated. 
Our study was performed in a community setting and aimed for diarrhea prevention, which 
is quite different from clinical or hospital settings focused on treatment. Only children with 
more severe diarrhea and dehydration symptoms (or additional underlying health problems) 
are hospitalized, and use of the WHO definition of diarrhea in such settings is highly 
applicable and valid. There are reasonable arguments to question whether it is equally valid 
in a community setting with generally milder diarrhea cases. Therefore, it is important to 
also separately report on all reported diarrhea because of the following reasons: (a) other 
clinical trials have used broader diarrhea definitions as well;59-61 (b) the WHO definition 
considers stool consistency to be more important than frequency;104,109 and their definition 
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leaves room for registration of any increase in normal stool frequency; (c) mothers also 
reported on diarrhea when they considered their children's stool appearance more watery 
and more frequent than normal, which was often before the WHO-definition of diarrhea was 
met; and (d) milder forms of diarrhea are more commonly seen by primary pediatricians and 
are considered a health problem too.62 Importantly, the WHO definition is the best validated 
definition, but it was not validated in community settings. It may not be generalizable to 
different settings such as our intervention, which included children of older age and an 
urban community setting.63    
To avoid overestimation of diarrhea frequency using both diarrhea definitions in this study, 
not every child’s defecation can be regarded as one frequency. Stool frequency was counted 
strictly when there was at least 1-hour interval since the previous defecation.64 We did not 
only rely on mother’s perception but implemented an active surveillance to verify mother’s 
daily records with twice-a-week visits of trained field workers and twice-a-month visits of 
field supervisors. The physician and monitoring expert accompanied the field workers on 
several of their home visits. All endpoints were assessed using structured and pretested 
forms as applied by others.64-67 The forms were adapted to the local situation and were used 
by field workers who were rigorously trained and supervised on their application (chapter 
2). To avoid over-reporting in using “all reported diarrhea”, we restricted the frequency of 
diarrhea with cut off 2 or more liquid/loose stool. To prevent potential bias of researchers in 
classifying “all reported diarrhea”, all data related to both diarrhea definitions were obtained 
when all researchers and study subjects were completely blinded to subjects' treatment and 
study outcome. For both WHO and the broader definition of diarrhea, probably some 
random misclassification of diarrhea incidence has occurred, but these misclassifications 
were probably distributed equally across the groups. WHO-defined diarrhea reduction was 
not statistically significant, whereas the reduction of "all reported diarrhea" was statistically 
significant, probably because of increased study power due to additional diarrhea cases. 
Assessment of incidence and duration 
Disease incidence was the number of episodes divided by child-years of observation.68 An 
episode was considered to have ended on the last day of diarrhea followed by 2 diarrhea-free 
days.69 The number of episodes is the sum of all diarrheal episodes that occurred during the 
intervention period.  To eliminate the effect of seasonal variation on diarrheal incidence, the 
eligible children were included during two different time periods: December 2007-June 
2008 (covering mainly rainy seasons) and March-September 2008 (representing the dry 
seasons). Children living in flooding areas were admitted in dry seasons and children in non-
flooding areas were included in rainy seasons. 
We defined duration of diarrhea in two ways: episode duration and cumulative (total) 
duration of all episodes (chapter 4). Episode duration was defined as number of days from 
first until last excretion of the loose or liquid stool that is not followed by another abnormal 
stool in each episode.64,70 In our prospective RCT, some children experienced recurrent 
episodes of diarrhea (more than one episode). Therefore, besides calculating the duration of 
each episode, we also calculated the cumulative (total) duration of all diarrhea episodes. The 
cumulative (total) duration of diarrhea was the sum of all diarrheal days of all episodes per 
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child per 6-month of the intervention period.71,72 It reflects the cumulative time spent with 
diarrhea of each child during 6 months of intervention.  
Assessment of severity 
Among the numerous methods to assess diarrhea severity, we selected clinical measurement 
by a modified Vesikari score (MVS) based on the mothers’ subjective information. In 
addition, objective measurements of fecal markers were used i.e. fecal osmolarity, mucin, 
and calprotectin. 
One of the most commonly used severity scales is the Vesikari 20-point scale (an episode of 
gastroenteritis with a score of ≥11 is considered severe).73,74  The Vesikari scale has not been 
formally validated and has not been applied by any trial on probiotics in a community setting 
in a developing country. However, this method has been commonly used in cohort studies on 
diarrhea and rotavirus vaccines, and has been adopted as reliable method on the basis of its 
frequent use in clinical trials.75 
We slightly adjusted the Vesikari score to better fit with our community situation and study 
population. We graded the severity by using this slightly modified Vesikari scale (18-point) 
and asked a qualitative report of the mothers for fever (yes or no) instead of rectal 
temperature. Also, the percent dehydration was replaced by estimated degree of 
dehydration73,75-77 since this variable is not easily assessed in our community. This MVS 
method was pre-tested to ensure its applicability in our study population.The MVS applied 
in our study is similar to MVS reported by Freedman et al.75 In the study of Freedman et al, 
MVS was considered to be reliable, valid, and easy to administrate by mothers and field 
workers. Also, the MVS was recently recommended to be used as a measure of diarrhea 
severity in outpatient clinical studies of young children.75 
Considering that expected effect sizes of dietary interventions in community setting are 
generally small, we included objectively measurable and quantitative fecal markers of 
diarrhea severity in our study besides the more subjective and semi-quantitative MVS.  
There is increasing interest in non-invasive, objective markers to assess intestinal infection 
severity and/or mucosal inflammation in clinical studies. Candidates of such potential 
markers are fecal osmolarity, calprotectin and mucin. Preventing ex-vivo bacterial 
fermentation and thus artificial osmolyte increases is very important in the measurement of 
fecal markers. Therefore, we implemented a very strict procedure for fecal sample collection 
to ensure quick cooling and storage of samples in freezers.  
Although, there has been scientific debate whether fecal osmolarity has the potential to 
differentiate osmotic from secretory diarrhea by evaluation of the stool ion gap,78 this marker 
is also useful to quantify diarrhea severity in children. When gastrointestinal digestion or 
microbiota-related metabolism is altered, diarrhea can result from osmotic forces in the 
lumen (e.g. lactose in lactose malabsorbers) or an increased secretory state (e.g. bacterial 
enterotoxin-induced diarrhea).79 
We used fecal calprotectin (FC) in our study because this marker is a valuable, non-
invasive and easily measured laboratory test in assessing children with acute diarrhea and 
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reflects infection-induced mucosal inflammation. FC is assumed to act as an early marker in 
younger children with acute gastroenteritis.80 However, FC is not specific for gastroenteritis 
as children with other gastrointestinal disorders i.e. inflammatory bowel disease have high 
FC concentrations reflecting increased numbers of inflammatory cells in stools.81-90 There 
are limited studies on the use of FC as a diagnostic test in pediatric care,82 especially in acute 
or chronic diarrhea infections in developing countries. Although the FC median value in our 
children in healthy state (61 µg/g of wet feces, n=489) is higher than those reported in 
healthy children in developed countries (range 11-49 µg/g of wet feces ),81, 82, 85, 88, 91-94 this 
value is comparable with the median value of children aged 1-12 years in a community study 
in Uganda (52 µg/g of stool, n=302).  
We also used fecal mucin (FM) as mucin excretion is stimulated during infectious 
diseases.4,95 The mucus layer is an important contributor to intestinal host defence and 
inhibits pathogens adhesion to epithelial cells and subsequent bacterial translocation of 
invasive strains.78, 79 Accelerated mucous secretion and mucin release may also contribute to 
delayed-onset diarrhea.96 So far, studies on intestinal mucin merely focused on qualitative 
differences in mucin oligosaccharides composition during various intestinal diseases97,98 
whereas quantitative aspects are understudied.  
Ideally, such severity markers can be explored to what extent they may (1) discriminate 
bacterial from viral infection; (2) associate with the severity classification of gastroenteritis 
by the above MVS; and (3) monitor the severity and course of diarrhea, which may provide 
information for disease management.99 To elaborate on this in relation to FC: recent studies 
documented that FC varies markedly depending on gut pathogens in acute gastroenteritis as 
higher FC was observed in children80 as well as adults100 with bacterial types of acute 
gastroenteritis. FC has favorable test characteristics in being sufficiently accurate for early 
discrimination between bacterial and viral acute gastroenteritis. Although this showed that 
FC can be used as a screening tool for predicting etiology of acute bacterial diarrhea, our 
study results so far cannot be used to verify such diagnostic application because, except for 
rotavirus, microbiological data for (bacterial) pathogen identification in diarrheal episodes is 
missing.  
The severity of gastroenteritis is related to etiology rather than to age, and rotavirus is 
responsible for the most severe cases.101 The severity of diarrhea is also closely related to the 
grade of dehydration; vomiting should be considered an indirect sign of severe acute 
gastroenteritis, and should be carefully considered in the management of diarrhea. Loss of 
appetite, fever, vomiting, and mucus in stools are frequently associated with persistent 
diarrhea. We failed to determine the association of the fecal markers and MVS, or diarrhea 
duration and severity (both MVS and fecal marker). This may be due to the fact that most 
diarrheal episodes in our study were classified as mild and the variability in scores was thus 
rather low (chapter 4). The relatively mild diarrheal episodes observed in our study 
population lead to rather homogeneous fecal marker responses. Unfortunately, this hampers 
conclusions whether fecal calprotectin, osmolarity and mucin are truly quantitative 
indicators of diarrhea severity. We are also not convinced whether the subjective MVS is 
more suitable to predict diarrhea severity in a community setting in contrast to single clinical 
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diarrhea severity indicators such as fever, vomiting, dehydration and prolonged duration as 
mentioned above. 
Assessment of growth, iron and zinc status 
We examined growth, iron and zinc in accordance to the recommended validated methods. 
Duplo assessment of supervised anthropometric measurements was done by well-trained 
field workers. Standard protocols and equipment as well as the same field workers to 
perform the assessment were applied to reduce potential variation in assessment due to intra 
and inter observer variations. At least 10% of the iron parameters (ferritin, sTfR) 
measurements assessed by the SEAMEO RECFON laboratory in Indonesia were validated by 
the laboratory of Wageningen University. The precision (coefficient of variation) of the 
methods was checked between duplo assessments and plates and was very good (coefficient 
variation between 2.07-3.68%). Validity and reproducibility methodology used by SEAMEO 
to analyze ferritin was checked earlier and appeared to be good.102  
Bias due to incomplete follow-up is unlikely to have influenced our results, because only few 
children failed to complete the assessment. Under- or overestimation of the effect is 
therefore unlikely, also because growth and iron and zinc status outcomes were comparable 
between completers and non-completers. To prevent bias due to selective drop-out, we 
analyzed the data with a repeated mixed coefficients model (SAS PROC MIXED procedure) 
for our analyses, which took into account subjects with incomplete follow-up data. As the 
sample size calculation was based on primary outcomes (diarrhea incidence and duration), 
we realize that sample size may have been inadequate to detect group differences in growth 
or micronutrient status.  A post-hoc power calculation shows that we have more than 90% 
power to detect a change in mean over the baseline to study end (within groups) of 
anthropometric indices (weight, height, WAZ, HAZ) and the level of Hb, serum ferritin, sTfR 
and zinc concentration. However, our sample size between group of comparisons, on the 
different secondary outcomes described here, permitted us to detect treatment related 
differences with an observed small to medium effect size (Cohen’s2) of <0.29, probability 
level (α) of 0.05, and a statistical power of <74%.  
Standards for reporting adverse events 
There is a lack of assessment and systematic reporting of adverse events in probiotic 
intervention studies.103 In our study, adverse events were carefully recorded by using 
International Classification of Diseases, 10th Revision codes. All diagnoses were confirmed by 
study physicians. Severity and likelihood of relation to the intervention were scored by the 
physician and continuously monitored by the DSMB. 
Interpretation and perspective: intervention study 
To our knowledge, our study is the first large randomized controlled trial, focusing on the 
effect of calcium with or without one of two specific probiotics to reduce incidence and 
duration of diarrhea and respiratory tract infections, to assess cumulative duration and 
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severity of diarrhea, and to measure growth and iron and zinc status  in young children in a 
community setting.  
Diarrhea incidence 
Previous evidence on the preventive effect of probiotics on diarrhea and ARTIs has been 
limited to hospital or day-care center based studies and performed in developed countries.6, 7, 
56,104,105 In our study, the effect size of diarrhea reduction by L. reuteri (20% for WHO-
defined diarrhea; and 32% for all reported diarrhea) was higher compared with three 
previous randomized trials in a community setting in developing countries;55,106,107 a 14% 
reduction by supplementing L. casei shirota was seen in a comparable study in India,107 a 6% 
reduction by Bifidobacterium lactis HN019 combined with prebiotic oligosaccharides in 
India106 and a 6% reduction using L. rhamnosus GG in Peru.55 It is difficult to provide 
estimates or draw conclusions of the overall probiotic effect based on these four studies 
(including our study) on diarrhea prevention in a community setting in developing 
countries,54,55,106,108 because of differences in probiotic strains and doses, intervention 
duration, and study subject’s age. An approximate estimate would be a reduction of diarrhea 
incidence between 6% to 32%, which is in line with observations of diarrhea prevention 
studies in day-care centers of developed countries using various probiotic strains25, 46, 47, 49, 51, 
53 or multi-micronutrients fortified food or drink.109 However, these reductions are lower 
compared to diarrhea risk reductions by hand washing with soap, improved water quality 
and excreta disposal (48, 17 and 36%, respectively).110 
Our results underline that probiotic effects are strain-specific as we found protective effects 
of L. reuteri DSM 17938 against acute diarrhea in children, whereas supplementation of L. 
casei CRL 431 (without other strains) was without effect. In our study, children 
supplemented with L. reuteri experienced a few adverse events, mainly referring to a less 
regular defecation pattern. L. reuteri did not lead to any serious events related to the 
intervention, and positive results included a lower proportion (9% in low calcium, 15% in 
regular calcium, 15% in L. casei and 9% in L. reuteri) and shorter duration of antibiotic use 
(median antibiotic duration: low calcium 4 days, regular calcium 10 days, L. reuteri 3 days, 
and L. casei 5 days). 
Diarrhea duration 
L. reuteri supplementation shortened the cumulative diarrhea duration by 1.35 days in a 6-
month period, which is in line with reduction of duration in single episode of other reported 
probiotic interventions in children. A recent Cochrane review concluded that diarrhea 
duration in infants and children  was reduced by 29.2 hours in those taking probiotics for 
<14 days for treatment purposes (95% CI 25.14–33.25 hours, fixed effect model; 30.48 
hours, 95% CI 18.51–42.46, random effects model, 12 trials, n =970).5, 111 This effect was 
larger than the previously reported effect sizes based on systematic review and meta-
analyses undertaken by Szajweska in 2001 and McFarland in 2006, respectively. Here for all 
probiotic strains for the treatment of diarrhea in children, a reduction was seen of 18.2 
hours104 and  13.4 hours,112 respectively. Our study is also consistent with reviews or meta-
analyses on efficacy of specific probiotics to reduce diarrhea duration in children: Van Niel et 
al showed a reduction of  0.7 days by Lactobacilli administration,56 Szajewska et al indicated 
General discussion Chapter 6  
 
 
117 
 
a reduction of 1.1 days in infants treated with L. casei GG113 and Chmielewska et al showed a 
reduction of 0.92 days by L. reuteri ATCC 55730.114,115 These effects were more evident in 
hospital-based settings of developed countries, whereas two studies performed in a 
community setting in developing countries106,107 did not explicitly present the effect on 
diarrhea duration and another study failed to show an effect of probiotics on diarrhea 
duration.55 Our observed reduction in rotavirus-specific diarrhea duration of 0.5 days was 
much lower than the 2.1 days reduction found in a meta-analyses in 2007.113  
In several RCTs on calcium in children, daily doses ranged from 79 mg to 1500 mg calcium 
per day.4,116-122 A recent study showed that the desirable fortification levels to achieve in foods 
for calcium in children of three Asian countries (Philippines n=1374, 6-36 months; 
Cambodia n=177, 12-36 months; and Mongolia n=179, 12-36 months) is around 313-389 mg 
per day (530-783 mg per 100 g dry weight).17 This is based on an Estimated average 
requirement cut-off point in order to have a prevalence of inadequate intake <2.5% and 
excessive intake <1% in these children.  Effective doses of calcium in RCTs aimed to reduce 
diarrhea incidence, duration and severity in children are unknown. In a former study with 
Dutch adults showing improved resistance to ETEC infection-induced diarrhea, study 
subjects were supplemented with 60 mg (placebo) and 1100 mg calcium per day (treatment 
group).4  
 
Diarrhea severity 
 
There was no significant beneficial effect of dietary calcium or one of probiotic strains on 
diarrhea severity measured by Vesikari score. In our study population, all diarrheal episodes 
with the exception of one, had a MVS<11. This  score  is categorized as mild and is in contrast 
with the high percentage of severe diarrhea (Vesikari>11) observed in rotavirus vaccine 
studies in medical care settings in sub-Sahara Africa (>45%)123 and Asia (>63%).124 The low 
MVS in our study (groups mean scores were 3-4) demonstrate that diarrhea in outpatients 
and/or children in community settings is typically of a milder type.  
Although our study population suffered from milder diarrhea than observed in the above-
mentioned studies, there were clear responses in the applied diarrhea severity markers when 
comparing normal fecal samples collected at study end with samples collected in diarrheal 
episodes. Diarrhea type was not the subject of our study, but results showed that acute 
diarrheal episodes were characterized by increased fecal osmolarity suggestive for the 
osmotic type of diarrhea.79 Fecal calprotectin concentrations increased >2-fold during acute 
diarrheal episodes in the present study.  These increased levels likely reflect infection-
induced intestinal mucosal inflammation.125 In support of this, approximately 50% of our 
diarrheal samples can be categorized as strongly positive inflammation based on the 
suggested upper limit cut-off point of FC in pediatric gastrointestinal diseases as previously 
described.82, 88 The suggested cutoff point of FC is >50 μg/g (<50 μg/g of stool = negative, 
50–100 μg/g of stool = weakly positive, and > 100 ìg/g of stool = strongly positive) for adults 
that can also be used for children aged from 4-17 years regardless of sex, as a marker of  
gastrointestinal inflammation.82 Canani et al used the cut-off of 102.9  μg/g to discriminate 
patients with active organic/inflammatory disorders from healthy subjects and from patients 
with functional bowel disorders.88 The median FC value of our diarrheal samples, 116 (35–
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301 interquartile range) μg/g of wet feces, is similar to the median FC value, 110 (0.3-244) 
μg/g of feces, for acute gastroenteritis in European children.88 Due to limited publications 
regarding the clinical applications of FC in acute diarrhea in children101 and in probiotic 
studies, it is not possible yet to make a direct comparison with other populations. Though 
not statistically significant, the reuteri group had the lowest infection-induced change in 
fecal osmolarity and Vesikari score, which may reflect lower diarrhea severity. On the other 
hand, L. reuteri supplementation might help in mucosal immunity maturation and 
attenuation of inflammatory responses to dietary and bacterial antigens.126 There was no 
attempt to correlate FC concentrations with pathogens as only rotavirus was determined and 
other pathogen's information is missing. However, this might be interesting for post-hoc 
exploration. 
The acute infection-induced changes in FM were not uni-directional among dietary 
treatment groups and less pronounced. The similar concentration of FM collected during 
diarrhea and at normal state (at study end) in our children is consistent with the FM 
concentration found in Finnish children aged 6-42 months.127 The casei group showed a 
significant increase, whereas fecal mucin in the regular calcium group tended to decrease 
during a diarrheal episode.  
Despite responsiveness of fecal calprotectin, osmolarity, and to a less extent mucin, levels of 
these markers were not significantly modified by dietary treatment. The absence of 
supplement-induced differences in diarrhea severity markers corresponds with the equal 
Vesikari scores among groups.  
Growth effect 
Overall, all treatments in our study resulted in normal growth in weight and height in our 
children. Our probiotics interventions, but not milk calcium, showed larger effects on growth 
than other nutritional interventions. A few studies have investigated probiotic effects on 
children's growth.128 These studies showed inconsistent effects and differed in probiotic 
strain and dose, intervention duration and children’s age. Our  reuteri and casei results on 
weight gain (effect size 0.29 and 0.23 in 6-month intervention period, respectively) are 
slightly larger compared to two RCTs investigating growth effects using combined probiotics 
and other components: Bifidobacterium lactis HN019 and prebiotic oligosaccharide versus 
control milk alone in Indian children of similar age (effect size 0.22 in 12-month period)129 
and B. longum, L. rhamnosus, prebiotics and polyunsaturated fatty acid versus control milk 
in Indonesian 12-mo-old toddlers (effect size 0.23 in 12-month period).130 However, 
differences in growth outcomes did not affect the prevalence of stunting and underweight in 
the reuteri and other groups. This may implicate that 6-mo intervention is too short to 
observe reduction of malnutrition prevalence.131 It may also be that the actual increment of 
0.09 for WAZ and 0.05 for HAZ, albeit statistically significant, were still too small, especially 
taking the average growth deficit of Asian and African children into account (~–2.0 Z).132 In 
contrast to our results, several other studies in infants receiving various probiotic strains, 
either alone25 or combined with prebiotics,48, 133  did not find any effects on growth.  
No effect on growth was observed in the RC (without probiotics) compared to the LC group. 
For growth outcome, the effective dose of calcium in younger children is unknown since 
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almost no study was performed in this age group. Three reviews on RCTs in mainly 
Caucasian pre-pubertal children and adolescents indicated a neutral effect (also no adverse 
effect) of dairy food or calcium consumption on body weight or height, body fat, or lean body 
mass with doses between 300 mg and 1500 mg calcium per day.134-136 However, one study in 
China showed that an increase in milk and thus calcium consumption (560 mg for 2 years) 
improves bone growth in children aged 10-12 year, especially when calcium intake and 
vitamin D status are low.137 This may indicate that increasing the daily calcium intake to 
support growth might be beneficial in children of lower nutritional status, whereas it might 
be without significant growth effects in children with higher habitual calcium intakes. 
Iron and zinc effect 
The present study showed that the probiotics did not affect iron and zinc status. Probiotics 
are claimed to improve digestibility and nutrient uptake by intestinal cells.138 A study in 
infant rhesus monkeys given L. reuteri showed an improved haematocrit,139  but so far no 
information is available about more relevant iron status markers (e.g. ferritin, sTfR). Levels 
of iron parameters, e.g. Hb, HCT and serum ferritin, decreased and sTfR increased over the 
6-mo intervention in all groups, whereas serum zinc remained constant. No treatment-
specific differences were observed in mean change of iron parameters and prevalence rate 
changes of anemia, iron-deficiency, and iron-deficiency anemia, or in zinc status. The 
reduced iron status over 6 months, independent of intervention type, may be due to 
insufficient iron homeostasis to compensate the fast iron mobilization from storage needed 
during growth.140 Chronic  blood loss may also contribute to iron deficiencies and anemia in 
children in developing countries and can be caused by gastrointestinal parasites,141 
Helicobacter pylori142 or allergy to cow’s milk protein.143 No information was available on the 
parasitic infestation or Helicobacter pylori prevalence, neither a deworming program was 
applied in our study population. No adverse events related to cow’s milk protein were 
present in our study. Also, the considerable prevalence of respiratory (90%) and 
gastrointestinal infections (27%) in our study children may have negatively affected iron 
metabolism,144 known as the anemia of infectious disease.145 In addition, the polyphenolic 
compounds of cocoa powder added to our study milk may have inhibited iron absorption.146, 
147 The addition of cocoa powder in our study milk, was intended to mask the discrepancy of 
the low and regular calcium taste. Besides, chocolate-flavor milk was also the most favorable 
milk taste in our previous acceptance test (data not shown). 
Conflicting results have been reported on the effect of calcium on iron absorption in adults 
and children, but studies greatly varied in study design, type and duration of 
supplementation, study population’s age and country.116-118, 148-150 Most studies evaluating 
iron status were conducted in developed countries involving children and adolescents with 
adequate iron and calcium intakes and reported no or a small effects on iron status.116-118 No 
difference in iron status of preschool children aged 3-5 y was observed after a 5 wk 
adaptation to a low- (502 mg/day) versus high- (1180 mg) calcium diet.116 Also, an RCT in 
pre-pubertal children found that low or moderate amounts of calcium (78 mg/d or 312 
mg/d) for 2 weeks did not interfere with iron absorption.117 A long-term, 1-year-intervention 
study in adolescent girls showed that daily calcium supplementation of 500 mg did not 
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compromise iron status.118 With regard to zinc, there is no reported evidence for a calcium 
effect on zinc absorption in children.  
Rationale of using calcium to influence diarrhea 
The rationale for using calcium in children is based on a proof-of-principle study with adults 
orally challenged with live but attenuated enterotoxigenic Escherichia coli. Dietary calcium 
strongly reduced infection-induced diarrhea in that study.4 Animal studies show protective 
effects against Salmonella as well,151, 152 but human verification for that is still lacking. 
Rotavirus is responsible for 60% of hospitalized and 41% of outpatient clinics diarrheal cases 
in Indonesian children.153 Important bacterial pathogens among children in developing 
countries are E. coli (10%–20%), Salmonella (<5%), Shigella (5%-10%), Campylobacter and 
Vibrio cholera (exact %’s unknown).154 The absence of a beneficial effect of calcium in our 
trial may indicate a difference in efficacy between children and adults and/or that protective 
effects are pathogen-dependent.  
How could probiotics influence diarrhea? 
The application of probiotics to prevent or treat acute diarrhea is based on three possible 
mechanisms155 (Figure 6.2):  
 
Figure 6.2 Three possible probiotic mechanisms: (1) Direct antagonism; (2) 
Immunonodulation; (3) Exclusion. B, B cell; DC, dendritic cell; IEC, intestinal epithelial cell; 
M, M cell; MAC, macrophage; T, T cell; TJ, tight junction. 
Sources: Adapted from Preidis et al (2011)155 
(1) Direct antagonism. Probiotics are assumed to antagonize intestinal pathogens. 
Probiotics kill or inhibit the pathogen to limit infection, or they down-regulate the 
expression of virulence factors, such as adhesins or toxins, required for pathogenesis.155 
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Possible mechanisms include the synthesis of antimicrobial substances, competitive 
inhibition of pathogen adhesion, and competition with pathogens for growth substrates, 
modification of toxin and non-toxin receptors involved in bacterial recognition.156 L. reuteri 
was known to produce a potent antibacterial compound, reuterin, that is capable of 
inhibiting a wide spectrum of microorganisms.157 
 
(2) Immunomodulation. The mechanisms by which probiotic bacteria affect the immune 
system are unknown yet.158,159  Probiotics can interact with the immune system to enhance 
the functionality of innate and/or adaptive immunity, or to limit the ability of the pathogen 
to initiate or facilitate an immune response.155 The underlying protective mechanisms of 
probiotics L. reuteri and L. casei  against gastrointestinal pathogens in children are 
unknown.157, 159 In an animal study, it was reported that L. reuteri DSM 17938 did not inhibit 
Liposacharide (LPS)-induced interleukin (IL)-8 production in cultured intestinal cells, in 
contrast with other L. reuteri species.157 Also in an animal model, Galdeano et al found that 
the main immune cells activated after oral L. casei administration were those of the innate 
immune response, with an increase in the specific markers of these cells (CD-206 and TLR-
2), with no modification in the number of T cells.159 They also demonstrated that L. 
casei CRL 431 interacts with the epithelial cells of the small intestine and that their 
fragments can internalize and activate the intestinal epithelial cells.160 
 
(3) Exclusion.  Probiotic may make the gastrointestinal environment become less favorable 
for pathogens.155 Probiotics can alter the microenvironment to prevent pathogens from 
gaining access to appropriate receptors, to limit pathogen attachment, entry, or 
translocation, or to improve barrier function.155 These mechanisms include altering the 
resident microbiota, decreasing luminal pH, improving epithelial barrier function, 
interfering with pathogen binding by down-regulating specific host receptors, and 
stimulating production of defense-associated factors, including mucins and defensins. A 
beneficial microbe may use a combination of these mechanisms and may employ different 
actions against different pathogens.  
 
 
6.2.2. Cross sectional study 
Study population 
Age-specific risk differences in many studies show that children have a higher overall risk of 
diarrhea than adults.161 Children aged less than 5 years are suffering most from diarrhea. We 
focused on children aged 12-59 months and excluded infants (0-11 months) in our study 
population because many studies reported about health condition, nutritional status, food 
intake and feeding practices during infancy that are different from older age.  We did not 
specifically focus on children <2 years, although diarrhea prevalence tends to be higher in 
this age group and decreases at older age.  
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Study design 
The association of food-hygiene practice and diarrhea was examined based on a cross-
sectional study (chapter 5), which may have weaknesses related to study design that could 
affect the validity of the findings. A main limitation of this design is that exposure (food-
hygiene practice) and outcomes (diarrhea prevalence) were assessed at the same moment in 
time which makes it difficult to assess the temporality of the association. It is possible that 
the presence of diarrhea in children may increase mothers’ work load or mothers’ attention 
to children that changed mothers’ practices (reverse causation). 
The municipality of East Jakarta was purposively selected on the basis of a number of 
criteria: high population density, low socioeconomic status, and high prevalence of diarrhea 
and underweight in under-five children, based on routine data from the primary health care 
system and local government. These criteria were also applied for Jatinegara sub district and 
four urban administrative villages that were involved in this study. In every village we 
selected 2–3 hamlets that had a large number of poor people. The list of children of all 
villages involved was compiled and the children were randomly selected to the study. The 
number of children in each hamlet in every village was distributed equally but according to 
the proportion of total children in each hamlet. This approach may introduce a bias in the 
selection of area, but not in the selection of children. As mentioned in Introduction 
(chapter 1), children were from areas that were selected because of their high population 
density, low socioeconomic status, and high prevalence of diarrhea and underweight in 
under-five children, and hence it may not be representative of the general Indonesian 
children. Random selection of children in this study avoided bias and may provide valid 
results.  
Assessment of exposure (food-hygiene practices) 
Information bias may have occurred because mothers may report social desirable practices 
which they do not perform.162,163 Moreover, mothers may forget some of the practices. 
Research has shown that responses tend to be biased towards over reporting of “good” 
practices.164 
As indicated previously in chapter 5, we included a complete set of food-hygiene practices 
identified in our community, which consisted of 36 variables. This approach clearly gives 
advantages because important and specific local practices are not missed. A previous study 
on food-hygiene missed some important practices such as food storage, thorough cooking 
and adequate food holding temperature165 as endorsed by World Health Organization 
(WHO).166 All individual variables were assigned equal importance and presented as 
separate variables reflecting individual dimensions. Breastfeeding between 4 and 9 months 
of age is known to have a protective effect on children’s health and growth. However, for 
children in the 9-18 months group or older it is not clear whether this is the case.  Since 
scientific evidence on this issue is mixed,164 we scored breastfeeding equal as other practices. 
These 36 single variables are also presented as a summary score reflecting a food-hygiene 
practice index. This index was classified into poor and better food-hygiene practice based on 
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the median score of the population. This scoring system for food-hygiene practices can be 
considered as a preliminary step in the development of a methodology to measure and 
quantify the different types of food-hygiene practices in a community setting. Many studies 
with much larger sample sizes classified the total score into tertiles or quartiles. However, in 
our study the total score was dichotomized: poor and better food-hygiene practice based on 
the median score of the population because the tertiles classification leads to very large 
confidence intervals, due to small numbers, which would complicate the interpretation. 
Assessment of outcome (diarrhea prevalence) 
To avoid information bias in diarrhea prevalence, we choose recalling of diarrhea during a 7-
day period. Recall methods may be the reason why we could not observe significant 
associations between overall and some of the single food-hygiene practices.  
Seasonal variation in the incidence of acute diarrhea has previously been identified from 
surveillance data in many countries.161 Yet, study results on the effect of seasonal variation 
on diarrhea prevalence are contradictory. Our study was conducted in a rainy season 
(November – April), which was assumed to be the peak of diarrhea prevalence as described 
in a previous study within a similar community.167 Performing the study in rainy season may 
lead to an overestimation of diarrhea prevalence because there is a strong link between 
foodborne and waterborne diarrheal illnesses and weather- and climate-related events. The 
incidence of diarrhea generally rises in the rainy season in developing countries, partly 
because of direct effects of temperature and rainfall on the growth and spread of 
pathogens.161 However, some recent studies in developing countries observed high diarrhea 
prevalence in dry seasons.168-172 The prevalence of diarrhea in our study (10-20%) 
corresponds with the known prevalence, thus an effect of season was not clearly seen. This is 
supported by the findings that although worldwide the seasonality of rotavirus may vary 
broadly, the lack of seasonal variations of rotavirus is more common in tropical developing 
countries than in temperate climates (zones in some western country that have warm/hot 
temperature but not as hot as the subtropical/tropical countries) in developed countries.173  
Confounding 
The overall incidence of diarrhea in developing countries has remained high due to multiple 
determinants.174 Besides lack of safe drinking-water and inadequate sanitation and poor 
hygiene,175,176 many studies in developing countries identified other important factors that 
were significantly associated with diarrhea in children such as younger age,161,165,177,178 
malnutrition,179  low socioeconomic status and education of mothers,180-182 low maternal 
age,183 overcrowding (family size),184,185 lack of completeness of immunization,186and number 
of under-five children  living under the same roof.187 These factors may become potential 
confounding variables. To reduce the influence of confounding, we adjusted for several 
variables i.e. child’s age, malnutrition, completeness of immunization, family size and 
number of under-five children living under the same roof. 
Interpretation and perspective: cross sectional Study 
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Despite the described limitations i.e., reverse causation, selection and information bias, and 
confounding the outcome-specific findings of diarrhea prevalence were consistent with many 
studies in developing countries (Vietnam,165 Thailand177 and Bangladesh178) and in similar 
settings confirming that children aged <2 years were more vulnerable to suffer from 
diarrhea. This finding is also in line with a previous review that diarrheal diseases are 
extremely high during the weaning period (6-24 months).188 
The association between food-hygiene practices and diarrhea prevalence in children has 
been examined in several epidemiologic studies in developing countries e.g. Vietnam,165 
Bangladesh,178, 189 Nigeria,190 Gambia,191 Nicaragua,192 Brazil,193 and Congo.194 The practices 
were evaluated either as combined or individual practices such as hand washing, food 
preparation and storage,  clean sewage, and safe water source and storage.191 These studies 
generally suggested a direct association between food-hygiene practice and diarrhea 
prevalence, but findings are not conclusive.195 Our study, using more complete set of local 
practices than other studies, indicates that the poor food-hygiene practice score was not 
associated with the prevalence of diarrhea among children under five, but was significantly 
associated with more diarrhea among children aged <2 years (chapter 2). Our present 
study typically: (1) provides a comprehensive and more complete set of local practices; (2) 
presents not only single variables, but also a summary score of practices; and (3) focus its 
findings on diarrhea of children aged<2 years. 
We speculate that the increased risk of having diarrhea in children aged <2 years whose 
mother had poor food-hygiene practices in our study may be explained by the fact that 
weaning foods prepared under unhygienic conditions are frequently contaminated with 
pathogens and are an important risk factor in the transmission of diarrhea (chapter 2). 
This observation is also reported in a peri-urban district of Guinea-Bissau.196 However, our 
study was not able to demonstrate an association between the contamination of weaning 
foods and diarrhea due to a lack of assessment of specific enteropathogens. Although food-
borne infection is the main route of transmission of gastrointestinal infections in developed 
countries, their contribution to the burden of diarrhea in low-income settings is still 
unclear.195 Contaminated weaning food has been suggested as a major contributor to 
diarrhea in low-income settings as up to 70% of diarrhea episodes are actually caused by 
water and food contaminated with pathogens,188 although observational studies gave 
inconclusive results.197 A study in Gambia failed to document an association between water 
or weaning food contamination and higher rates of diarrheal morbidity.191Two more recent 
studies have found an increased risk of diarrhea associated with the consumption of maize-
based weaning foods.191, 194 However, in one of these studies, this association was only 
significant in children living in rural communities.194 Therefore, association between 
contaminated weaning foods and diarrheal diseases in young children living in urban setting 
of  developing countries remains lacking.197 
The best studied hygiene practice in developing countries is that of hand washing. Evidence 
from all four types of sources is consistent, with RCTs on hand washing showing reductions 
in diarrhea of around 30%, and of 43–47% if soap is used.195 Our study found that mother’s 
and child’s hand washing, seemed to be protective against diarrhea, however, our study 
failed to demonstrate statistically significant associations. We must remark that the lack of 
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association between hand washing and diarrhea in our study may be due to application of 
single instead of repeated observation methods to assess hand washing practices.  
Our study confirmed that children who lived in a house with clean sewage had significantly 
lower risk of having diarrhea than children who did not have one. A previous study 
conducted in an urban poor setting in Indonesia  also reported an increased  risk of having 
diarrhea in children with unavailability of sewage and/or place to dispose the child’s 
stools.198 Contamination of drinking water by sewage through pump failure or blockage of a 
sewage system has been previously described.199 Overwhelmed sewage systems might be an 
important contributor to the increased prevalence of acute gastrointestinal illness during the 
rainy season in Cuba161 and also in many other studies conducted in a community setting. In 
developing countries, both E. coli and rotavirus were the common pathogens associated with 
waterborne disease especially for children who live in poor environmental conditions. Also, 
outbreaks of viral gastroenteritis resulting from sewage contamination of water supplies 
have been well described.200,201 Unfortunately, information on diarrhea-causing pathogens 
could not be obtained in our study.  
6.3. Implication for public health 
In this section, we will focus on the consequences of our research for public health on the 
basis of the four major research questions that were addressed in this thesis. 
Probiotics as an alternative prevention strategy  
Public health perspective 
According to WHO South-East Asia, many countries in the region are facing difficulties in 
achieving the Millennium Development Goal 4 which calls for the reduction of child 
mortality by two third by the year 2015 due to high morbidity and mortality from acute 
diarrhea and ARTIs in the region.3 Simultaneously, most of developing countries including 
Indonesia are facing a public health threat due to the overuse and misuse of antibiotics202 in 
the treatment of diarrhea which yields progressive increase in antibiotic resistance of enteric 
pathogens in the communities.203 Therefore, evidence on probiotics efficacy for treating 
diarrhea in children,5 administered in addition to rehydration therapy, has become an 
alternative solution for medical purposes. Based on our present findings, probiotics may 
serve as an alternative solution beyond treatment.  As presented earlier in this chapter, there 
is suggestive evidence for a beneficial effect of L. reuteri for Indonesian children in reducing 
incidence (24-32%) especially in lower nutritional status ones, shortening total duration of 
diarrhea (1.35 days) and modestly improving growth over 6 months period, whereas. L. 
casei, although giving less benefit, modestly improved weight velocity. These beneficial 
microbes offer potential alternatives for the prevention of diarrhea in vulnerable children 
and improvement of child growth in developing countries. 
In practice, this proven probiotics efficacy may provide additional information to health 
professionals in choosing the right strain for preventing the progression of acute and 
persistent diarrhea associated malnutrition in the future. Reduction of illness will 
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significantly impact on family dynamics and economic situation because parents could work 
regularly204 and do not spend money for extra health care costs. Children may grow normally 
and will become a productive generation for the nation. Therefore, the role of probiotics 
should not be limited to simply addressing a narrow range of unsubstantiated individual 
effects.156 There should be room for probiotics to be seen as an alternative strategy for 
diarrhea prevention. However, to recommend policy makers to adopt probiotics in a 
diarrhea prevention program in a community setting in developing countries, it is important 
to explore how strong its disease reduction evidence would be as compared to other existing 
preventive measures. Moreover the acceptability in a community, affordability, cost-
effectiveness and the risk of adverse effects for long term use need to be faced.7 
Looking at the reduction of diarrhea incidence and duration, L. reuteri in our trial is better 
than other probiotic strains. However, it seems too early to recommend probiotics (e.g. L. 
reuteri) for routine use or for follow-up in public health programs to prevent diarrhea in 
children in developing countries. It is not only because there is limited data on probiotic 
studies in a community setting, but also the current effect size of probiotics for the reduction 
of diarrhea incidence is rather similar with nutritional intervention (non-probiotic based) 
and lower than the non-nutritional intervention (hand washing with soap, improved water 
quality and excreta disposal).110 The child growth outcome in our study using L. reuteri 
showed a promising effect, but probably it is not massive enough to really overcome the high 
stunting and underweight problem in children in the developing countries. In addition, no 
data is available for the assessment of mortality reduction due to diarrhea by probiotics.  
Until now, no single intervention is sufficient to eliminate the persistent burden of diarrheal 
diseases.155 Therefore, probiotics intervention should not be introduced alone into 
prevention strategy because it may be difficult to contribute to public health goals, and will 
not simply replace the existing health strategy. Probiotic intervention should be part of an 
integral system of existing prevention strategies. Lesson learned from the past showed there 
has been temporary or delayed improvements of diarrhea morbidity using various 
interventions especially those that required behavior changes.205 Multiple interventions 
could work synergistically, such as the combination of existing improved water and 
sanitation, vaccines, micro- and macronutrient provision, and probiotics for this specific age 
group. These combined efforts might be also able to address broader and long-term benefits 
to growth and developmental processes of the children.155 Multiple approaches will be a good 
solution if each single approach has been shown efficacious and effective. It is possible that 
part of single approaches is not proven efficacious and therefore, the combination of 
interventions should be evaluated for its efficacy and effectiveness. Effective promotion 
strategy should be indentified to encourage individuals and the community to comply 
towards several interventions (including probiotic) and to sustain their positive behavior 
change.  
Clearly substantial savings and reduction of health care costs have been predicted by the 
routine use of probiotics in diarrhea treatment.206 So far, there is no published data to 
support that probiotics in children 1-6 years provide a better cost-effective program as 
compared to other existing health intervention programs.  In terms of affordability, policy 
makers in developing countries like Indonesia should carefully evaluate the economic 
implications before applying probiotics, e.g. L. reuteri in diarrhea prevention programs. 
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Policy makers should also encourage probiotics manufacturers to voluntary produce a mass 
probiotic food product affordable to most vulnerable children in Indonesia who mostly live 
in poverty. An existing affordable probiotic drink product (e.g. using L. casei shirota) is 
widely consumed by Indonesian children. This product was not specifically studied in 
Indonesian children but was shown effective in reducing diarrhea in India.54 Other probiotic 
products, in the form of yogurt are introduced in the Indonesian market, but information on 
the scientific benefit for diarrhea reduction are not available. The formulation of affordable 
products has to be accompanied with quality control, good manufacturing practices, 
sufficient dose and proper storage of probiotic strain from production line until consumer’s 
home. The feasibility to develop such products in the Indonesian situation with its tropical 
climate should be evaluated. In addition, manufacturers are obliged to serve better education 
on probiotics and avoid misleading information or too promising advertisement.  
Fermented products are widely consumed by people in developing countries like Indonesia. 
However, the acceptability towards probiotic products (and its food carrier) will be another 
critical challenge and may face cultural barriers. L. reuteri is a non-indigenous/overseas type 
of microbe that has to be proven safe for long-term use in Indonesian children. If L. reuteri 
will be introduced in Indonesian children using probiotic dairy products, specific acceptance 
evaluation and efforts should be made to convince the community to consume this product. 
Not only because milk is considered as an exotic and expensive product, but also because of 
potential lactose intolerance in Asian children.207 On the other hand, dairy is well accepted 
because it has been believed as “nutritious product” (e.g. due to calcium). Innovative 
technology using straw coating for the delivery of L. reuteri like in our study in combination 
with Tetra Pak milk was proven useful for Indonesian children. The acceptability of these 
products is excellent as shown in our acceptability and intervention study. Many factors 
influenced the success story of the probiotic and calcium milk acceptability in our study such 
as low lactose milk with good sensory aspects for children, intensive communication, 
creativity program, simple packaging, community involvement, solid team workers, role of 
health volunteers (kaders), local physicians and leaders. Therefore, these types of strategy 
are essential for the success of probiotic acceptance in the future. Also, appropriate probiotic 
storage systems have to be feasible and well instructed to the community. The introduction 
of milk in the community may raise ethical and political issues because the enhancement of 
this commodity will stimulate a change in dietary habits and resistance towards 
overseas/imported products. The national production of probiotic product may be an option 
in the near future. 
The reported risk of adverse effects of probiotics use is very minimal. For public health 
intervention, the use of probiotics should be targeted to healthy and non-severely 
malnourished children with specific dose and duration as it was used in our intervention. 
Caution has to be made for the immuno-compromised children and/or with severe barrier 
dysfunction such as critically ill patients because these populations might be at higher risk 
for adverse effects such as the development of septic conditions due to their reduced 
capability for microbial clearance.208 
We failed to show beneficial effects of calcium in milk in this study. Calcium intake was 
increased to meet the specific recommended daily allowance for calcium. This calcium 
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increase did not negatively influence iron or zinc status in children when not consumed 
together with meals. Benefits beyond diarrhea prevention might exist but were not assessed. 
Although we did not find specific adverse effects of calcium on iron absorption, we did find 
an iron status reduction in all intervention groups. It is unclear whether this is due to 
consumption of the supplied milk products or to other confounding factors as described 
earlier in this chapter (e.g. increased iron requirement during growth,140 chronic  blood loss 
due to parasites141 or  Helicobacter pylori,142 allergy to cow’s milk protein,143 high prevalence 
of infections,144  presence of polyphenolic compounds of cocoa powder146,147 or increasing 
food crisis). Addition of a fifth trial arm receiving no dietary intervention at all could have 
discriminated whether it was due to milk consumption or to other causes.  For now, it is 
important for the policy maker that milk interventions need specific attention as assurance 
of an adequate iron and zinc intake in children in the growing phase is as important as a 
sufficient calcium intake. 
Regulatory standpoint on probiotic claims 
Probiotic products have received significant attention from the public, industries and 
scientific community due to their perceived potential health benefits.156, 209-211 Indonesia, and 
other developing countries, are currently bombarded with strong marketing and 
advertisement of probiotic bacteria in food products. These products are mainly probiotic 
dairy for young children such as fermented milks, baby-food and milk powder, probiotic 
drinks and milk powder for children. However, this market expansion is not supported by a 
similar increase in scientific evidence and is insufficiently regulated in most of the 
developing countries. At present, regulatory issues on probiotics are unclear and subject to 
misinterpretation.212 In Europe, the European Food Safety Authority (EFSA) and the Panel 
on Dietetic Products, Nutrition, and Allergies (NDA) have rejected the majority of claims of 
the benefits of probiotic products submitted to EFSA (≈260 out of 300 claims)213,214 due to 
insufficiency in the characterization of microorganisms. This situation has raised concern 
from the International Scientific Association for Probiotics and Prebiotics (ISAPP) because 
in their opinion that claims supported by solid scientific evidence are also being rejected.215 
The Indonesian National Drug and Food Control Agency (NADFC) regulates probiotics 
through a pre-market evaluation of Functional Food products. However, most probiotic 
products registered or rejected by this agency give insufficient efficacy and safety 
information, and in some cases, studies were not performed with the intended target 
population. Moreover, based on a report of the NADFC, post-market evaluation showed that 
unsubstantiated and non-approved claims were used. Good Manufacturing Practices 
producers were not always maintained and handling practices during storage and retailing 
were not in place.216 This situation raises concerns not only from regulatory agency and 
industries in providing quality and substantiated probiotic products to protect consumers, 
but also from the scientific community in performing high quality probiotic studies. From a 
regulatory perspective, it is important that agencies improve their existing regulation and as 
soon as possible provide specific and clear probiotic regulation guidelines and standards that 
should be adhered by industries. On the other hand, the scientific community in Indonesia 
and developing countries should carefully perform probiotic studies in the right target 
population, with appropriate strain selection, a sound study design, with validated outcomes 
and results published in peer reviewed journals.  
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Innovative technology 
Efforts in developing innovative technology on probiotics should be advocated for Indonesia 
and many other developing countries. As one of the mega biodiversity countries in the world, 
Indonesia is also unique with typical multiple-ethnicities that maybe potentially rich in 
genetic resources, traditional fermented foods, and abundance of microbiota variations. This 
give a great opportunity to develop indigenous probiotic products through innovation216 
without excluding or becoming exclusive to the potential probiotic products from other 
countries. The potential local probiotic strains are probably more effective in fighting against 
local pathogens adhesion. The beneficial effect of some Indonesian traditional fermented 
products such as tempeh (fermented soy-bean from Java)217 and dadih (yogurt-like product 
from West Sumatera)218 on reduction of diarrhea in Indonesian children has been explored, 
and their potential isolated microbes need to be further researched. Public-private 
collaboration between Indonesian academia, industries, and government should strengthen 
the development of probiotics in Indonesia. Furthermore, international collaboration should 
be encouraged among developed and developing countries in applying innovative technology 
in probiotics with commitment mutual benefit for both continents.  
Food-hygiene practices  
Proper food-hygiene practice of mothers is important for the prevention of diarrhea in 
children <2 years (especially non-breastfed infants and young children, or those who 
receiving breast-milk in combination with complementary feeding), in line with the results 
of present and previous studies on food-hygiene practice and diarrhea.   
A program on hand washing with soap has been introduced as a simple and cost effective 
means to reduce the incidence of food-borne disease. However, more comprehensive food 
safety education to mothers of young children with special emphasis on good food-hygiene 
practices and clean sewage seems to be more effective than only one single food safety 
message to prevent diarrhea among children in these areas. For a sustained program, the 
implementation of food safety education should involve community participation and 
integrated stakeholders such as local government, academia, health authorities, non-
governmental organization, and industries. Based on our study, refinement of the sewage 
system is a promising measure for the prevention of diarrhea. However, this program will be 
difficult to be implemented in the Jakarta urban slum area especially in flooding areas. The 
urban slum areas of Jakarta are not only lacking proper sewages, as Jakarta's municipality 
sewage system serves only 2% of the population,219 but are often overcrowded settlements. 
Both are known as risk factors of diarrhea among children.  Infrastructure refinement plans 
to improve sewage system and slum dweller families relocation (especially those who live in 
flooding area) should be advocated to local government. A combination of an existing 
diarrhea prevention program and allocating resources for a food safety program and 
infrastructure refinement for sewage system might lower the prevalence of acute diarrhea 
disease in these populations.161 
Promotion of hygiene might be the single most cost-effective way of reducing the global 
burden of infectious disease. Governments and funding agencies increasingly accept that 
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hygiene promotion should be an integral part of health investments across the wider 
community, not just in health-care settings. Policy makers are also realising that the health 
benefits of increased investment in water and sanitation infrastructure refinement are 
largely delivered through improvements in personal and domestic hygiene. Original 
approaches using new insights are modernising the hygiene sector, making it more attractive 
to investors. Improved water supplies and sanitation facilities make it easier to practice food-
hygiene, keeping children from infection. It might be almost impossible in an area near the 
river site.195 But even without improved facilities, better food-hygiene can still make a huge 
difference to health and may contribute to the achievement of Millennium Development 
Goals (MDGs) and beyond. 
6.4. Recommendations for future research 
This section gives suggestions for future research. Figure 6.3 (A and B) are used as a 
framework for some potential interventions and propose new research questions. Figure 
6.3 (A) shows the potential of various interventions that may inhibit progression to a further 
development of the infection-malnutrition cycle, and minimize both acute and chronic 
morbidities: including probiotics, micronutrients (calcium, iron and zinc) and food hygiene 
practices that were highlighted in our study (orange boxes). Figure 6.3 (B) presents a 
recommendation for future research: employing a spectrum of disease outcome measures for 
new research questions. Although we studied three elements of possible interventions, in 
this thesis we specifically focus on the proposed research questions to the probiotic 
intervention (orange box). 
6.4.1. Multicenter study on probiotics using L. reuteri (and/or other strains): 
longer duration, larger sample size, higher prevalence of severe diarrhea in community-
based trial in South East Asia Region. 
Reduction of diarrhea incidence 
Further investigations are needed to confirm whether our documented successful prevention 
strategy using probiotics (L. reuteri) can be confirmed and replicated by studies in similar 
settings in South East Asia Region. A multicenter community trial should be initiated for 
further studyparticularly in the apparently healthy population, with larger sample size, 
longer duration, and in a population with higher prevalence of (severe) diarrhea. Population 
with more severe diarrhea is indeed important due to some reasons e.g. high placebo 
response and the possible "floor effect"221 which means the severity of symptoms is too low to 
measure any improvement. This doesn't mean that L. reuteri or L. casei cannot work against 
incidence or severity of diarrhea in a community setting, but the relatively low severity cases 
and the room for improvement is low compared to the diarrhea patient in a hospital setting, 
where symptom severity is much higher. We like to stress that  definitions of all reported 
diarrhea, besides the strict one of WHO, need to be applied in follow up trials to investigate 
dietary intervention effects in community settings. It is also encouraged to include 
comparative strains and to evaluate the most effective probiotic organisms and optimal 
dosage. Financial and logistic arrangements, community acceptance, laboratory 
infrastructure   and  capacity as well as  human resources  involved for  proper study conduct  
General discussion Chapter 6  
 
 
131 
 
 
Figure 6.3 The vicious cycle of diarrhea and undernutrition in susceptible children. (A) 
Various interventions: probiotics, micronutrients (calcium, iron and zinc) and food hygiene 
practices that were highlighted in our study (orange boxes); (B) Recommendation for 
future study: employing a spectrum of disease outcome measures. Adapted from Guerrant et 
al, Nutrition Reviews copyright 2008;220 and Preidis et al, Gastroenterology, copyright 
2011155  
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be crucial factors to get high-quality data and this can be improved in developing countries. 
Such studies are important to further advice policy makers and regulators on applying 
probiotics into diarrheal prevention programs in developing countries. 
Reduction of duration and severity of diarrhea 
In our present study, we were not able to conclude: (a) whether the subjective modified 
Vesicari scale is an appropriate diarrhea severity measure in a community setting in contrast 
to single clinical diarrhea severity parameters such as fever, vomiting, dehydration and 
prolonged duration; or (b) whether fecal calprotectin, osmolarity and mucin are truly 
quantitative indicators of diarrhea severity. Further study to confirm whether L. reuteri, L. 
casei and calcium, can shorten acute diarrheal episodes dependent on the intestinal 
pathogen involved, needs to come from larger (>500 subjects) controlled intervention 
studies. Confirmation needs to come from future infection studies in subjects with a wider 
range of diarrhea severity. It is clinically important to find means to reduce diarrhea severity 
in addition to reduction of diarrhea incidence in the community because diarrhea severity 
might affect prolongation or chronic diarrhea and other functional disorders (eg. immune 
status, gut integrity, malabsorption, severe malnutrition) leading to diarrhea-related 
mortality and malnutrition. Identification of etiologic pathogens (rotavirus and other 
common bacteria) may also be useful to be included in planning further study.  
Growth, iron and zinc status effect 
Following the above mentioned outcomes, it is always useful to include growth and 
micronutrient status assessment in future studies in developing countries. Attention has to 
be made on longer study duration (6-24 months). Meta-analysis or systematic reviews of 
probiotic effects (versus other nutritional interventions) needs to be specifically carried out 
to evaluate what the best interventions are to reduce chronic stunting and underweight in 
children in developing countries.  
6.4.2. Mechanistic study 
Diarrhea severity, immuno-modulatory and intestinal barrier status markers 
Further studies are needed to investigate the effect of probiotics on diarrhea severity 
markers and other functional outcomes, such as immune and gut integrity parameters. 
Besides three fecal markers presented in our study, it is scientifically crucial to further 
identify markers for outcomes of diarrhea reduction in a community settings. The usefulness 
of other rapid stool tests such as fecal occult blood, fecal lactoferrin, fecal leukocytes for the 
evaluation of diarrhea severity in community setting requires attention. This will prevent 
physicians to rely on expensive fecal cultures to determine severity and etiology of diarrhea, 
but to make use of objective and inexpensive markers. Besides feces and blood that was 
collected in our study, future research should also explore the use of other non-invasively 
obtainable biological samples such as urine and saliva. For fecal calprotectin it needs to be 
explored whether this marker truly aids in assessment of diarrhea severity or pathogen 
identification or only reflects intestinal immune response.81 The underlying mechanism of 
the protective effect of L reuteri was unclear. The potential of this strain to enhance the 
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production of a balanced T-helper-cell response, stimulate production of interleukin (IL)-10, 
transforming growth factor (TGF)-β and stimulate the synthesis and secretion 
of immunoglobulin A (sIgA)  are scientifically interesting to explore.222 
In our study, we included measurement of serum antibodies to the conserved core of 
endotoxin (EndoCab) as a newly proposed marker of intestinal barrier function. Circulating 
immunoglobulin levels can go up following translocation of gut-derived endotoxins. Further 
validation of this marker and the assay, and exploration of other methods for assessment of 
intestinal barrier integrity status and function loss, are needed to obtain more advanced 
insight on the role of probiotics on the gut wall integrity.  
Motivation: To improve understanding on main mechanism of probiotic actions in the small 
and large intestine (bacterial-epithelial “cross talk”) in the prevention of infectious diarrhea. 
Disturbed intestinal barrier integrity and function is linked to a range of diseases.223 The role 
of probiotics or calcium in the improvement of the gut barrier integrity and function may 
therefore be imperative for clinical practice and important to explore. It will result in better 
understanding of disease etiology and pathophysiology. 
Molecular mechanism 
As mentioned above, Indonesia is one of the mega biodiversity countries that are rich in 
genetic resources. It is crucial to identify specific microbial genes and their interaction that 
mediate the probiotic beneficial functions in this country.155 The International human 
microbiome consortium studies and human microbiome project published a catalogs 
reference on human genomes, but these genomes are mostly from human microbiome of 
subjects in developed countries.155, 224 We are not sure about country-specific microbial genes 
or microbiota or probiotics, but diarrhea, for instance, disturbs commensal microbiota, and 
the pathogens responsible to this are geographical dependent. Microbioma profile may 
depend on several factors such as environmental condition (hygiene-hypothesis), lifestyle, 
food intake, cultures and ethnicity,225-227 which are nearly country specific. Looking at the 
biodiversity in Indonesia, it is worth to put this potential field into the future research 
agenda and a wide range of studies can be done in this field. It is also important to identify 
whether there is a great difference of microbial composition in children with different 
nutritional status and from different ethnicities in Indonesia. This study will help to have 
separate unique data of microbiome that could be different from developed countries. 
Further, isolation of new probiotics can be done by selecting the most potential microbes 
from these various ethnicities. Studies on the link between gut microbiota and health are 
very popular nowadays. This may have gone way too far and draws attention away from 
more obvious and direct nutritional intervention strategies to achieve health. However, we 
may consider an innovative research on a potential role of gut microbiota to the most 
emerging disease in the country.  
6.4.3. Innovative technology and efficacy study for indigenous probiotic strain 
development   
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It is necessary for the government of Indonesia and other developing  countries  to  seriously 
put their investment on innovative technology studies and to establish efficacy of existing or 
new indigenous probiotic strains through public-private cooperation. This investment 
should be planned on a long term basis. Microbial culture collection should be initiated at 
national as well as regional level. The majority of probiotic strains are currently owned by 
profit companies in Western countries who have the right to control who has access to their 
strains and what studies can be performed using their products.228 The accumulating 
scientific evidence on benefits to reduce diarrhea in developing countries (such as in our 
study) will have two sides of a coin. On the one hand, it gives a bright future support for the 
prevention of diarrhea in children. But on the other hand, it will raise a problematic 
challenge because these strains are not available in the developing world. It might cause 
dependence on the Western profit companies.  The role of probiotics in public health 
(specifically diarrhea) will stimulate the benefit for business partners.  It can also cause a 
publication bias, because most data are derived from Western countries, and researchers 
from the developing world might not have much freedom to publish their findings or having 
the possibility of patent ownership when using overseas strains.228 FAO/WHO has to take a 
role in providing more guidelines to enhance the development of local probiotic strains for 
non-profit usage when probiotics will be applied in large scale programs, although the 
private ownership of probiotic strain may not be prevented. 
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Acute diarrhea and acute respiratory tract infections (ARTIs) continue to lead the infectious 
cause of morbidity and mortality among children <5 years of age in developing countries, 
including Indonesia. The burden of this problem calls for effective public health intervention 
to support the existing preventive strategies (including provision of safe water and 
sanitation, exclusive breastfeeding, hand washing, vitamin A and zinc supplementation, and 
vaccinations) that are available, but not always effective to reduce the burden of these 
diseases. Efforts to prevent diarrheal disease by probiotics and milk calcium 
supplementation as alternative strategy are promising. Probiotics are often supplemented to 
dairy foods and both probiotics and calcium in milk may strengthen intestinal infection 
resistance.  
Several meta-analyses, systematic reviews and trials on probiotics and diarrhea were 
published. These studies concluded that probiotics may prevent or reduce duration of 
diarrhea in children. However, the reported beneficial effects are probiotic strain and dose 
dependent and evidence was obtained mainly in hospital-based settings in developed 
countries aiming at treatment of diarrhea. Studies on the prevention of diarrhea in 
apparently healthy children living in the community were mainly in day-care center based 
studies in Western countries. Currently, only three randomized trials have focused on the 
role of probiotics in the prevention of acute diarrhea in a community setting in developing 
countries. Moreover, several randomized trials have explored benefits of probiotics in the 
prevention of ARTIs in children, but have yielded contradictory conclusions. Calcium has 
previously shown to reduce infection-induced diarrhea in adults, but the efficacy in children 
with a low habitual calcium intake and frequent episodes of intestinal infections is currently 
unknown. So far, recommendations to supplement with calcium or probiotics in community 
settings in developing countries are not justified.  
Currently, it is unclear, whether probiotics and calcium supplementation do affect incidence 
and duration of diarrhea and ARTIs, severity of diarrhea as well as growth, iron and zinc 
status in Indonesian children. For this purpose, we conducted an intervention study and 
answers to this question will provide recommendations for nutritional intervention 
strategies to prevent diarrhea and ARTIs. Moreover, it may show medical professionals, 
public health and food policy makers how to improve growth, iron and zinc status.  Although 
the determinants of diarrhea in children are well described, information on whether poor 
food-hygiene practices are associated with diarrhea in children in low socioeconomic urban 
areas of East Jakarta is generally lacking. The answer to this question will provide important 
information to design intervention studies, health plans and policies related to mother and 
child hygienic behavior, which was described in our cross sectional study.  
In chapter 2, we investigated the efficacy of milk calcium with or without two probiotic 
strains, Lactobacillus casei CRL 431 and Lactobacillus reuteri DSM 17938 tested 
independently, on incidence and duration of acute diarrhea and acute respiratory tract 
infections in a 6-month, double-blind, placebo-controlled trial. A total of 494 healthy 
Indonesian children aged 1 to 6 years from a low socioeconomic urban area of East Jakarta 
randomly received low-lactose milk with low calcium content (LC; ∼50 mg/day; n = 124),
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regular calcium content (RC; ∼440 mg/day; n = 126), RC with 5.108 colony-forming units 
per day of L. casei CRL 431 (casei; n = 120), or RC with 5.108 colony-forming units per day of
L. reuteri DSM 17938 (reuteri; n = 124). Number and duration of diarrhea and ARTIs 
episodes were primary and secondary outcomes, respectively. Our study showed an excellent 
compliance rate (94%), which was similar among the four groups. The incidence of World 
Health Organization-defined diarrhea (≥3 loose/liquid stools in 24 hours) was not 
significantly different between RC and LC (relative risk 0.99; 95% confidence interval [CI]: 
0.62-1.58), between casei and RC (relative risk 1.21; 95% CI: 0.76-1.92), or between reuteri 
and RC (relative risk 0.76; 95% CI: 0.46-1.25) groups. Incidence of all reported diarrhea (≥2 
loose/liquid stools in 24 hours) was significantly lower in the reuteri versus RC group 
(relative risk 0.68; 95% CI: 0.46-0.99). Irrespective of the definition used, reuteri 
significantly reduced diarrhea incidence in children with lower nutritional status (below-
median height-and-weight-for-age z score). None of the interventions affected ARTIs.  
To investigate further the efficacy of milk calcium with or without two probiotic strains, in 
chapter 3, we investigated their effects on cumulative (total) duration and severity of acute 
diarrheal disease due to rotavirus or other causes. Diarrhea duration and severity were 
observed during each episode.  The cumulative (total) duration of diarrhea was assessed by 
summing up of all diarrheal days of all episodes per child per 6-month of intervention 
period. Severity of diarrhea was assessed by using a modified Vesikari score based on the 
mothers’ subjective information and by using objective measurement of the markers 
osmolarity, mucin and calprotection in diarrheal and normal fecal samples collected during 
the intervention.  A total of 131 children experienced 190 diarrheal episodes. Probiotic 
strains and calcium did not significantly affect the number of diarrheal episodes, but mean 
total duration was 1.35 days shorter in the reuteri group (relative risk 0.60; 95% CI: 0.36-
0.99) and tended to be 0.93 days shorter in the casei group (relative risk 0.64; 95% CI: 0.39-
1.03). Rotavirus prevalence in diarrheal cases was 30% and not significantly different 
between treatment groups.  Rotavirus-positive episodes (36 of 120 analyzed samples) were 
shortened by L. reuteri (P = .04) and calcium (P = .009), whereas, L. casei shortened 
duration of rotavirus-negative episodes (P = .04). None of the supplements affected diarrhea  
severity based on Vesikari score and the fecal markers, except  for a higher fecal mucin 
concentration in the casei group (P = .006). 
In chapter 4, we investigated whether milk supplemented with probiotics would improve 
growth, and iron and zinc status of Indonesian children, whereas milk calcium alone would 
improve growth, but reduce iron and zinc status. Dietary intake, growth, anemia, iron and 
zinc status were assessed before and after the intervention. The increase in weight gain, 
weight-for-age z score (WAZ) changes and monthly weight and height velocities were 
significantly higher in the reuteri compared with RC group [0.22 (95% CI: 0.02-0.42) kg, 
0.09 (95% CI: 0.01-0.17) Z, 0.03 (95% CI: 0.002-0.05) kg and 0.03 (95% CI: 0.01-0.05) cm, 
respectively]. Casei significantly increased average monthly weight velocity [0.03 (95% CI: 
0.001-0.05) kg], but not height. However, the changes in underweight and stunting 
prevalence, anemia prevalence and iron and zinc status were similar among groups.  
Summary 
146 
 
In chapter 5, we reported on the prevalence of diarrhea and malnutrition in Indonesian 
children and assessed the association of food-hygiene practice with the occurrence of 
diarrheal disease. We conducted a cross-sectional study among 274 randomly selected 
children aged 12-59 months in selected low socioeconomic urban areas in Jatinegara sub-
district of East Jakarta. The prevalence of diarrhea was assessed by using a 7-day record of 
frequency and consistency of the child’s defecation pattern. Food-hygiene practices including 
mother’s and child’s hand washing, food preparation, cleanliness of utensils, water source 
and safe drinking water, habits of buying cooked food, child’s bottle feeding hygiene, and 
housing and environmental condition were obtained through home visit interview and 
observation by field workers. Thirty six practices were scored and classified into poor 
(median and below) and better (above median) food-hygiene practices. Nutritional status of 
children, defined anthropometrically, was measured through height and weight. Factors 
found to be significantly associated with diarrhea were age, nutritional and immunization 
status, family size and number of under-five children living under the same roof.  Among the 
individual food-hygiene practices, children  living in  a house with clean sewage had a 
significantly lower diarrhea prevalence compared to those who did not have one or had dirty 
sewage (adjusted odds ratio 0.16; 95% CI: 0.03-0.73). The overall food-hygiene practice 
score was not significantly associated with diarrhea in the total group, but it was in children 
aged < 2 years (adjusted odds ratio 4.55; 95% CI: 1.08-19.1). 
Finally, the main findings and clinical effects of the interventions, methodological issues, 
interpretation and perspective of the study findings are discussed in chapter 6.  The public 
health implications and recommendations, and directions for future research are also 
presented. 
To our knowledge, this Indonesian study is the first large randomized controlled trial, 
focusing on the effect of calcium with or without one of two specific probiotics on incidence 
and duration of diarrhea and respiratory tract infections, diarrhea severity, growth, and iron 
and zinc status in these settings. In conclusion, we observed a consistent benefit of the 
probiotic strain L. reuteri DSM 17938 for several outcomes. L. reuteri may prevent diarrhea 
especially in children with lower nutritional status and reduce total duration of diarrheal 
episodes. This probiotic modestly improved growth, by increasing weight gain and WAZ 
changes over 6 months and monthly weight and height velocity in Indonesian children. 
However, L. reuteri did not affect diarrhea severity. The other probiotic strain, L. casei CRL 
431 modestly improved monthly weight velocity, but this strain did not reduce diarrhea 
incidence and duration or severity of episodes. In contrast to these findings, milk calcium 
alone did not affect any of the outcomes. Also, none of the dietary treatments affected 
incidence and duration of ARTIs and iron and zinc status in Indonesian children. However, 
it seems too early to recommend probiotics (e.g. L. reuteri) for routine use or for follow-up in 
public health programs to prevent diarrhea in children in developing countries. Further 
investigations are needed to confirm whether our intervention results using probiotics and 
calcium can be confirmed and replicated by studies in similar settings in developing 
countries. Several important factors should be taken into consideration in conducting 
studies in a community such as ways to maintain compliance, cultural, ethical issues in 
recruiting subjects, and cooperation with local university, government, leaders and health 
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care facilities. Our cross sectional study showed that in addition to other major 
determinants, poor mother’s food-hygiene practices contributed to the occurrence of 
diarrhea in Indonesian children <2 years from low socioeconomic urban areas of East 
Jakarta, Indonesia. 
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Acute diarree en acute luchtweginfecties zijn nog steeds de grootste infectieuze veroorzakers 
van morbiditeit en mortaliteit bij kinderen <5 jaar in ontwikkelingslanden, zoals Indonesië. 
De ziektelast van deze infecties vraagt om een effectieve volksgezondheidsinterventie om de 
bestaande preventieve strategieën (waaronder de voorziening van veilig water en sanitair, 
het exclusief geven van borstvoeding, handen wassen, suppletie met vitamine A en zink en 
vaccinaties) te ondersteunen, aangezien deze wel beschikbaar zijn, maar niet altijd effectief 
zijn om de ziektelast te verminderen. Suppletie met probiotica en calcium in melk zijn 
veelbelovend als alternatieve strategie ter preventie van diarree. Probiotica worden vaak 
toegevoegd aan zuivelproducten en zowel probiotica als calcium in melk zouden de 
resistentie van de darmen tegen infecties kunnen verhogen. 
Er zijn verscheidene meta-analyses, systematische reviews en interventiestudies over de 
relatie tussen probiotica en diarree gepubliceerd. Deze studies concludeerden dat diarree bij 
kinderen zou kunnen worden voorkomen of de duur ervan zou kunnen worden verkort door 
probiotica. De gerapporteerde gunstige effecten zijn echter afhankelijk van de stam en dosis 
probiotica en de bewijslast is veelal verkregen uit onderzoeken in ziekenhuizen in 
ontwikkelde landen waarbij het doel van het onderzoek de behandeling van diarree was. 
Onderzoeken naar de preventie van diarree in ogenschijnlijk gezonde kinderen in de open 
populatie zijn met name uitgevoerd bij kinderdagverblijven in Westerse landen. Op dit 
moment zijn er slechts drie gerandomiseerde interventiestudies die de rol van probiotica ter 
preventie van acute diarree in ontwikkelingslanden hebben onderzocht. Daarnaast hebben 
verscheidene gerandomiseerde interventiestudies de gunstige effecten van probiotica ter 
preventie van luchtweginfecties bij kinderen onderzocht, maar deze lieten tegenstrijdige 
resultaten zien. In het verleden is aangetoond dat calcium door infectie geïnduceerde diarree 
in volwassenen kan verminderen, maar het effect bij kinderen met een lage calcium inname 
en frequente episodes van darminfecties is op dit moment niet bekend. Tot op heden zijn 
aanbevelingen om te suppleren met calcium of probiotica in ontwikkelingslanden dan ook 
niet gerechtvaardigd. 
Op dit moment is het onduidelijk of suppletie met probiotica en calcium de incidentie en 
duur van diarree en luchtweginfecties, de ernst van diarree alsmede groei, ijzer- en 
zinkstatus van Indonesische kinderen gunstig zou kunnen beïnvloedt. Daarom hebben wij 
een interventiestudie uitgevoerd, waarvan de resultaten kunnen leiden tot aanbevelingen 
voor voedingsinterventie strategieën ter preventie van diarree en luchtweginfecties. 
Daarnaast kunnen de resultaten medische professionals, beleidsmakers van volksgezondheid 
en voedingsbeleid inzicht geven in hoe groei, ijzer- en zinkstatus verbeterd zouden kunnen 
worden. Hoewel de determinanten van diarree bij kinderen bekend zijn, ontbreekt over het 
algemeen informatie over hoe een slechte voedselhygiëne gerelateerd is aan diarree bij 
kinderen in stedelijke gebieden van Oost Jakarta met een lage sociaal economische status. 
Het antwoord op deze vraag zal belangrijke informatie geven om interventiestudies, 
gezondheidsplannen en beleid gerelateerd aan het hygiëne gedrag van moeder en kind, zoals 
beschreven in onze cross-sectionele studie,  op te zetten. 
In hoofdstuk 2, zijn de effecten van calcium in melk met of zonder twee verschillende 
stammen probiotica, Lactobacillus casei CRL 431 en Lactobacillus reuteri DSM 17938, op 
incidentie en duur van acute diarree en acute luchtweginfecties, onafhankelijk van elkaar 
onderzocht in een  dubbelblinde, placebo gecontroleerde interventiestudie gedurende 6 
maanden. In totaal kregen 494 gezonde Indonesische kinderen in de leeftijd van 1 tot 6 jaar
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wonende in een stedelijk gebied van Oost Jakarta met een lage sociaal economische status, 
op basis van loting melk met een laag lactose gehalte met een laag calcium gehalte (LC; ∼50 
mg/dag; n = 124), regulier calcium gehalte (RC; ∼440 mg/dag; n = 126), RC met 5.108 
kolonievormende eenheden per dag van L. casei CRL 431 (casei; n = 120), of RC met 5.108 
kolonievormende eenheden per dag van L. reuteri DSM 17938 (reuteri; n = 124). Frequentie 
en duur van diarree en luchtweginfecties waren respectievelijk de primaire en secondaire 
uitkomstmaten. Onze interventiestudie liet een excellente therapietrouw zien (94%), die 
vergelijkbaar was tussen de vier groepen. De incidentie van diarree, zoals gedefinieerd door 
de Wereld Gezondheidsorganisatie, (≥3 losse/vloeibare defecaties binnen 24 uur) was niet 
significant verschillend tussen RC en LC (relatief risico 0.99; 95% betrouwbaarheidsinterval 
[CI]: 0.62-1.58), tussen casei en RC (relatief risico 1.21; 95% CI: 0.76-1.92), of tussen reuteri 
en RC (relatief risico 0.76; 95% CI: 0.46-1.25). Incidentie van alle gerapporteerde diarree (≥2 
losse/vloeibare defecaties binnen 24 uur) was significant lager in de reuteri vergeleken met 
de RC groep (relatief risico 0.68; 95% CI: 0.46-0.99). Reuteri reduceerde significant de 
incidentie van diarree bij kinderen  met een relatief lage voedingsstatus (onder de mediane 
lengte-en-gewicht-voor-leeftijd z score), ongeacht de gebruikte definitie. Geen van de 
interventies had effect op luchtweginfecties.  
In hoofdstuk 3 hebben we het effect van calcium in melk met of zonder twee verschillende 
stammen probiotica op cumulatieve (totale) duur en ernst van acute diarree veroorzaakt 
door rotavirus of andere oorzaken verder onderzocht. De duur en ernst van de diarree zijn 
iedere episode vastgesteld. De cumulatieve (totale) duur van diarree is bepaald door alle 
dagen met diarree van alle episodes per kind per zes maanden interventie periode bij elkaar 
op te tellen. Ernst van diarree is bepaald door middel van een gemodificeerde Vesikari score, 
gebaseerd op de subjectieve informatie van de moeders en door middel van een objectieve 
meting van de markers osmolariteit, mucine en calprotection in monsters van diarree en van 
normale feces die verzameld zijn gedurende de interventie. In totaal 131 kinderen hadden 
190 episodes van diarree. Probiotica en calcium hadden geen significant effect op het aantal 
episodes diarree, maar de gemiddelde totale duur was 1,35 dagen korter in de reuteri groep 
(relatief risico 0.60; 95% CI: 0.36-0.99) en neigde tot 0.93 dagen korter in de casei groep 
(relatief risico 0.64; 95% CI: 0.39-1.03). De prevalentie van rotavirus in de gevallen van 
diarree was 30% en niet significant verschillend tussen de interventie groepen.  Rotavirus-
positieve episodes (36 van de 120 geanalyseerde monsters) waren korter door L. reuteri (P 
= .04) en calcium (P = .009), terwijl, L. casei de duur van rotavirus-negatieve episodes 
verkortte (P = .04). Geen van de supplementen had effect op de ernst van diarree gebaseerd 
op de Vesikari score en de fecale markers, behalve  voor een hogere fecale mucine 
concentratie in de casei groep (P = .006). 
In hoofstuk 4, hebben we onderzocht of melk gesuppleerd met probiotica de groei en ijzer- 
en zinkstatus van Indonesische kinderen zou verbeteren, terwijl alleen calcium in melk de 
groei zou verbeteren, maar ijzer- en zinkstatus zou verlagen. Voedingsinname, groei, anemie, 
ijzer- en zinkstatus zijn zowel voor als na afloop van de interventie bepaald. Toename in 
gewicht, veranderingen in gewicht-voor-leeftijd (WAZ) score en de maandelijkse 
groeisnelheid voor gewicht en lengte waren significant hoger in de reuteri groep vergeleken 
met de RC groep [0.22 (95% CI: 0.02-0.42) kg, 0.09 (95% CI: 0.01-0.17) Z, 0.03 (95% CI: 
0.002-0.05) kg en 0.03 (95% CI: 0.01-0.05) cm, respectievelijk]. Casei verhoogde de 
gemiddelde snelheid van maandelijkse gewichtstoename significant [0.03 (95% CI: 0.001-
0.05) kg], maar niet die van lengte. De veranderingen in de prevalentie van ondergewicht en 
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achterstand in lengtegroei, de prevalentie van anemie en ijzer- en zinkstatus waren echter 
gelijk tussen de groepen.  
In hoofstuk 5 wordt gerapporteerd over de prevalentie van diarree en ondervoeding in 
Indonesische kinderen en over de associatie tussen voedselhygiëne gewoontes en het 
ontstaan van diarree. We hebben een cross-sectioneel onderzoek verricht bij 274 random 
geselecteerde kinderen tussen de 12 en 59 maanden oud wonend in geselecteerde stedelijke 
gebieden met een lage sociaal economische status in het Jatinegara district in Oost Jakarta. 
De prevalentie van diarree is gemeten middels een 7-daagse vragenlijst naar de frequentie en 
consistentie van het defecatie patroon van de kinderen. Informatie over de gewoontes met 
betrekking tot voedselhygiëne, zoals handen wassen door moeder en kind, de bereiding van 
het eten, de properheid van kookgerei, waterbron en veilig drinkwater, gewoontes met 
betrekking tot het kopen van gekookt eten, hygiëne bij het flesvoeden van kinderen en woon- 
en omgevingscondities is verkregen door interviews en observatie tijdens huisbezoeken door 
veldwerkers. Zesendertig gewoontes zijn gescoord en geclassificeerd naar lage (gemiddeld en 
lager dan gemiddeld) en betere (boven gemiddeld) voedselhygiëne. De voedingsstatus van 
kinderen, antropometrisch gedefinieerd, is bepaald door het meten van lengte en gewicht. 
Factoren die significant gerelateerd waren aan diarree waren leeftijd, voedings- en 
immunisatiestatus, gezinsgrootte en aantal kinderen onder de vijf jaar die onder hetzelfde 
dak woonden. Kinderen die woonden in een huis met een schone riolering hadden een 
significante lagere diarree prevalentie vergeleken met kinderen die geen of een bevuilde 
riolering hadden (gecorrigeerde odds ratio 0.16; 95% CI: 0.03-0.73). De totale 
voedselhygiëne score was niet significant gerelateerd met diarree in de totale groep, maar 
wel in kinderen onder de 2 jaar oud (gecorrigeerde odds ratio 4.55; 95% CI: 1.08-19.1). 
Ten slotte worden de belangrijkste resultaten en klinische effecten van de interventies, 
methodologische aspecten, interpretatie en perspectief van de bevindingen bediscussieerd in 
hoofdstuk 6. De implicaties en aanbevelingen voor de volksgezondheid en suggesties voor 
toekomstig onderzoek worden hier ook beschreven. 
Deze Indonesische studie is, voor zover bij ons bekend, de eerste grote gerandomiseerde, 
gecontroleerde interventiestudie naar het effect van calcium met of zonder één of twee 
specifieke stammen probiotica op de incidentie en duur van diarree en luchtweginfecties, de 
ernst van diarree, groei en ijzer- en zinkstatus in deze leefomstandigheden. Concluderend, 
vonden we een consistent gunstig effect van de probiotische stam L. reuteri DSM 17938 op 
verschillende uitkomstmaten. L. reuteri kan preventief werken tegen diarree, met name in 
kinderen met een lage voedingsstatus en kan de totale duur van episodes van diarree 
verkorten. Deze probiotica lieten ook een bescheiden verbetering zien in groei, door een 
stijgende gewichtstoename en gewichts-voor-lengte veranderingen over 6 maanden en 
snelheid van maandelijkse stijging in gewicht en lengte in Indonesische kinderen. L. reuteri 
had echter geen effect op de ernst van de diarree. De andere probiotische stam, L. casei CRL 
431 liet een kleine verbetering zien in snelheid van maandelijkse gewichtstoename, maar 
deze stam verminderde de incidentie,  duur of ernst van de diarree episodes niet. In 
tegenstelling tot deze bevindingen had calcium in melk op zichzelf op geen van de 
uitkomstmaten effect. Ook had geen van de interventies effect op de incidentie en duur van 
luchtweginfecties en ijzer- en zinkstatus bij Indonesische kinderen. Echter, het is te vroeg om 
probiotica  (zoals bijvoorbeeld L. reuteri) aan te bevelen voor dagelijks gebruik of om te 
gebruiken in volksgezondheidsprogramma’s om diarree te voorkomen bij kinderen in 
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ontwikkelingslanden. Meer onderzoek is nodig om te bevestigen of de resultaten van onze 
interventie met probiotica en calcium gerepliceerd kunnen worden in studies in vergelijkbare 
situaties in ontwikkelingslanden. Bij het uitvoeren van studies in de open gemeenschap 
moeten rekening worden gehouden met een aantal belangrijke factoren, zoals manieren om 
therapietrouw te behouden, culturele en ethische aspecten bij het werven van deelnemers en 
samenwerking met lokale universiteiten, regeringen, leiders en de faciliteiten voor de 
gezondheidszorg. Ons cross-sectionele onderzoek heeft aangetoond dat, naast andere 
belangrijke determinanten, een slechte voedselhygiëne van de moeder bijdroeg aan het 
ontstaan van diarree bij Indonesische kinderen onder de 2 jaar oud in stedelijke gebieden 
met een lage sociaal economische status in Oost Jakarta, Indonesië.  
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Diare akut dan infeksi saluran pernapasan akut (ISPA) senantiasa menjadi penyebab 
morbiditas dan kematian pada anak-anak <5 tahun di negara berkembang, termasuk 
Indonesia. Beban permasalahan kesehatan ini membutuhkan intervensi kesehatan 
masyarakat yang efektif untuk mendukung strategi pencegahan yang telah ada sebelumnya 
(termasuk penyediaan air bersih dan sanitasi, pemberian ASI eksklusif, mencuci tangan, 
suplementasi vitamin A dan zink, serta vaksinasi) tetapi belum efektif untuk mengurangi 
beban penyakit ini. Upaya untuk mencegah penyakit diare dengan probiotik dan susu 
berkalsium sebagai strategi alternatif cukup menjanjikan. Probiotik sering ditambahkan 
dalam susu dan baik probiotik maupun kalsium yang terkandung dalam susu dapat 
memperkuat ketahanan usus terhadap infeksi. 
Beberapa meta-analisis, penelaahan secara sistematik dan penelitian probiotik dan diare 
telah dipublikasikan. Studi ini menyimpulkan bahwa probiotik dapat mencegah atau 
mengurangi durasi diare pada anak. Namun, efek positif penggunaan probiotik sangat 
tergantung pada jenis dan dosis strain probiotiknya, dan studi probiotik tersebut pada 
umumnya dilakukan di negara maju dalam rangka pengobatan diare di rumah sakit. Studi 
probiotik yang memfokuskan pada pencegahan diare pada anak-anak sehat yang hidup di 
masyarakat umumnya dilakukan di pusat penitipan anak yang dilakukan di negara-negara 
Barat. Hingga saat ini, hanya ada tiga penelitian di komunitas yang berfokus pada peran 
probiotik dalam pencegahan diare akut di negara-negara berkembang. Lebih jauh, beberapa 
studi telah melakukan penelitian mengenai manfaat probiotik dalam pencegahan ISPA pada 
anak, namun masih menghasilkan kesimpulan yang bertentangan. Kalsium, sebelumnya 
telah terbukti mengurangi infeksi yang menyebabkan diare pada orang dewasa, tetapi 
manfaatnya pada anak-anak yang memiliki asupan kalsium yang rendah dan episode 
penyakit infeksi usus berulang sampai saat ini belum dapat diketahui. Sejauh ini, 
rekomendasi untuk memberikan suplementasi kalsium atau probiotik pada anak dalam 
masyarakat di negara berkembang belum teruji. 
Saat ini, belum jelas, apakah pemberian asupan probiotik dan kalsium berdampak positif 
terhadap kejadian dan durasi penyakit diare serta ISPA, tingkat keparahan, tingkat 
pertumbuhan, status zat besi dan zink pada anak-anak Indonesia. Untuk tujuan inilah, kami 
melakukan studi intervensi. Sebagai jawaban dari pertanyaan diatas, studi ini akan 
memberikan rekomendasi untuk strategi intervensi gizi dalam pencegahan diare dan 
ISPA. Selain itu, studi ini dapat memperlihatkan kepada para profesional bidang medis, 
kesehatan masyarakat dan pembuat kebijakan pangan mengenai bagaimana meningkatkan 
pertumbuhan serta status zat besi dan zink. Meskipun faktor-faktor penyebab diare pada 
anak telah diketahui dengan jelas, pengetahuan mengenai hubungan praktik perilaku 
higienis pada penanganan makanan dengan tingginya prevalensi diare pada anak-anak di 
daerah perkotaan dengan tingkat sosial ekonomi rendah di Jakarta Timur, umumnya masih 
kurang. Jawaban atas pertanyaan ini akan memberikan informasi penting untuk merancang 
studi intervensi, perencanaan kesehatan dan kebijakan yang berkaitan dengan perilaku 
higienis ibu dan anak, yang merupakan bagian dalam penelitian potong lintang (cross 
sectional) kami. 
Dalam bab 2, kami meneliti manfaat susu berkalsium dengan atau tanpa dua jenis 
probiotik, Lactobacillus casei 431 dan Lactobacillus reuteri DSM 17938 yang diuji secara 
  Ringkasan   
 
157 
 
terpisah, terhadap kejadian dan durasi diare akut serta ISPA dalam penelitian double-blind, 
placebo-controlled trial selama 6 bulan.  Sebanyak 494 anak Indonesia sehat berusia 1-6 
tahun berasal dari daerah perkotaan dengan tingkat sosial ekonomi yang rendah di Jakarta 
Timur secara acak menerima susu rendah laktosa dengan kandungan kalsium rendah (LC; ~ 
50 mg/hari, n = 124), kandungan kalsium biasa (RC; ~440 mg / hari, n = 126), RC dengan 
5.108 colony-forming unit per hari L. casei CRL 431 (casei, n = 120), atau RC dengan 5.108 
colony-forming unit per hari L. reuteri DSM 17938 (reuteri, n = 124). Jumlah episode dan 
durasi diare merupakan hasil akhir utama, sedangkan insiden dan durasi ISPA adalah hasil 
akhir sekunder. Studi kami menunjukkan tingkat kepatuhan yang sangat baik (94%), yang 
tidak berbeda di antara empat kelompok. Kejadian diare berdasar definisi World Health 
Organization (≥ 3 tinja lembek/cair dalam 24 jam) tidak berbeda secara signifikan antara 
kelompok RC dan LC (relative risk 0,99; 95% confidence interval (CI): 0,62-1,58), antara 
kelompok casei dan RC (relative risk 1,21; 95% CI: 0,76-1,92), atau antara kelompok reuteri 
dan RC (relative risk 0,76; 95% CI: 0,46-1,25). Kejadian semua diare (≥2 tinja lembek/cair 
tinja dalam 24 jam) secara signifikan lebih rendah pada kelompok reuteri dibandingkan RC 
(relative risk 0,68; 95% CI: 0,46-0,99). Terlepas dari definisi yang digunakan, reuteri secara 
signifikan mengurangi kejadian diare pada anak dengan status gizi rendah [di bawah 
median-z score tinggi badan terhadap umur (TB/U) dan berat badan terhadap umur 
(BB/U)]. Tak satu pun dari intervensi mempengaruhi ISPA. 
Untuk meneliti lebih lanjut manfaat kalsium susu dengan atau tanpa dua jenis probiotik, 
dalam bab 3, kami meneliti pengaruhnya terhadap kumulatif (total) durasi dan tingkat 
keparahan penyakit diare akut dikarenakan rotavirus atau penyebab lainnya. Durasi dan 
tingkat keparahan diare diobservasi setiap episode.  Kumulatif (total) durasi diare dinilai 
dengan menjumlahkan semua hari diare dari semua episode per anak dalam 6 bulan periode 
intervensi. Tingkat keparahan diare dinilai dengan menggunakan modifikasi skor Vesikari 
berdasarkan informasi subyektif ibu dan dengan menggunakan pengukuran objektif berupa 
uji osmolaritas, calprotection dan mucin dalam sampel tinja yang dikumpulkan selama 
intervensi. Sebanyak 131 anak mengalami 190 episode. Strain probiotik dan kalsium tidak 
terlalu berpengaruh pada jumlah episode diare, tetapi rerata durasi diare menjadi 1,35 hari 
lebih pendek pada kelompok reuteri (relative risk 0,60; 95% CI: 0,36-0,99) dan cenderung 
0,93 hari lebih pendek pada kelompok casei (relative risk 0,64; 95% CI: 0,39-
1,03).  Prevalensi rotavirus pada kasus diare adalah 30% dan tidak berbeda secara signifikan 
antara semua kelompok penelitian. Durasi episode rotavirus positif (36 dari 120 sampel yang 
dianalisa) menjadi lebih singkat dengan pemberian L. reuteri (P = 0,04) dan kalsium saja (P 
= 0,009), sedangkan, durasi episode rotavirus-negatif menjadi lebih pendek dengan 
pemberian L. casei (P = 0,04). Tak satu pun dari keempat intervensi tersebut berpengaruh 
pada tingkat keparahan diare berdasarkan skor Vesikari dan fecal markers, kecuali adanya 
konsentrasi yang lebih tinggi pada pemeriksaan mucin tinja pada kelompok L. casei (P = 
0,006). 
Dalam bab 4, kami meneliti apakah susu yang dilengkapi dengan probiotik akan 
meningkatkan pertumbuhan dan status zat besi dan zink pada anak-anak Indonesia, 
sedangkan susu berkalsium saja (tanpa probiotik) akan meningkatkan pertumbuhan tetapi 
mengurangi status zat besi dan zink. Asupan makanan, pertumbuhan, anemia, status zat 
besi dan zink dinilai sebelum dan sesudah intervensi. Peningkatan berat badan, perubahan 
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BB/U, velocity berat badan dan tinggi badan bulanan secara signifikan lebih tinggi pada 
kelompok reuteri dibandingkan pada kelompok RC [0,22 (95% CI: 0,02, 0,42) kg, 0,09 
(95% CI: 0,01, 0,17) Z, 0,03 (95% CI: 0,002, 0,05) kg dan 0,03 (95% CI: 0,01, 0,05) cm, 
secara berurutan]. Casei secara signifikan meningkatkan rerata velocity berat badan  
bulanan [0,03 (95% CI: 0,001, 0,05) kg], tetapi tidak tinggi badan. Perubahan prevalensi 
kurus dan pendek, prevalensi anemia dan status zat besi dan zink tidak berbeda di antara 
kelompok intervensi. 
Dalam bab 5, kami melaporkan prevalensi diare dan gizi kurang pada anak-anak Indonesia 
dan menilai hubungan antara praktik kebiasaan higienis pada penanganan makanan dengan 
terjadinya penyakit diare. Kami melakukan studi cross-sectional di antara 274 anak usia 12-
59 bulan yang dipilih secara acak dari daerah perkotaan dengan tingkat sosial ekonomi 
rendah terpilih di kecamatan Jatinegara, Jakarta Timur. Prevalensi diare dinilai dengan 
menggunakan catatan 7 hari frekuensi dan konsistensi pola buang air besar anak. Kebiasaan 
higienis makanan termasuk kebiasaan mencuci tangan anak, persiapan makanan, 
kebersihan peralatan makan, air dan sumber air minum yang aman, kebiasaan membeli 
makanan yang dimasak, kebersihan botol susu anak, dan kondisi rumah dan lingkungan 
dilakukan dengan wawancara dan observasi rumah oleh peneliti lapangan. Tiga puluh enam 
kebiasaan diberi skor dan dikelompokkan dalam rendah (rata-rata dan di bawah) dan lebih 
baik (di atas rata-rata). Status gizi anak, yang didefinisikan secara antropometrik, diukur 
melalui tinggi dan berat badan. Faktor-faktor yang secara signifikan terkait dengan diare 
adalah usia, status gizi dan imunisasi, jumlah anggota keluarga dan jumlah balita. Di antara 
kebiasaan higienis makanan secara perorangan, anak-anak yang tinggal di rumah dengan 
saluran pembuangan limbah yang bersih memiliki prevalensi diare jauh lebih rendah 
dibandingkan dengan mereka yang tidak memiliki atau memiliki saluran pembuangan 
limbah yang kotor (adjusted odds ratio 0,16; 95% CI: 0,03-0,73). Hubungan antara skor 
perilaku higienis pada penanganan makanan dan diare secara keseluruhan tidak signifikan, 
tapi berpengaruh pada anak usia <2 tahun (adjusted odds ratio 4,55; CI 95%: 1,08-19,1). 
Akhirnya, temuan utama dan dampak klinis dari intervensi, isu-isu metodologis, interpretasi 
dan perspektif temuan penelitian dibahas dalam bab 6. Implikasi kesehatan masyarakat 
dan rekomendasi, serta arah untuk penelitian di masa depan juga disampaikan pada bab ini. 
Sepanjang pengetahuan kami, studi terhadap anak Indonesia ini adalah studi pertama 
berbasis komunitas yang terbesar dengan fokus pada efek kalsium dengan atau tanpa salah 
satu dari dua probiotik pada kejadian dan durasi diare dan ISPA, tingkat keparahan diare, 
pertumbuhan, serta status zat besi dan zink.  Sebagai kesimpulan, kami mengamati manfaat 
yang konsisten dari jenis probiotik L. reuteri DSM 17938 untuk beberapa hasil akhir 
(outcomes). L. reuteri dapat mencegah diare terutama pada anak dengan status gizi rendah 
dan mengurangi total durasi dari semua episode diare. Probiotik ini dapat meningkatkan 
pertumbuhan dengan meningkatkan pertambahan berat badan dan perubahan BB/U serta 
velocity berat badan dan tinggi badan bulanan dalam 6 bulan intervensi. Namun, L. reuteri 
tidak berpengaruh terhadap tingkat keparahan diare. Jenis probiotik lainnya, L. casei CRL 
431 meningkatkan velocity berat badan bulanan, tetapi jenis probiotik ini tidak mengurangi 
kejadian, durasi, ataupun tingkat keparahan diare. Berbeda dengan temuan ini, susu 
berkalsium saja tidak berpengaruh apapun. Juga, tidak ada satupun dari intervensi tersebut 
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berpengaruh pada angka kejadian dan durasi ISPA serta status zat besi dan zink. Namun 
demikian, tampaknya masih sangat dini untuk merekomendasikan probiotik (misalnya. L. 
reuteri) untuk penggunaan secara rutin atau untuk tindak lanjut dalam program kesehatan 
masyarakat dalam pencegahan diare pada anak-anak di negara-negara berkembang. 
Penelitian lanjutan dari penelitian ini diperlukan untuk mengonfirmasi apakah hasil studi 
intervensi kami menggunakan probiotik dan kalsium dapat dikonfirmasikan dan direplikasi 
oleh studi-studi lain dengan desain yang sama di negara-negara berkembang. Beberapa 
faktor penting yang harus dipertimbangkan dalam studi yang dilakukan di masyarakat 
seperti studi ini adalah cara untuk menjaga kepatuhan, masalah etika dalam merekrut 
subyek penelitian, dan kerjasama dengan akademisi, pemerintah daerah, para pemimpin 
serta petugas kesehatan. Studi cross sectional kami menunjukkan bahwa selain faktor 
penentu utama lainnya, kebiasaan kebersihan makanan pada ibu berkontribusi pada 
terjadinya diare pada anak-anak Indonesia <2 tahun di daerah perkotaan dengan tingkat 
sosial ekonomi yang rendah di Jakarta Timur, Indonesia. 
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